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Abstract 
Human natural killer (NK) cells have been shown to respond to numerous pathogenic 
stimuli, producing IFN-y as well as cytolytic effector molecules such as perforin and 
granzymes. Previous work on NK cell responses to Plasmodium fa/ciparum-infected 
erythrocytes (Pf-RBC) has shown that these responses are dependent on contact 
with accessory cells, such as macrophages and myeloid-lineage dendritic cells 
(mDCs), as well as on soluble mediators such as IL-2, IL-12, IL-15, IL-18 and IFN-a. 
It has also been observed that these responses are heterogeneous between donors; 
part of this heterogeneity seems to be genetically encoded, depending for example 
on killer immunoglobulin-like receptor (KIR) genotype, but heterogeneity in accessory 
cell stimuli has also been observed. The work described in this thesis further dissects 
the NK cell response to Pf-RBC in malaria na·ive donors, with a focus on describing 
the role of T cells in NK cell responses to pathogens. My data demonstrate that while 
NK cells are dependent upon accessory cell signals, they are also highly dependent 
upon signals emanating from antigen-specific CD4+ T cells; T cell help for NK cell 
responses is MHC class II-dependent, IL-2-dependent and contact-independent. I 
have observed significant production of IL-2 from CD4+ T cells in the very early 
hours of co-incubation of peripheral blood mononuclear cells (PBMC) and Pf-RBC, 
preceding NK cell-derived IFN-y. 
Having documented T cell-dependent NK cell activation by Pf-RBC in malaria na"ive 
donors, I next explored whether similar T cell-dependent NK cell responses were 
observed in African children undergoing vaccination with the candidate pre-
erythrocytic malaria vaccine, RTS,S. I characterized expression of CD69 and 
production of IFN-y in NK cells and T cells and expression of CD25 in T cells. My 
data demonstrate that robust recall NK cell and T cell responses are mounted during 
in vitro re-stimulation with the RTS,S vaccine antigen, Hepatitis B surface antigen 
(HBs) peptides and while circumsporozoite (CS)-induced IFN-y responses were not 
as strong, expression of CD25 in T cells and CD69 in NK cells and in T cells were 
significantly higher in RTS,S vaccinated children than in rabies vaccinated controls. 
Nearly half of the IFN-y was derived from NK cells. I also measured secreted levels 
of IFN-y, IL-2 and IL-10 in culture supernatants. I observed high levels of IFN-y in 
culture supernatants of RTS,S vaccinated PBMC only in response to HBs peptides, 
however, there was strong vaccine antigen-specific IL-2 production to both HBs and 
CS peptides, which was significantly more robust in RTS,S vaccinees than in the 
rabies vaccinated controls. Finally, my data demonstrate that the IL-2 secretion in 
response to HBs and CS peptides was highly correlated with the early activation of 
NK cells (expression of CD69). 
Finally, to formally test the hypothesis that antigen-specific CD4+ T cells can 
enhance NK cell responses to pathogens, I carried out a study of the T cell and NK 
cell response to heat-killed rabies virus in individuals undergoing rabies vaccination. 
The results of this study demonstrate that vaccine antigen-specific CD4+ T cells 
induced by vaccination can recruit NK cells to secrete IFN-y, to degranulate, to 
release perforin and to proliferate. The post-vaccination NK cell response is detected 
within 6-12 hours after re-exposure to rabies virus and, somewhat unexpectedly, is 
sustained for at least 7 days, well after the T cell response is underway. Importantly, 
in the first 24 hrs after re-exposure to virus, NK cells represent more than 70% of the 
IFN-y secreting effector cells, indicating a potentially very important role for NK cells 
in the early phase of the post-vaccination effector response. 
Ever since the immune system was dichotomized into innate and adaptive arms, 
vaccine-induced immunity has been explained solely in terms of priming of effector 
and memory Band T lymphocytes. The potential for innate immune celis to 
contribute to enhanced cytotoxicity or cytokine production post-vaccination has been 
almost completely overlooked. My data suggest that IL-2 secreting CD4+ T celis and 
NK cell activation markers, such as IFN-y production, expression of CD69 and CD25, 
upregulation of the lysosome-associated membrane protein (LAMP)-1 and release of 
perforin, may prove to be more reliable indicators of vaccine efficacy than simply 
counting the numbers of IFN-y-secreting PBMCs and that these parameters need to 
be considered for inclusion of future protocols for evaluating vaccine immunogenicity 
and efficacy in clinical trials. 
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1. Introduction 
1.1 Innate and adaptive immune responses 
The innate immune system, comprising large populations of cells expressing non-
rearranging receptors for non-self molecules, is designed to provide rapid but generic 
responses to foreign organisms. Conversely, the adaptive immune system comprises 
very many small populations of cells expressing highly diverse, clonally rearranged 
receptors for foreign antigens; adaptive responses are thus slow (since clonal 
expansion is required to generate sufficiently large populations of effector and 
memory cells) but highly specific. Immune memory is an intrinsic feature of adaptive 
responses and underpins the concept of vaccination but has been assumed to be 
lacking in the innate response. 
Bi-directional interactions between the innate and adaptive immune systems are 
essential for effective immunity to infection as well as for successful vaccination. 
Innate effector cells amplify and direct the subsequent adaptive response, a function, 
which is deliberately imitated by vaccine adjuvants (Schijns 2000; Pashine, Valiante 
et al. 2005; Kanzler, Barrat et al. 2007). Conversely, a key mechanism by which 
antigen-specific T cells mediate anti-microbial immunity is by releasing cytokines 
(such as IFN-y) that activate innate cells to kill pathogens or pathogen-infected cells. 
The cells that are commonly described in orchestrating the innate immune response 
include monocytes (which differentiate into macrophages), dendritic cells (DCs), y8+ 
T cells, Natural Killer (NK) T cells and NK cells. Through contact-dependent as well 
as contact-independent (secretion of cytokines and chemokines) mechanisms, the 
innate immune response is largely responsible for directing/polarizing the 
downstream adaptive immune response, which is primarily credited to Band T 
Iym phocytes. 
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1.2 Innate immune response to infection 
While the innate immune response is viewed as having very little pathogen 
specificity, there are groups of pattern recognition receptors (PRRs), such as the toll-
like receptors (TLRs),that are triggered by receptor engagement of pathogen 
associated molecular patterns (PAMPs) during phagocytosis of infected or non-self 
cells. These receptor-ligand interactions occur both at the surface of, as well as 
inside, the phagocytes. These phagocytes - most notably monocytes/macrophages, 
neutrophils and DCs - produce a wide array of cytokines (IL-12, IL-15, IL-18, IFN-a/~, 
IL-10 and TGF-~) following exposure to and recognition of pathogens, and the 
spectrum of the cytokine array will vary greatly depending on the specific PRRs 
engaged and will in turn influence the nature of the developing T cells. This cytokine 
cascade manifests in the form of inflammation, triggering microbicidal activity and 
priming the downstream Band T cell responses. Infection-induced immunopathology 
is commonly due to the poor regulation of these inflammatory cytokines. 
1.3 NK cell responses 
NK cells are classified as large, granular lymphocytes that are derived from bone 
marrow. NK cells are innate immune effectors that, by cytokine production or 
cytotoxicity, help to contain an infection until an effective adaptive T and B cell 
response is mounted. NK cells become activated either in the absence of potent 
inhibitory signalling via their cell surface receptors for self-MHC molecules (the 
"missing-self' phenomenon; direct/classical activation) and/or in the presence of 
activating signals provided by virally infected cells or by myeloid accessory cells 
responding to microbial ligation of pattern recognition receptors (indirect activation) 
(Newman and Riley 2007). To date, no antigen-specific receptors have been 
identified on human NK cells, although the some activating receptors have been 
shown to directly recognize pathogen-derived ligands, e.g. haemagglutinins on 
influenza-infected cells (Mandelboim, Lieberman et al. 2001). 
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1.4 Classical or direct activation of NK cells 
NK cells were first defined by their spontaneous ability to kill transformed cells 
(Kiessling, Klein et al. 1975). In 1986, Karre demonstrated in vivo that NK cells were 
able to target and kill tumour cells that had down-regulated expression of MHC class 
I molecules (Karre, Ljunggren et al. 1986; Ljunggren and Karre 1990). Later in 1990, 
Ljunggren and Karre coined the term, "missing-self hypothesis" to describe the 
general phenomenon whereby cells that did not express markers of "self' would be 
killed by NK cells. More recently, it has become clear that the "classical" or "direct" 
pathways of activating NK cells are actually a balance between numerous activating 
and inhibitory receptors. A schematic representation of this balance of activating and 
inhibitory receptors is shown in Figure 1.1. 
Table 1 summarizes our current understanding of NK activating and inhibitory 
receptors, with their respective ligands. To date, there are 3 known families of 
inhibitory receptors: Killer Ig-like receptors (KIRs) in humans or the equivalent Ly49 
homodimers in mice, Immunoglobulin like transcripts (IL Ts) and CD94/NKG2 
heterodimers. All these families of inhibitory receptors recognize and bind to various 
regions of MHC class I molecules (classical HLA-A, -8, -C or HLA-E). Inhibition of NK 
cells is regulated via an immunoreceptor tyrosine-based inhibition motif (ITIM), which 
contains a conserved sequence of amino acids (S/INILxYxxINIL) located in the 
cytoplasmic tails of these proteins. Upon triggering via binding to its respective 
ligand, the ITIM becomes phosphorylated by Src kinase, providing a docking site for 
recruitment of the phosphotyrosine phosphatases SHP-1 and SHP-2, or the inositol-
phosphatase called SHIP. Once bound to ITIMs, these phosphatases then transduce 
signals to couple into distinct Signaling pathways, which result in varying degrees of 
inhibition (Ono, Okada et al. 1997; Ravetch and Lanier 2000). 
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Figure 1.1 Direct activation of NK cells (Newman and Riley 2007). 
The "classical" or direct model of activation of NK cells involves a balance of signals 
between inhibitory and activating NK cell receptors. Inhibitory receptors bind to MHC 
class I molecules and prevent NK cell-mediated killing of "self"-cells, whereas 
activating receptors bind to stress-induced ligands that are upregulated on infected or 
transformed cells. Numerous infections cause down-regulation of MHC class I 
molecules which skews the balance of strength between activating and inhibitory 
receptors allowing for effective activation of NK cells. 
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Table 1.1 NK cell receptors involved in classical activation or inhibition 
pathways (adapted from)(Di Santo 2006). 
H = human 
M = mouse 
? = unknown 
There also exist activating KIR and NKG2 molecules that lack ITIMs but instead 
associate non-covalently via a charged residue in the receptor transmembrane 
domain with the immunoreceptor tyrosine-based activating motif (ITAM)-containing 
adaptors DAP12, FC£Rly, or CD3s, Natural cytotoxicity receptors, such as NKp30, 44 
and 46 as well as the FcyRillA (CD16) also have charged residues , which associate 
with ITAMs, ITAMs differ from ITIMs in that they contain a conserved sequence of 4 
amino acids that is repeated twice in the cytoplasmic tails (YxxL), which are 
commonly separated by 7-12 amino acids (YXXL(7-12)YxxL) , Upon phosphorylation of 
the tyrosine residues , these ITAMs form docking sites for the above mentioned 
adaptor proteins which recruit and activate the Syk or ZAP70 tyros ine ki nases (or in 
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some cases involve the adaptor protein OAP1 0) and initiate the cell signaling 
pathways (Oi Santo 2006, Orr and Lanier 2010). This mechanistic overview of 
classifying activating and inhibitory receptors has recently become somewhat 
confused in that numerous monovalent ligands have been described to induce 
inhibitory signaling when IT AM-phosphorylation occurs (Pinheiro da Silva, Aloulou et 
al. 2008). 
There are also several co-activating/co-stimulatory receptors that are expressed on 
NK cells, such as C02, LFA-1, C0244 (2B4) and C0226 (OYNAM-1). These 
receptors recognize self-derived ligands which are naturally found to be expressed 
on many tissues in the host (Lanier 2008). 
It seems increasingly clear that the degree of direct activation of NK cells in response 
to pathogens, transformed or non-self cells is the result of skewing the balance 
between engagement of inhibitory and activating receptors. We know that, by 
engaging inhibitory receptors, MHC class I molecules expressed on normal cells 
prevent the activation of NK cells, but it is far less clear which activating receptors are 
required for NK cell activation when MHC class I molecules are down-regulated. NK 
cell-mediated killing of cytomegalovirus (CMV)-infected cells has been noted for in 
vivo (Karre, Ljunggren et al. 1986) in mice as well as in vitro (Nishimura, 
Stroynowski et al. 1988; Leiden, Karpinski et al. 1989; Pena, Alonso et al. 1990; 
Litwin, Gumperz et al. 1993). In numerous studies, down-regulation of MHC class I 
molecules has been documented in response to CMV infection, possibly as a mode 
of immune evasion from CTL-mediated killing of infected cells (Fletcher, Prentice et 
al. 1998; Biron, Nguyen et al. 1999; Tortorella, Gewurz et al. 2000). 
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Direct activation of NK cells has also been well characterized in Hepatitis C virus 
(HCV) infection. It has recently become understood that KIR2DL2 and KIR2DL3 
molecules compete for binding to HLA-C (Khakoo, Thio et al. 2004; Ahlenstiel, Martin 
et al. 2008; Romero, Azocar et al. 2008). Because the binding affinity for KIR2DL3 
interactions with HLA-C is significantly lower than for KIR2DL 1-HLA-C interactions, 
NK cells from these individuals become more easily activated via the NKG2D-
mediated pathway presumably by binding stress-inducible class I-like molecules 
(MICA/B) and ULBPs as has been demonstrated by numerous cancer models. This 
direct pathway of NKG2D-mediated activation of NK cells has been associated with 
protection from HCV persistence. The role of NK cells and KIR-MHC interactions in 
acute HCV infection is much less understood. Very recently, Amadei et at. 
demonstrated that NKG2D expression was upregulated in patients with acute HCV 
as compared to healthy controls (Amadei, Urbani et al. 2010). They also observed 
significantly higher levels of activation of NK cells in the patients with acute HCV as 
measured by IFN-y production and degranulation (CD1 07a). Interestingly, subset 
analyses revealed that both CD56dim and CD56bright NK cell subsets had elevated 
expression of NKG2D as well as both subsets carried HLA-C group 1 and 2 ligand-
specific KIR receptors. These data strongly support the notion that balance between 
inhibitory and activating signaling will largely determine the whether the NK cells 
become activated. 
1.5 Indirect activation of NK cells 
Indirect activation of NK cells results secondarily from activation of accessory cells 
such as monocytes/macrophages and myeloid DCs (mDCs), following ligation of 
pathogen ligands by PRRs. While there are certainly scenarios of pathogens or 
pathogen-derived ligands that directly activate NK cells, most pathogens seem to 
activate NK cells indirectly, by way of accessory cells. Activation of antigen 
presenting cells (APCs) leads to secretion of soluble cytokines (e.g. IL-12, IL-15, IL-
18 
18 and IFN-a) (Newman, Korbel et al. 2006; Newman and Riley 2007), which bind to 
cytokine receptors on NK cells. Contact-dependent interactions, (e.g. ICAM-1/LFA-1) 
(Baratin, Roetynck et al. 2007) also lead to NK cell activation. These observations 
have been documented in numerous viral [e.g. Influenza (Monteiro, Harvey et al. 
1998; He, Draghi et al. 2004; Siren, Sareneva et al. 2004; He, Holmes et al. 2008)], 
bacterial [e.g. Lactobacillus casei (Takeda, Suzuki et a/. 2006)] and protozoal [e.g. 
Plasmodium falciparum and Leishmania major (Akuffo, Alexis et a/. 1999; Newman, 
Korbel et a/. 2006)] models of infection. 
There are numerous other viral and bacterial infections where NK cells have played 
significant roles in controlling acute infection. For example, a recent study 
characterizing flaviviruses (West Nile virus (WNV) and Dengue virus (DV)) 
demonstrated direct recognition of envelope (E) protein by NKp44 activating receptor 
and the data strongly suggested that this was a direct route for activation of NK cells 
(Hershkovitz, Rosental et al. 2009). However, NKp44 is only expressed on NK cells 
upon activation (Vitale, Bottino et al. 1998), which suggests that these cells must 
have received other signals (indirect activation) upstream to the E protein, e.g. 
soluble signals from accessory cells (IL-12, IL-18, IFN-a) and from T cells (IL-2). In 
another study, activation of NK cells was observed in response to Mycobacterium 
bovis BCG, Nocardia farcinica and Pseudomonas aeruginosa (Esin, Batoni et al. 
2008). Esin et a/. observed that NK cells were activated via NKp44 recognition of cell 
wall-derived proteins. These proteins, however, were not identified, and again 
NKp44-mediated signaling implies some prior upstream NK cell activation. 
Figures 1.2 and 1.3 are schematic representations demonstrating the complex 
interactions between NK cells, APCs and pathogens. 
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Figure 1.2 Indirect activation of NK cells upon interaction with accessory cells 
and pathogens (taken from (Newman and Riley 2007)). APCs directly recogn ize 
pathogens via PRRs and upon activation secrete cytokines, such as IL-12, IL-12, IL-
15 and IFN-aJ~. APCs also make direct contact with NK cells , possibly through 
ICAM-1/LFA-1 interaction. NK cells respond to soluble and contact-dependent stimu li 
and quickly become activated (as early as 3-6 hours), resulting in robust production 
of IFN-y as well as the release of cytolytic granules, such as perforin and granzymes. 
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Figure 1.3 Signals passed from accessory cells to NK cells (taken from 
(Newman and Riley 2007)). Pathogens are recognized by PRRs located on the 
plasma membrane, in the cytoplasm and in endosomal compartments. APCs will 
pass a wide array of signals, both membrane-bound as well as soluble, to NK cells . 
The nature of the specific NK cell response will vary greatly depending on the 
signals , which are passed from the APCs. 
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Our lab has had a long-standing interest in the indirect activation of NK cells in 
response to malaria-infected erythrocytes (Pf-RBC), and we have previously 
demonstrated that NK cell activation is also dependent on IL-2 (Newman, Korbel et 
al. 2006). Furthermore, although myeloid cells were essential for NK cell activation 
by Pf-RBC (Newman, Korbel et al. 2006) we were never able to fully recapitulate the 
NK cell response of mixed peripheral blood mononuclear cells (PBMC) by addition of 
myeloid cells (plastic adherent monocytes, macrophages and dendritic cells) to 
purified NK cells (unpublished data). This observation suggested that there may be 
another important cell type involved in providing essential signals to NK cells. 
These observations, bolstered by reports of T cell and IL-2-dependent activation of 
human NK cells by influenza A virus (He, Draghi et al. 2004) and of an increase in 
the frequency of IFN-y-producing NK cells among re-stimulated PBMCs after 
influenza vaccination (Long, Michaelsson et al. 2008) led us to speculate that IL-2 
from antigen-specific T cells might allow NK cells to contribute to the effector arm of 
adaptive immune responses. Testing this hypothesis was one aim of my PhD 
research (Chapter 3). 
1.6 NK cells in adaptive immune responses 
It is now known that appropriately activated murine NK cells can assume some 
functional characteristics of memory cells (O'Leary, Goodarzi et al. 2006; Cooper, 
Elliott et al. 2009; Sun, Beilke et al. 2009), raising the possibility that NK cells may 
also contribute to adaptive immune responses. This idea that NK cells share features 
of the adaptive immune system such as memory is very new. In 2006, O'Leary and 
colleagues, using the hapten-induced contact hypersensitivity (CHS) response model 
in Rag-I- mice, demonstrated clear NK cell responses to the sensitizing agent that 
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persisted for at least 4 weeks, whereas no response was seen in unsensitized 
animals (O'Leary, Goodarzi et a!. 2006). Using adoptive transfer of hapten-sensitized 
NK cells into na'ive mice, they demonstrated 'transferable' hapten-specific memory, 
which was shown to be localised within a Ly49C-I+ population of NK cells residing in 
the liver. These findings suggested for the first time a specific role for sustained 
"antigen-specific" memory recall responses by NK cells, a feature previously only 
credited to B cells and T cells in the adaptive arm of immunity. 
In 2009, two further landmark studies were published characterising 'memory-like' 
NK cells in mice (Cooper, Elliott et a!. 2009; Sun, Beilke et a!. 2009). In one of the 
studies, Sun and colleagues demonstrate that a population of NK cells bearing the 
murine cytomegalovirus (MCMV)-binding Ly49H receptor expanded by 100-fold and 
1000-fold in the spleen and liver, respectively, within 7 days following infection. Sun 
and colleagues also showed that although these cells undergo a contraction phase in 
the months after resolution of infection Ly49H+ cells persist at higher than normal 
levels in both lymphoid and non-lymphoid tissues and that these self-regenerating 
NK cells can respond rapidly to re-infection by degranulating and producing effector 
molecules. Finally they demonstrated that upon adoptively transferring these 
'memory-like' NK cells into na'ive mice and then challenging with MCMV, a rapid 
secondary expansion ensued leading to protective immunity. Furthermore, at least 
ten-fold more na"ive NK cells than 'memory' NK cells were required in order to 
achieve similar levels of protection against MCMV infection. 
The other study by Cooper and colleagues demonstrated that by adoptively 
transferring cytokine-activated (IL-12, IL-18, and low-dose IL-15) NK cells (from Rag-
/- mice) into na"ive mice, these cells could be easily detected more than 20 days later 
when they no longer show any phenotypic differences from the na"ive host cells. They 
observed significantly greater levels of IFN-y production by these cells when re-
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stimulated as compared to na"ive host NK cells or to the transferred control NK cells 
(preactivated with low dose IL-15 alone), suggesting the ability of retention of 
memory to prior activation. 
NK cells have also been documented to play significant roles in vaccine-induced 
immune responses. In 2008, Long and colleagues investigated the effects of the 
routinely used trivalent influenza virus vaccine on the cellular immune response in 
healthy adult volunteers (Long, Michaelsson et al. 2008). They demonstrated that 
immunization with influenza vaccine caused significant increases in the frequency of 
IFN-y+ NK cells in the majority of the vaccinees. These increases were shown to be 
as high as 70-fold greater than seen among the pre-vaccinated PBMCs. These 
findings were complemented by another study demonstrating that NK cell activity to 
influenza virus following vaccination with the inactivated whole virus vaccine 
depended on IL-2 from influenza-specific memory T cells (He, Draghi et al. 2004). 
Interestingly, another study characterising yellow fever vaccination (YF17D), which is 
a highly protective single injection of live, attenuated yellow fever virus (YFV), 
demonstrated significantly increased NK cell expression of TLR3 and TLR9 which 
peaked by 7 days following vaccination. This increased expression of TLRs 3 and 9 
correlated positively with increased CD69 expression as well as increased I FN-y 
(reaching statistically Significant levels by 2 days and 15 days following vaccination, 
respectively) (Neves, Matos et al. 2009). This study implicates a role for TLRs in the 
activation of NK cells following vaccination. These findings are supported by another 
study looking at in vivo recall activation of YF vaccinated NK cells, mediated by TLR3 
and TLR9 in the presence of IL-12, following YF vaccine virus infection of murine 
DCs (Sivori, Falco et al. 2004). 
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1.7 Aim of the project 
Despite recent evidence from murine models strongly suggesting a capacity for NK 
cells to differentiate into a 'memory' phenotype, there have been no studies in human 
NK cells to explore the potential for NK cell memory. NK cell activation during 
infection depends upon a fine-tuned orchestration of signals (both contact-dependent 
as well as contact-independent) in response to pathogens or pathogen-infected cells 
that derives from activation of accessory cells. I hypothesize that NK cell activation 
also depends upon rapid secretion of IL-2 from effector memory CD4+ T cells. This 
antigen-specific T cell compartment is extremely small in the immediate hours after 
primary exposure to a foreign antigen but will be significantly greater at secondary 
exposure. I hypothesize that these antigen-specific CD4+ T cells recruit IL-2 
responsive NK cells to the adaptive immune response, allowing them to amplify the 
inflammatory milieu until the Band T cell responses are fully realized. Conventional 
dogma of the innate and adaptive immune responses to primary and secondary 
infection has overlooked the possibility that NK cells may respond in a "recall"-like 
manner during secondary exposure to antigen during infection or as a result of 
vaccination. 
I further hypothesize, therefore, that NKce11 responses should be stronger in the 
presence of pathogen-specific T cells, i.e. during secondary responses (after 
vaccination), than in the absence of such cells (i.e. before vaccination). 
The major objective of my thesis is to describe the sequence of events leading to 
optimal "indirect" activation of NK cells during "recall" responses to infection or 
following vaccination. In order to achieve this objective, the specific aims of this 
thesis are: 
• To investigate the role of T cells and the interactions with NK cells in 
response to Plasmodium falciparum-infected red blood cells (Pf-RBC) as well 
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as other non-viral pathogens such as Mycobacterium bovis BCG (BCG) and 
LPS, by way of identifying the key signals that lead to activation of NK cells 
as well as the precise sequence of these events (Chapter 3). 
• To determine if NK cells playa role during vaccine-induced recall responses 
by way of characterising NK and T cell responses of children in a phase lib 
vaccine trial of the RTS,S/AS01 E-adjuvanted malaria vaccine (Chapter 4). 
• To further dissect the "recall" NK cell response following vaccination using 
rabies virus vaccine as a model (Chapter 5). 
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Chapter 2: Materials and Methods 
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2.1 Isolation of PBMC 
Venous blood was collected into heparinised tubes (CP Pharmaceuticals, Wrexham, 
UK), and diluted 1: 1 in RPMI-1640 (Gibco BRL, UK). Up to 35ml of the cell 
suspension was carefully layered onto 15 ml of a Histopaque 1077 gradient (Sigma, 
Dorset, UK) and spun at 400 x g for 30 minutes with the centrifuge brake turned off. 
The PBMC formed a distinct buffy coat layer at the top of the gradient and were 
carefully transferred into a fresh tube with a sterile, disposable 3ml pastette and 
washed twice in RPMI 1640 (500 g, 10 minutes). The cell pellet was resuspended in 
a small volume of complete growth medium (GM; RPMI 1640, 10% autologous 
serum or heat-inactivated Fetal Calf Serum (HI-FCS), 100 IU/ml 
penicillin/streptomycin (Gibco), 2 mM L-glutamine (Gibco)) and the cells were 
counted in a haemocytometer using a 1 :10 dilution of Trypan blue (Sigma) to 
determine the cell viability. 
2.2 Cryopreservation of PBMC 
Freshly isolated PBMC were resuspended at 2 x 107 PBMC/ml ice cold heat-
inactivated (56°C water bath; 30 minutes - gently invert every 10-15 minutes) fetal 
calf serum (HI-FCS; Gibco) and incubated on ice for 30 minutes. An equal volume of 
HI-FCS (20% DMSO (Sigma)) was added for a final concentration of 107 PBMC/ml in 
HI-FCS (10% DMSO). Cryovials were stored in a Mr. Frosty® container (Nalgene) at 
-80°C overnight and then transferred to liquid nitrogen for long-term storage. 
Individual vials were thawed in 37°C water bath (until only small amount of frozen 
suspension remaining) and then immediately transferred to ice to maintain 
temperature of O°C. Using sterile disposable 3ml transfer pastette, cell suspension 
was transferred to a new sterile 15 ml Falcon tube containing RPMI (10% HI-FCS) 
with special attention to transferring solution in a drop-wise manner in order to ensure 
very thorough washing of PBMC. Cells were centrifuged at 300 x g for 5 minutes at 
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4°C with brakes on low setting. Supernatant was discarded with special attention not 
to disturb cell pellet. Washes were repeated 3 times. Cell pellets were resuspended 
at a concentration of 5 x 106 cells/ml in GM and then were allowed to recover 
overnight at 37°C with 5% CO2. The following morning, cells were transferred from 
culture plates to new 15ml Falcon tubes and washed 2 times at 300 x g for 5 minutes 
at 4°C with brakes on low setting. Cells were counted immediately before final wash. 
After final wash, cells were resuspended at a concentration of 2 x 106 cells/ml in GM 
and set on ice until ready for use. 
2.3 Plasmodium falciparum culture 
P. fa/ciparum parasites (strain 307) were grown as previously described (Horowitz 
and Riley 2010) in ORh- human erythrocytes (National Blood Service, London, UK) in 
RPMI 1640 (Gibco) supplemented with 25 mM HEPES (Sigma), 28 mM sodium 
bicarbonate (BDH), 20 1J9II hypoxanthine (Sigma) and 10% normal human AB serum 
(National Blood Service). Cultures were gassed with 3% O2, 4% CO2 and 93% N2 
and incubated at 37CC. Parasite cultures were routi nely shown to be free from 
mycop/asmaJacho/ep/asma species contamination using an elisa based Mycoplasma 
Detection Kit (Roche). ORh- human erythrocytes were aliquoted into 50ml conical 
tubes upon arrival and stored at 4°C for up to 3 weeks. 
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2.4 Preparation of antigens for in vitro stimulation assays 
2.4.1 Purification of live schizonts 
Highly pure (>95%) mature schizonts (Pf-RBC) were harvested from cultures of 5-
15% parasitaemia by adherence to a lD separation column (Miltenyi Biotec). 
Columns were washed thoroughly with RPMI (0.1 % BSA) to remove uninfected 
erythrocytes before elution. Purified Pf-RBC were washed in chilled RPMI-1640 and 
then resuspended at 109 Pf-RBC/ml in RPMI-1640. 
2.4.2 Mycobacterium bovis Bacillus Calmette-Guerin culture 
Mycobacterium bovis Bacillus Calmette-Guerin (BCG, Pasteur strain; kind gift from 
U. Schaible) was grown in Difco Middlebrook 7H9 Broth (Becton Dickinson) 
complemented with 0.05% Polysorbate 80 (v/v) BDH, UK) and 10% (v/v) BBl oleic 
acid, bovine albumin, dextrose, and catalase (OADC, Becton Dickinson). BCG 
cultures were incubated at 30°C with gentle shaking to avoid cell clumping. Cultures 
were typically grown until the medium appeared very murky. Cultures were then 
allowed to settle and then passed through a 25-gauge needle syringe by aspirating 
up and down 15-20 times. Finally the suspension was aliquoted into 1 ml cryovials 
and frozen at -80°C. Three vials from randomly selected positions in each frozen box 
were grown on agar plates in a dilution series to allow enumeration of viable 
bacteria/ml. Numbers of viable BCG were enumerated from the average count from 
all vials, and the multiplicity of infection (MOl) could then be established. 
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2.4.3 Preparation of RTS, 5 malaria vaccine antigens 
Peptide pools representing the circumsporozoite protein (CS) and the Hepatitis B 
surface antigen (HBs) were provided by Glaxo-Smith-Kline (GSK). Peptides were 
frozen at a concentration of 1 mg/ml, and used at a final concentration of 1 J.lg/ml. 
2.4.4 Preparation of rabies vaccine antigens 
Ampoules of rabies vaccine standard were purchased from the National Institute of 
Biological Standards and Controls (NIBSC, UK). Each ampoule contained the freeze 
dried residue of 0.5 ml aliquots of a commercial rabies vaccine containing inactivated 
Pitman Moore virus grown in Vero cells and freeze dried at NIBSC. Each ampoule 
was resuspended in 0.5ml of sterile water and allowed to sit for 30 minutes at RT. 
The concentration of each ampoule was 6.6 IU/ml of rabies virus glycoprotein 
content. 1:10 and 1:100 dilutions were used for in vitro assays. 
2.5 Cell culture 
Cells were resuspended at 2 x 106 PBMC/ml and transferred in 200J.l1 volumes into 
96-well U-bottom plates (400,000 cells/well) for overnight (24 hour) assays. For 
CFSE-Iabelled proliferation assays, PBMC were resuspended at 5 x 105 PBMC/ml 
and transferred in 200J.l1 volumes into 96-well U-bottom plates (100,000 cells/well) for 
up to 7 days. Overnight assays were run in duplicates and proliferation assays were 
run in triplicates. Cultures were incubated at 37°C in a humidified atmosphere of 5% 
CO2• For cultures lasting longer than 3 days, half of the volume in each well was 
replaced with fresh medium on Day 4 in order to replenish depleted nutrients and 
balance the pH of the medium. Phorbol myristate acetate (PMA) and lonomycin (P/I) 
were used at a concentration of 50ng/ml PMA and 1 J.lg/ml of ionomycin. P/I was 
typically added to cultures for the last 5 hours. Recombinant human cytokines: IL-12 
(Peprotech) and IL-18 (MBL) (rhIL-12+IL-18) were used at a concentration of 0.1 
mg/ml each. rhIL-12+IL-18 were added to cultures at the start of culture. 
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Lipopolysaccharide (LPS) purified from Salmonella typhimurium (Sigma) was used at 
a concentration of 1 I-Ig/ml as an irrelevant antigen control; GM served as a negative 
control for all assays. Finally, Brefeldin A (10llg/ml, eBioscience) and monensin (BD 
bioscience; golgistop) were added to cultures for the last 5 hours of incubation. 
2.6 Depletion of Specific Subsets of T cells 
2.6.1 CD3 depletion 
PBMC were selected for CD3 expressing cells using one of 2 kits: 
1. EasySep CD3 T cell selection kit (Stemcell technologies): 
Briefly, PBMC were incubated with EasySep anti-CD3 antibody cocktail for 15 
minutes at RT. Then, EasySep magnetic nanoparticles were added and the cell 
suspensions were incubated for another 10 minutes at RT. Finally, the tube 
containing the cells was placed in the EasySep magnet and allowed to sit for 5 
minutes. The CD3-depleted PBMC were then decanted into a new tube. The original 
tube was washed 2 times in PBS and allowed to sit in the magnet in order to retrieve 
a sufficiently high yield of CD3-depleted PBMC. The cells were resuspended at 2 x 
106 CD3-depleted PBMC/ml in GM and set on ice until ready for use. Cells were 
checked by flow cytometry to determine the purity and quality of depletions. 
2. CD3 FlowComp Dynalbeads (Dynal/invitrogen): 
This kit was not yet available commercially and was kindly provided by Karoline 
Schjetne at Oynal/invitrogen. Briefly, PBMC were incubated in the presence of the 
CD3 FlowComp antibody cocktail for 10 minutes. The cells were then washed and 
resuspended in Isolation buffer (Mg 2+ and Ca2+ free PBS containing 0.1 % BSA and 
2mM EDTA) followed by addition of FlowComp dynalbeads. The cell suspension was 
incubated for an additional 15 minutes at RT with gentle rotation. After the incubation 
was complete, the tubes were placed in a magnetic particle separator (Dynal MPC™_ 
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L} for 5 minutes at RT. The cell supernatant was then transferred to a new tube and 
washed. The cells were resuspended at 2 x 106 CD3-depleted PBMC/ml in GM and 
set on ice until ready for use. Cells were checked by flow cytometry to determine the 
purity and quality of depletions. 
2.6.2 CD4+, CD8+, TCRwyo+, and TCR-a~+ T cell depletions 
These depletions were carried out using MACS beads and column separation 
(Miltenyi Biotec). Briefly, cells were labelled with antibodies specific for either CD4+, 
CD8+, TCR-yo+, or TCR-a~+ T cells. All the stains were added separately in their 
own tubes and all antibodies were conjugated to Phycoerythrin (PE) and cell 
suspensions were incubated on ice for 30 minutes. Cells were then washed and 
supernatant was discarded. Cells were resuspended in MACS buffer (PBS containing 
0.1 % BSA and degassed), and then incubated with magnetic beads labelled with 
anti-PE antibodies on ice for 20 minutes. Cells were then washed and resuspended 
in 500~1 buffer/107 cells. Cell suspensions were carefully pipetted onto magnetic 
columns and allowed to filter through via gravity. Columns were then washed 3 times 
using MACS buffer. Columns were removed from magnets and set onto 15ml falcon 
tubes. Five ml of MACS buffer was then plunged through the column with sufficient 
force to dislodge the bound cells using plunger provided in kit. Cells were washed 
and then resuspended at 2 x 106 PBMC/ml in GM and set on ice until ready for use. 
All cell suspensions were then stained for respective T cell subsets to confirm purity 
and quality of depletions. Only preparations giving at least 97% purity were used in 
subsequent experiments. 
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2.7 Cell phenotyping using Flow Cytometry 
After the relevant culture period, the cells were washed twice in FACS buffer (1x 
PBS, 0.1 % sodium azide (Sigma), 2% HI-FCS) and centrifuged in 96-well plates for 2 
minutes at 500 x g. Fluorochrome conjugated antibodies were added in the dark at 
4'C and at concentrations previously determined by titration. Panels of antibody 
cocktails can be found in Table 4. The plates were incubated in the dark at 4'C for 30 
minutes. The cells were then washed twice in 200~1 of FACS buffer. The cells were 
then fixed at room temperature for 15-30 minutes in 1 OO~I fixation buffer (1 x PBS, 
2% paraformaldehyde or BD cytofix solution (1x; BD Pharmingen)). The cells were 
then washed once in FACS buffer. The cells were then resuspended in 100~1 
permeabilization buffer (BD Pharmingen, UK). Intracellular antibody cocktails were 
added, and the plates were incubated in the dark at 4'C for 30 minutes. Details of 
cell surface and intracellular antibody cocktails can be found in Table 2.1 (FACS 
Caliber), Table 2.2 (FACS Canto II) and Table 2.3 (Becton Dickenson Cyan ADP). 
Cells were then washed twice in permeabilization buffer. Finally, the cells were 
resuspended in 200~1 of fixation buffer and stored at 4'C until ready for acquisition 
on the flow cytometer. All antibodies were mouse monoclonals with the exception of 
anti-IL2 APC, which was a monoclonal rat antibody. Flow cytometric analyses were 
performed using a Becton Dickinson FACSCalibur or FACSCanto II flow cytometer or 
Becton Dickenson Cyan ADP flow cytometer and FlowJo analysis software 
(TreeStar). All statistical analyses were performed using Prism 5 software (Graph 
Pad Software Inc., San Diego, USA) and STATA 10 software (Stata Corp.). 
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Table 2.1 . Antibody cocktails used for 4 colour flow cytometry 
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Table 2.2 Antibody cocktail used for 8 colour flow cytometry 
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Table 2.3 Antibody cocktail used for 9 colour flow cytometry 
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Chapter 3: Cross-talk between T cells and 
NK cells generates rapid effector 
responses to P. fa/ciparum-infected 
erythrocytes 
Adapted from (Horowitz, Newman et al. 2010) 
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3,1 Introduction 
3,1,1 The burden of malaria 
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Fig. 3.1: The burden of malaria 
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(A) Estimated number of malaria-related fatalities (per 1000) as defined as 
fatalities due to low blood pressure, severe anaemia (iron deficiency) , pulmonary 
oedema , kidney failure , internal bleeding (haemorrhaging) , jaund ice, state of shock, 
coma, convulsions and paralysis. ; (8) Estimated incidence of clinical malaria as 
defined by the number of cases (per 1000). World Malaria Report, 2008 (WHO 
2008). 
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While malaria has officially been eliminated from temporate zones such as Europe 
and North America during the last century, it remains an overwhelming problem for 
public health throughout the tropics (Hay, Guerra et al. 2004; WHO 2008). It is 
currently documented in 109 countries, potentially affecting 3.3 billion people (Figure 
3.1) (WHO 2008). Malaria parasites are transmitted to vertebrates through the bite of 
the female anopheline mosquito. There are 4 well characterized species of 
Plasmodium that infect humans: P. falciparum, P. vivax, P. ovale and P. malariae, 
although it has recently been shown that many diagnosed P. malariae infections are 
actually the simian-derived species, P. knowlesi (Garnham 1996; Singh, Kim Sung et 
al. 2004; Cox-Singh, Davis et al. 2008). P. fa Icipa rum , which is the most common 
species, accounts for the highest mortality rates and is responsible for more than 
90% of all reported cases of malaria infection (WHO 2008). 
The burden of malaria is most pronounced in young children « 5 years) and 
primigravid women (McGregor 1984; Snow, Korenromp et al. 2004; Desai, ter Kuile 
et al. 2007). Malaria has also been shown to have severe impacts on socio-economic 
indices at both family and community levels (Breman 2001; Sachs and Malaney 
2002). Aside from public and personal costs for treatment and prevention measures, 
it leads to a loss of productivity due to chronic physical disabilities and disrupted 
education (Fernando, Gunawardena et al. 2003; Mung'Ala-Odera, Snow et al. 2004; 
Carter, Ross et al. 2005). 
Public health initiatives such as indoor residual spraying (Sadasivaiah, Tozan et al. 
2007) and the use of insecticide treated bednets (Diallo, Cousens et al. 2004; 
Lengeler 2004; Lindblade, Eisele et al. 2004) have all proven very effective at 
reducing the global burden of malaria. Studies characterizing the efficacy of 
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intermittent preventive anti-malarial treatments (IPT) (van Eijk, Ayisi et al. 2004; 
Schellenberg, Cisse et al. 2006) suggested much promise as well, however, more 
recent meta-analysis suggested that IPT is less effective than originally envisaged 
(Aponte, Schellenberg et al. 2009). More recently, the use of artemisinin combination 
therapies (ACT), shown to have high efficacy at killing both erythrocytic as well as 
sexual stages of the plasmodium parasite, has been linked to a significant reduction 
in transmission (Greenwood and Mutabingwa 2002; White 2004; Okell, Drakeley et 
al. 2008); however, cases of drug resistance have already been reported (Eastman 
and Fidock 2009). While all of these initiatives have been demonstrated as 
invaluable tools in the fight against malaria, they all share a common obstacle, i.e. 
they require continuous applications raising concerns regarding their long-term 
financial sustainability. In order to achieve true global eradication, a cheap and 
sustainable vaccine is needed. 
Unexpectedly, we have witnessed a sudden decline in malaria prevalence in many 
regions of Africa in recent years (Barnes, Durrheim et al. 2005; Nyarango, 
Gebremeskel et al. 2006; Bhattarai, Ali et al. 2007; Ceesay, Casals-Pascual et al. 
2008; O'Meara, Bejon et al. 2008; .Rodrigues, Schellenberg et al. 2008; WHO 2008). 
Recent large-scale initiatives such as the Roll Back Malaria Programme (Mufunda, 
Nyarango et al. 2007) and The US President's Malaria Initiative (Loewenberg 2007) 
have been credited as having an effect on the prevention and treatment of malaria by 
implementing transparency mechanisms to ensure that medications and bed nets are 
effectively delivered to those in need; however, factors such as climate change may 
also be influencing transmission rates by affecting the amount of rain fall and 
temperatures and their consequent effects on mosquitoes. However, much more 
rigorous scientific approaches will need to be taken in order to assess the true 
causes and likely duration of this decline. 
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3.1.2 Malaria Parasites and Pathogenesis 
Plasmodium has 3 distinct stages of its life cycle: pre-erythrocytic and erythrocytic 
and sporogonic. Figure 3.2 illustrates the life cycle of P. falciparum and in the 
description listed below numbers and letters refer to this figure. 
When the female anophelene mosquito transmits haploid sporozoites (1) into the 
host sub-dermal layer, the parasite travels through the capillary vessels into the 
blood stream leading to the liver where it infects hepatocytes. This process is thought 
to occur within minutes of sporozoite inoculation. Up to 20 sporozoites are released 
from the mosquito with each bite (Rosenberg, Wirtz et a!. 1990; Ponnudurai, Lensen 
et a!. 1991). However, some sporozoites remain in the skin (Sidjanski and 
Vanderberg 1997; Sinnis and Coppi 2007; Ejigiri and Sinnis 2009) where they are 
targeted by phagocytic cells, such as macrophages or traverse to the lymphatics and 
drain to the lymph nodes where they can prime CD8+ T cells (Chakravarty, Cockburn 
et a!. 2007; Yamauchi, Coppi et a!. 2007; Amino, Giovannini et a!. 2008). The 
sporozoites that do reach the liver pass through kupffer cells (Baer, Roosevelt et a!. 
2007) and hepatocytes (Mota, Pradel et a!. 2001; Frevert 2004), which is thought to 
be a necessary step in activation of sporozoites to initiate stable infection. Once 
inside the hepatocyte, they form parasitophorous vacuoles (2) and develop into exo-
erythrocytic schizonts (3) through a process known as liver schizogony, which 
requires several rounds of asexual reproduction. This process is referred to as the 
exo-erythrocytic (asexual) cycle (A) and can take more than 5 days before being able 
to initiate stable blood-stage infection by releasing merozoites, although the timing 
can differ significantly for other Plasmodium species (4). Merozoites then infect 
erythrocytes (Pf-RBC) (5), and this stage represents the erythrocytic stage of malaria 
infection (8). The erythrocytic stage of infection involves the maturation of 
trophozoites into schizonts leading to the lysis of RBC and release of 16-32 new 
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merozoites (6), which infect new RBG. Rather than undergoing schizogony, some 
merozoites develop into male or female gametocytes (7); male and female 
gametocytes are taken up by the mosquito (8) and fertilize in the gut to form a zygote 
(9), which initiates the sporogonic cycle (C). Depending on ambient temperature, this 
process (9-11) can require up to 3 weeks, culminating in migration of thousands of 
new sporozoites into the salivary glands (12), ready for inoculation into a new host 
(Sinden 1999; Mota and Rodriguez 2004). 
The symptoms of malaria infection are often times very mild, in the form of 
headaches, myalgia, fever, vomiting, diarrhea and malaise. These symptoms are 
highly correlated with the onset of erythrocytic stage infection and become more and 
more debilitating as blood stage parasitaemia increases. The degree of severity of 
malaria-associated pathology varies. While the majority of infections present as mild 
illness, a small subset of non-immune individuals develop more severe symptoms, 
such as anaemia, which is most commonly seen in young children and pregnant 
women (Duffy and Fried 2005). A percentage of individuals progress to renal failure 
and liver dysfunctions. Other symptoms include cerebral malaria (most common in 
slightly older children and non-immune adults (Reyburn, Mbatia et al. 2005), 
respiratory dysfunctions, hypoglycaemia, metabolic acidosis, and pulmonary oedema 
(Miller, Baruch et al. 2002). 
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3.1.3 Innate immune responses to Plasmodium infection 
Without the intervention of anti-malarial treatments or immunity, blood stage parasitaemia can 
increase at an exponential rate, leading to death. The innate, and adaptive, immune responses 
are capable of containing peak parasitaemia by limiting the number of infected erythrocytes, and 
subsequently preventing onset of severe pathology. There is a systemic Th1 response to the 
lysis of Pf-RBC, however, and this can contribute to pathology. In the context of malaria 
infection, the cells that are thought to playa role in the innate immune response include, 
macrophages, monocytes, and dendritic cells (DCs), yo+ T cells, Natural Killer (NK) T cells, and 
Natural Killer (NK) cells. 
3.1.4 Cellular Sources of IFN-r 
The optimal immune response to a malaria infection likely comprises rapid induction of 
inflammatory anti-parasitic responses followed by equally rapid resolution of inflammation 
(mediated by anti-inflammatory cytokines) to prevent immunopathology (Artavanis-Tsakonas, 
Tongren et al. 2003). Rapid and robust cell-mediated immune responses can inhibit intra-
erythrocytic replication of malaria parasites and thereby prevent onset of clinical malaria 
(Stevenson and Riley 2004). This process can be primed by ultra-low dose infection/vaccination 
(Pombo, Lawrence et al. 2002; Roestenberg, McCall et al. 2009) but has yet to be mimicked by 
subunit vaccines. Understanding the cellular and molecular pathways of this very early cellular 
response may allow the design of new approaches to vaccination but there is still considerable 
debate over the precise sequence of events. In particular, the timing and magnitude of IFN-y 
secretion are thought to be pivotal in determining the outcome of disease and it is thus of 
importance to identify the major cellular sources of Interferon (IFN)-y, the kinetics of its 
production and the pathways by which it is induced and regulated. 
3.1.5 NK cells in P. fa/ciparum infection 
Data from murine models as well as from clinical studies have suggested that early production 
of IFN-y, i.e. within the first 24 hours during blood stage malaria infection can sign ificantly 
reduce the degree of pathology, especially in non-immune individuals (De Souza, Williamson et 
al. 1997; Mohan, Moulin et al. 1997; Stevenson and Riley 2004). Subsequently, studies have 
shown that human NK cells can be a very early source of IFN-y when cultured in vitro with Pf-
RBC for 24 hours, although the response is quite heterogenous (Artavanis-Tsakonas and Riley 
2002; Artavanis-Tsakonas, Eleme et al. 2003; Korbel, Newman et al. 2005; Korbel 2006; 
Newman, Korbel et al. 2006) and the underlying mechanisms leading to the activation of NK 
cells is only beginning to unfold. It is known that NK cells can be activated or inhibited via 
numerous pathways, however the nature and sequence of events by which the bi-directional 
interactions between APCs and T cells interact with NK cells remain unclear and will be 
discussed in detail later in this section. Some potential pathways of NK cell activation can be 
seen in Figure 3.3. 
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Figure 3.3 - Potential pathways of NK cell activation by P. falciparum-infected erythrocytes - Adapted from 
(Korbel 2006) 
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Figure 3.3 illustrates the potential pathways of NK cell activation in response to Pf-RBC, and in 
the description below, numbers refer to the figure. 
Direct recognition of schizont infected RBC by accessory cells (I) (monocytes/macrophages and 
mDCs) likely occurs via pattern recognition receptors (PRRs) such as TLR4 (Seixas, Moura 
Nunes et al. 2009) and TLR9 (Franklin, Parroche et al. 2009; Seixas, Moura Nunes et al. 2009; 
Coban, Igari et al. 2010; Wu, Gowda et al. 2010) in mice and TLR1, TLR2 and TLR4 (McCall, 
Netea et al. 2007) in humans. Interestingly, one study demonstrated direct sensing of Pf-RBC 
by NK cells (IV) via binding of the Pf erythrocytic membrane protein-1 (PtEMP-1) to chondroitin 
sulfate A, (CSA; host receptor on NK cells) along with binding of Intracellular adhesion 
molecule-1 (ICAM-1; expressed on NK cells) with Lymphocyte function-associated antigen 
(LFA)-1 (expressed on APC) (Baratin, Roetynck et al. 2007). 
Upon recognition, the schizonts are then phagocytosed, and Ag processing ensues. This 
process leads to activation of accessory cells (II) but can also lead to DC inhibition (V) (Urban, 
Ferguson et al. 1999). Acccessory cell activation by Pf-RBC has been shown to lead to 
secretion of Th1 cytokines (e.g. IL-12, IL-18, IFN-a). IL-15, which mediates peripheral T cell 
maturation, is also released and has been reported to drive T cell-mediated production of IL-21, 
which has been shown to act synergistically with IL-15 and/or IL-18 in the activation of human 
NK cells in vitro (Strengell, Matikainen et al. 2003). Activated T cells also secrete IL-2, which 
subsequently acts on NK cells. Both, IFN-y and TNF-a, produced by T cells and NK cells can 
act in a feedback cycle with the accessory cells leading to further secondary activation as well 
as priming of the adaptive immune response. 
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NK cells make contact with accessory cells (III), possibly via CD40:CD40L and/or ICAM-1 with 
its host ligand complex, CD11 a/CD18 (LFA-1) (Korbel 2006; Baratin, Roetynck et al. 2007). It is 
also possible that accessory cells are delivering cytokines such as IL-12 in a polarized manner, 
as observed by confocal image based microscopy (Newman, Korbel et al. 2006). This same 
report has shown that without this interaction between accessory cells and NK cells, there is 
sub-optimal expression of CD25 (IL2Ra), Lysosome Associated Membrane Protein-1 (LAMP-1), 
and IFN-y production. 
NK cells interact directly with Pf-RBC (Artavanis-Tsakonas, Eleme et al. 2003; Korbel, Newman 
et al. 2005; Korbel 2006). The pathway for this interaction remains unknown but the interaction 
has been documented via confocal microscopy which demonstrated conjugate formation 
between NK cells and Pf-RBC in 8 of 9 donors tested and in more than 40% of the NK cells 
imaged as well as cytoskeletal reorganization in a proportion of the conjugates (Korbel, 
Newman et al. 2005). 
NK cell activation may be negatively regulated via anti-inflammatory cytokines, e.g. TGF-~ and 
IL-10 (Omer, Kurtzhals et al. 2000). These cytokines are extremely important at turning off pro-
inflammatory pathways and preventing downstream tissue damage and seem likely produced 
by accessory cells in response to Pf-RBC, although recent reports suggest that subsets of NK 
cells can also playa regulatory role by producing IL-1 0 (Maroof, Beattie et al. 2008; Perona-
Wright, Mohrs et al. 2009; Yoshida, Akbar et al. 201 0). TGF-~ and IL-10 can also be produced 
prematurely by malaria parasites as a mode of immune evasion. A previous report 
demonstrated that latent TGF-~ could be directly activated by Pf-RBC to modulate the innate 
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Th1 response by malaria parasites in a process involving thrombospondin (TSP)-like molecules 
and metalloproteinase activity (Omer, de Souza et al. 2003; Newman, Korbel et al. 2006). 
Several features of NK cell responses to Pf-RBC suggest that there are genetic factors 
influencing their responses. For example: 1) There is a large degree of heterogeneity between 
individuals' NK cellIFN-y production, as well as expression of activation markers CD69, CD25, 
and LAMP-1; 2) For any individual, the NK celllFN-y response to Pf-RBC over time is very 
stable; 3) Different sub-populations of NK cells within an individual will respond differently, and 
the response of each subset is consistent over time, suggesting that there exist stable 
differences between NK clones (Korbel, Norman et al. 2009). 
It has been firmly established that NK cells are very early responders to infection with malaria, in 
vivo and in vitro with respect to IFN-y production. It still remains unclear, however, what the 
actual triggers are, which cause these cells to become activated or inhibited. In 2009, we 
demonstrated a highly significant correlation between the relative activation responses of 
CD56dim and CD56bright NK cells with KIR genotype (Korbel, Norman et al. 2009), demonstrating 
that these 2 subsets of NK cells are independently regulated. Furthermore our study 
demonstrated that the anti-microbial response by CD56brigh\ but not CD56dim , NK cells is highly 
correlated with the degree of activation in myeloid accessory cells and that CD56dim cells tend to 
be relatively inhibited. Finally, the data also revealed that the ratios of CD56dim to CD56bright NK 
cells producing IFN-y varies between individuals, however, they remain constant within an 
individual over time. Taken together, these data demonstrate that there exist at least 2 
independent regulatory mechanisms responsible for modulating NK cell activation/inhibition. It 
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remains unclear if KIR genotypes regulate the specific NK cell subsets in a similar manner in 
response to other pathogens or if this is a unique effect in response to Pf-RBC. 
To briefly summarize the sequence of events taking place during the innate immune response 
to malaria, Pf-RBC are recognized by accessory cells via various potential PRRs, such as TLRs 
4 and 9 in mice and TLRs 1,2 and 4 in humans. This leads to accessory cell activation and the 
release of type-1 cytokines, such as IL-12, IL-18, and IFN-a. These cytokines have been shown, 
in vitro (Currier, Sattabongkot et al. 1992; Fell, Currier et al. 1994; Dick, Waterfall et al. 1996; 
Artavanis-Tsakonas and Riley 2002; Newman, Korbel et al. 2006), to be required for optimal NK 
celllFN-y production, however, it is important to note that the PBMC response to malaria is not 
recapitulated, simply by adding activated DC and macrophages to purified NK cells, suggesting 
that the presence of other cell types are involved in this response. We hypothesized that T cells 
may contribute to NK cell activation. 
In this chapter, I have carefully compared the magnitude and the timing of T cell and NK cell 
responses to Pf-RBC in a large cohort of malaria-na'(ve donors. 
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3.2 Materials and methods 
3.2. 1 Blood donors 
Adult blood donors were recruited at the London School of Hygiene and Tropical Medicine 
through an anonymous blood donation system. All donors were malaria na'lve and healthy and 
gave fully informed consent for their blood to be used in this study. Ethical approval was given 
by the LSHTM Ethics Committee, application #805. 
3.2.2 P. falciparum parasites 
P. falciparum parasites (strain 3D7) were grown in ORh- human erythrocytes (National Blood 
Service, London, UK) in RPMI 1640 (Gibco) supplemented with 25 mM HEPES (Sigma), 28 mM 
sodium bicarbonate (BDH), 20 IJg/1 hypoxanthine (Sigma) and 10% normal human AB serum 
(National Blood Service). Cultures were gassed with 3% O2, 4% CO2 and 93% N2 and incubated 
at 37'C. Parasite cultures were routinely shown to be free from mycoplasma/acholeplasma 
species contamination using an ELISA-based Mycoplasma Detection Kit (Roche) 
incorporating polyclonal antibodies against M. arginini, M. hyorhinis, A. laidlawii and M. orale. 
Highly pure (>95%) mature schizonts were harvested from cultures of 5-15% parasitaemia by 
adherence to a LD separation column (Miltenyi Biotec). Columns were washed thoroughly with 
PBS to remove uninfected erythrocytes before elution. Schizont-infected (Pf-RBC) or uninfected 
(uRBC) erythrocytes were added at a ratio of 3 RBC per mononuclear cell. 
3.2.3 M. bovis BCG bacteria 
Mycobacterium bovis Bacillus Calmette-Guerin (BCG, Pasteur strain; kind gift from U. Schaible) 
was grown in Difco Middlebrook 7H9 Broth (Becton Dickinson) complemented with 0.05% 
Polysorbate 80 (v/v) BDH, UK) and 10% (v/v) BBL oleic acid, bovine albumin, dextrose, and 
catalase (OADC, Becton Dickinson). BCG cultures were incubated at 30°C with gentle shaking 
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to avoid cell clumping. Cultures were grown typically until the culture appeared very murky. 
Cultures were then allowed to settle and then solution was passed through a 25-gauge needle 
syringe by aspirating up and down 15-20 times. Finally solution was aliquotted into 1 ml cryovials 
and frozen at -80°C. Three vials from randomly selected positions in each frozen box were 
grown on agar plates in a dilution series to allow for enumeration of viable bacteria/ml. Numbers 
of viable BCG were enumerated from the average count from all vials, and the multiplicity of 
infection (MOl) could then be established. 
3.2.4 Depletion of T cell subsets 
PBMC were depleted of specific T cell subset populations by methods described in Chapter 2 
(Materials and Methods) but after depletion, the cell concentration was readjusted to 2 x 106/ml 
and cells were cultured with Pf-RBCs at a ratio of 1:3 (as previously) and also at a ratio of 1:10 
to ensure that changing the ratio of NK cells and accessory cells to Pf-RBCs did not adversely 
affect the outcome of the experiments. No significant differences were seen between the 1:3 
and the 1 :10 cultures, so only data from 1:3 cultures are presented. 
3.2.5 Blocking experiments 
Two million PBMC were cultured overnight in 24 well flat bottom plates in the presence of 
purified blocking/neutralising antibodies or appropriate isotype control antibodies for the 
following cytokines, cytokine receptors, and MHC molecules (all BD Bioscience): anti-IL-12 
(p40/p70; clone C11.5), anti-IL-18-\Xchain (clone H44), anti-IL-2 (clone M01 17H12), anti-IFNR-
!X[2b] (clone 7N4-1), anti-TNF (clone MAb1), anti-MHC class I (HLA-A, B, C; clone W6/32), and 
anti-MHC class II (HLA-DR, DP, DO; clone TO-39). 
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3.2.6 Cell surface and intracellular staining for flow cytometry 
Surface and intracellular staining was performed as described previously in Chapter 2 (Materials 
and Methods). The antibodies/reagents used were: anti-C03 PerCP, anti-a~ TCR-FITC, anti-yb 
TCR (biotinylated), Strepdavidin PerCP, anti-IFN-y APC, anti-C04 APC-Cy7, anti-C08 Pacific 
Blue and anti-C03 PE-Texas Red (BO Bioscience); anti-C056 APC (Beckman Coulter), anti-
IFN-y FITC, anti-IL-2 APC (SO biosciences), anti-C056 PE-Cy7 (SO biosciences). All antibodies 
were mouse monoclonals with exception of anti-IL-2 APC (rat monoclonal). Anti-C03 antibodies 
were included in the intracellular staining mixes to ensure that T cells that down-regulated C03 
upon stimulation were not misclassified. 
3.2.7 Cytokine assays 
Secreted IL-2 and TNF-a were measured, according to the manufacturer's instructions, by 
cytometric bead array (CSA Th1ITH2ITH17 kit; SO Siosciences). All samples were acquired 
using FACScaliber flow cytometer and analysis was performed using FCAP Array software (Soft 
Flow Inc.). 
3.2.8 Statistical analysis 
All statistical analyses were performed using Prism 5 software (Graph Pad Software Inc., San 
~iego, USA) and STATA10 (StataCorp.). 
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Figure 3.4 Titrating Pf·RBC input dose to define optimal multiplicity of infection. 
(A) Representative flow cytometry data from 1 donor demonstrating gating strategy for NK cells 
(CD56+ CD3- lymphocytes) and T cells (all CD3+ lymphocytes) and for detection of intracellular 
IFN-y after 24 hrs co-culture with (right column) or without (left column ; GM) Pf-RBC (MOl = 
3:1). (B) The proportion of all NK cells expressing intracellular IFN-y after 21 hrs co-culture with 
Pf-RBC at varying MOl. N= 5 malaria na"ive donors. Data are representative of median values 
with error bars representing range. 
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3.3 Results 
3.3.1 T cells and NK cells both contribute to the early IFN-yresponse to P. falciparum 
We have previously demonstrated that both NK cells and T cells can produce IFN-y following 
incubation for 18-24hrs with Pf-RBC (Artavanis-Tsakonas and Riley 2002) but others have 
concluded that yoT cells are the only significant source of early IFN-y (Hensmann and 
Kwiatkowski 2001; D'Ombrain, Hansen et al. 2007). This discrepancy may reflect, in part, 
heterogeneity between human blood donors in the timing and magnitude of the response and in 
the source of IFN-y (Korbel, Newman et a!. 2005). I sought, therefore, to characterise more 
systematically the early IFN-y response to Pf-RBC. 
I first titrated the concentration of Pf-RBC in the cultures to identify the optimum Pf-
RBC:monconuclear cell (MNC) ratio for induction of IFN-y. (Figure 3.4). PBMC were cultured for 
21 hours either without stimulus (GM) or in the presence of varying amounts of Pf-RBC (ranging 
from 1:1 to 50:1 Pf-RBC:PBMC). Lymphocytes were identified as CD3+ T cells or as CD3-CD56+ 
NK cells (Fig. 3.4A). I found that a multiplicity of infection (MOl) = 3:1 Pf-RBC:PBMC was the 
optimal dose input, confirming previous studies in our laboratory (Fig.3.4B) (Artavanis-
Tsakonas and Riley 2002). 
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Figure 3.5 NK cells and T cells contribute to the early IFN-y response to Pf·R8C 
PBMC were cultured overnight, either without stimulus (GM) or with Pf-RBC at an MOl of 1 
PBMC : 3 Pf-RBC. (A) The proportion of all NK cells or all T cells expressing intracellular IFN-
yafter 24 hrs co-culture with Pf-RBC. N= 50 malaria na"lve donors. (8) Gating strategy for 
identification of all IFN-y+ lymphocytes and their subsequent identification as either NK cells or 
T cells. (C) The number of IFN-y+ NK cells or T cells per 100,000 lymphocytes after 24 hrs co-
culture with Pf-RBC. N= 50 na"lve donors. (0) The MFI of staining for intracellular IFN-y in NK 
cells and T cells after 24 hrs co-culture with Pf-RBC. N= 50 na"lve donors. (E) The percentage of 
aIlIFN-y+ cells that are either NK cells (black bars) or T cells (white bars) after 6, 12 or 24hrs or 
2, 4 or 6 days co-culture with Pf-RBC. Numbers on X axis identify individual blood donors. 
B,D,E: Horizontal lines represent medians. P-values are for 2 tailed paired Wilcoxon tests with 
95% CI comparing NK cells with T cells from the same donor. 
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I next evaluated the NK cell response to Pf-RBC at a MOl of 3:1 in a large cohort of donors (N = 
50). After 21 hours co-culture with Pf-RBC, the proportion of NK cells which contained 
intracellular IFN-y ranged from 0% to 81 % with a median of 4.65%. The proportion of T cells, 
which were positive for IFN-y was significantly lower, ranging from 0% to 7% with a median of 
0.82% (Fig. 3.5A). However, since T cells outnumber NK cells by -10:1 among PBMCs, when I 
gate on all IFN-y+ cells (Fig. 3.58) I find that T cells and NK cells contribute approximately 
equally to the population of IFN-y+ cells (Fig. 3.5e). On the other hand, IFN-y staining intensity 
(MFI) is significantly higher for NK cells than for T cells (p < 0.0001) (Fig. 3.50) indicating that 
NK cells are producing more IFN-y per cell than T cells. 
To determine whether NK and T cells responded to Pf-RBC with similar kinetics, I determined 
the proportion of all IFN-y+ cells that were either NK cells or T cells after co-culturing for periods 
from 6 hrs to 6 days (Fig. 3.5E). Although there is heterogeneity in the response among donors, 
the distinct trend was for IFN-y+ cells to be almost exclusively NK cells after 6 hrs of co-culture 
and for NK cells to continue to dominate the IFN-y response at 12 hrs. However, by 24 hrs the 
response was evenly split between NK cells and T cells and T cell responses gradually came to 
dominate the IFN-y response over the next 5 days. This observation, that the NK cell IFN-y 
response is very rapid but transient, is not unexpected but does likely explain many of the 
apparent discrepancies in the literature where "innate" responses tend to have been assayed at 
a single point in time (Hensmann and Kwiatkowski 2001; D'Ombrain, Hansen et al. 2007). 
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Figure 3.6 IFN-y response of NK cells and T cell subsets. 
PBMC were incubated with Pf-RBC for periods of 6hrs to 6 days and analysed by flow cytometry. (A) 
Representative flow cytometry data from 1 donor demonstrating gating strategy for (I) NK cells (CD56+ 
CD3- lymphocytes) and T cells (all CD3+ lymphocytes), which are then further classified as (II) TCR-y8+ or 
TCR-a~+ T cells and then all TCR-a~+ T cells are identified as being CD4+ or CDS+ T cells. Each 
population of lymphocytes can then be gated (III) for detection of intracellular IFN-y after 24 hrs co-culture 
with Pf-RBC (right column) or without (left column; GM).(8) The percentage of all NK cells or all y8+ T 
cells , CD4+ T cells or CDS+ T cells expressing intracellular IFN-y after 24 hrs co-culture with Pf-RBC. N= 
14 na"lve donors. (C) Gating strategy for identification of all IFN-y+ lymphocytes and their subsequent 
identification as either NK cells or y8+ T cells , CD4+ T cells or CDS+ T cells. (0) The percentage of IFN-y+ 
cells that are NK cells or y8+ T cells , CD4+ T cells or CDS+ T cells per 100,000 lymphocytes after 24 hrs 
co-culture with Pf-RBC. N= 14 naIve donors. (E) The percentage of all IFN-y+ cells that are either NK 
cells or T cells after 6, 12 or 24 hrs or 2, 4 or 6 days co-culture with Pf-RBC. Numbers on X axis identify 
individual blood donors. B,D,E: Horizontal lines represent medians. P-values are for 2 tailed paired 
Wilcoxon tests with 95% CI comparing NK cells with T cells from the same donor. 
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Since potent antigen-specific T cell responses to Pf-RBC might not be expected among malaria 
na"lve donors I next sought to identify which subsets of T cells were producing IFN-y. PBMCs 
from 14 donors were incubated with Pf-RBC for 21 hours and gated as NK cells, as CD3+ 
y8TCR+ or CD3+ a~TCR+ T cells; at some key time points~ a~ T cells were gated as either CD4+ 
or CD8+ T cells (Fig. 3.6A). When each lymphocyte population was separately analysed for 
IFN-yexpression we again found that - on average - a higher proportion of NK cells than T cells 
produce IFN-y, but among the T cell populations, a significantly higher proportion of y<3TCR+ T 
cells were IFN-y+ than either of the a~TCR+ T cell subsets (Fig. 3.6B). However, because the 
majority of circulating T cells are a~TCR+, when I gate on all IFN-y+ cells (Fig. 3.6e) I find that 
the majority oflFN-y+ T cells are CD4+ a~TCR+ and that CD4+ a~TCR+T cells and NK cells 
contribute equally to the total IFN-y+ population with CD8+ a~TCR+ and y<3TCR+ cells making 
only a minor contribution (Fig. 3.60). To make sure that I had not missed the optimal timing for 
responses of any particular T cell subset, I repeated the kinetic analysis over 6 days (Fig. 3.6E) 
and found that TCR-a~+ T cells were the major contributing T cell population throughout the 
response. 
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Figure 3.7 Representative flow cytometry plots to show the effects of blocking antibodies 
on NK cell and T cellIFN-y responses to Pf-RBC. 
PBMC were cultured in with Pf-RBC in the presence of blocking antibod ies to IL-12, IL-18, IL-2, 
IFN-aR[2b], MHC Class 1 or MHC Class II , or their respective isotype matched controls , 
Representative flow cytometry data are shown for 1 donor demonstrating the gating strategy for 
(A) NK cells (CD56+ CD3- lymphocytes) and (B) T cells (all CD3+ lymphocytes), wh ich are then 
further classified as IFN-y+ (% shown) or IFN-y-, 
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3.3.2 NK cell and T cell responses to Pf-RBC are both cytokine and MHC-c/ass " dependent 
Our group has previously shown that NK cell responses to Pf-RBC are absolutely dependent 
upon myeloid cell-derived IL-12 (Artavanis-Tsakonas, Eleme et al. 2003) and partially 
dependent upon IL-18, IFN-a and IL-2 (Newman, Korbel et al. 2006). Moreover, it has 
previously been shown that memory CD4+ T cells from malaria na'lve individuals are able to 
respond to Pf-RBC in a classical MHC-c1ass II-restricted manner (Jones, Hickling et al. 1990; 
Currier, Sattabongkot et al. 1992; Dick, Waterfall et al. 1996) and it is now generally accepted 
that these cells have been primed by cross-reacting antigens (Currier, Sattabongkot et al. 1992; 
Riley 1999). To confirm and extend these observations, PBMC from 10 malaria na'lve donors 
(selected to represent a range of NK responses from non-responders to high responders) were 
cultured with Pf-RBC for 24 hours in the presence of blocking or neutralising antibodies to IL-12, 
IL-18, IL-2, IFN-a receptor, MHC-Class I, MHC-Class /I or the relevant isotype control 
antibodies. A representative data set for one donor is shown in Figure 3.7; data for all 10 
donors are shown in Figure 3.8. As expected, NK cell IFN-y responses were markedly and 
significantly diminished by anti-IL-12, anti-IL-2 and anti-IFN-aR although the effect of anti-IL-18 
was less obvious (Fig. 3.8A-D). Also in confirmation of a previous study (Korbel, Norman et al. 
2009), blocking antibody to MHC-Class I had no effect on the NK cell response (Fig. 3.8E). 
Somewhat unexpectedly however, NK cell responses to Pf-RBC were markedly reduced in the 
presence of MHC-Class II blocking antibody (Fig. 3.8F). 
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Figure 3.8 NK cell and T cell responses to Pf-R8C are both cytokine and MHC-class II 
dependent. 
PBMC from 10 donors were cultured with Pf-RBC for 24 hours in the presence of blocking 
antibodies to cytokines, cytokine receptors or MHC molecules or with isotype matched control 
antibodies and the percentages of NK cells (left columns) and T cells (right columns) expressing 
intracellular IFN-y determined by flow cytometry. P-values are for 2-tailed paired Wilcoxon test 
with 95% CI. (A) anti-IL-12; (8) anti-IL-18; (C) anti-IL-2; (0) anti-IFN-a receptor; (E) anti-MHC 
Class I; (F) anti-MHC Class II. 
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Figure 3.9 Titrating M. bovis BeG input dose to define optimal multiplicity of infection for 
NK cell activation. The proportion of all NK cells expressing intracellular IFN-:yafter 21 hrs co-
culture with BCG at varying MOl in 5 donors who have received BCG vaccination. Data are 
representative of median values with error bars representing the range. 
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As expected, given the previously published data (Jones, Hickling et al. 1990; Currier, 
Sattabongkot et al. 1992; Dick, Waterfall et al. 1996; Riley 1999; Artavanis-Tsakonas, Eleme et 
al. 2003; Newman, Korbel et al. 2006; Korbel, Norman et al. 2009), the preponderance of CD4+ 
T cells in the IFN-y responding population and the small but noticeable contribution of CD8+ T 
cells, total T cell IFN-y responses were markedly diminished in the presence of anti-MHC-Class 
II antibodies (Fig. 3.8F) and significantly, but less markedly, diminished by MHC-Class I 
blockade (Fig. 3.8E). Total T cell responses were also significantly inhibited by neutralising 
antibodies to IL-12, IL-18 and IL-2 and there was a marginally significant effect of anti-IFN-aR 
(Figure 3.8A-D) indicating that T cells are also dependent upon accessory cell-derived 
cytokines. 
The observation that blocking MHC class II molecules inhibited the production of IFN-y, led me 
to question if this was unique to NK cell and T cell responses to Pf-RBC or if responses to other 
pathogens or pathogen-related stimuli are similarly regulated by MHC class II presentation. I 
used Mycobacterium bovis Bacillus Calmette-Guerin (BCG, Pasteur strain; kind gift from U. 
Schaible) as a model organism as well as LPS and recombinant human IL-12 and IL-18 (rhIL-12 
+ rhIL-18) to represent pathogen-derived proteins and exogenous stimuli. I first co-incubated 
PBMC with varying doses of BCG, in order to establish the most effective MOl (Figure 3.9). 
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Figure 3.10. Prior BCG vaccination has no significant effect on the NK cellIFN-y response 
to BCG. PBMC were cultured overnight with BCG at an MOl of 1 PBMC : 10 BCG. The 
proportion of all NK cells expressing intracellular IFN-y after 24 hrs co-culture with BCG. N= 50 
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significance. 
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Figure 3.11 NK cell and T cell responses to BCG are also MHC-class II dependent 
PBMC from 10 donors were cultured with BCG for 24 hours in the presence of blocking 
antibodies to (A) MHC class I molecules molecules or (B) MHC class /I molecules or with 
isotype control antibodies and the percentages of NK cells (left columns) and T cells (right 
columns) expressing intracellular IFN-y determined by flow cytometry. P-values are for 2-tailed 
paired Wilcoxon test with 95% CI. 
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Once I had established that 10 BGG : 1 PBMG was the optimal MOl, I tested the NK celllFN-y 
response to BGG in the same 50 malaria na'ive donors (Fig ure 3.10). Of the 50 donors, 36 were 
previously BGG-vaccinated and 14 were not. I did not observe any significant differences in NK 
celllFN-y responses between the BGG-vaccinated (exact range unknown but all donors >20 
years) and unvaccinated group. 
I next co-incubated PBMG from 10 donors with BGG for 24 hours either in the presence of 
blocking antibodies for MHG class I and MHG class II molecules or with their respective isotype 
control antibodies. As for the experiments using Pf-RBG, blocking MHG class I presentation had 
no significant effect on BGG-induced IFN-yproduction by NK cells orT cells (Fig. 3.11A) but 
blocking MHG class II presentation nearly ablated the IFN-y response in both NK cells and T 
cells (Fig. 3.11 B). 
This observation of NK cell and T cell dependency on MHG class II presentation of antigen is 
not universal as we also measured IFN-y production from NK cells and T cells in response to 
LPS and found that these responses were independent of blocking either MHG class I or II 
molecules (Figure 3.12). These results are not unexpected as it is considered well-established 
that LPS-induced activation is mediated by TLR 4 pathways leading to the activation of NFKB 
signalling in macrophages (Moore, Goodrum et al. 1976; Beutler and Rietschel 2003). 
65 
ns 
15.0 I I r=:::: I/J Q) 12. 0 
~ 10.0 
Z ~ + 7. ;-I Z 
u.. 
0 0 ~ 2. 0-0 
-0 
0.0 
isotype o-MHC I 
p = 0.06 
1 
I/J 
Q) 
0 $:: ~ 10 Z + ;;-
Z 0-
u.. t=== --0 '::R. 
------
~ 0 
0 
iSotype o-MHC II 
5 
~ 
Q) 4 
0 
I- 3 
+ ;-
I 
2 Z 
lL. 
~ 0 1 
0 
I/J 
Q) 4 
u 
I- 3 
+ ;-
I 
Z 2 
lL. 
~ 0 1 
0 
ns 
Q e 
0----_--0 
isotype o-MHC I 
ns 
:= ~ 
~ 
==~ 
isotype o-MHC II 
Figure 3.12 NK cell and T cell responses to LPS are independent of MHC class I and class 
II presentation 
PBMC from 8 donors were cultured with LPS for 24 hours in the presence of blocking antibodies 
to (A) MHC class I molecules molecules or (8) MHC class II molecules or with isotype control 
antibodies and the percentages of NK cells (left columns) and T cells (right columns) expressing 
intracellular IFN-'Y determined by flow cytometry. P-values are for 2-tailed paired Wilcoxon test 
with 95% CI. 
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Figure 3.13 Representative flow cytomtery plots demonstrati n9 effects of depleti n9 T cell 
subsets on IFN-y production by NK cells in response to Pf-RBC 
Representative flow cytometry data from one donor showing the percentages of NK cells 
expressing intracellular IFN-y after 24 hours co-incubation with Pf-RBC, 
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3.3.3. NK cell responses to Pf-RBC are dependent upon T cell help 
The observation that NK cell responses to Pf-RBC were highly dependent upon both IL-2 and 
MHC Class II raised the possibility that - as previously described for human NK cell responses 
to influenza (Fehniger, Cooper et al. 2003; He, Draghi et al. 2004) - NK cells require signals 
(such as IL-2) from antigen-specific CD4+ T cells in order to respond optimally to Pf-RBC. To 
test this hypothesis, I depleted PBMCs of various lymphocyte populations and tested the 
remaining PBMCs for their ability to make IFN-y in 24 hr cultures (Figure 3.13 and Figure 3.14). 
NK cells among CD3-depleted PBMCs made strong responses to rhIL-12+IL-18 (Fig. 3.14A) 
indicating that these two cytokines (at optimal concentrations) are sufficient for NK cell 
activation. Conversely, NK cells among CD3-depleted PBMCs were completely unable to make 
IFN-y in response to Pf-RBC (Fig. 3.148) but NK cells among CD20 (B cell)-depleted PBMCs 
made a robust IFN-y response to Pf-RBC (Fig. 3.14C). To determine which subset(s) of T cells 
provide help to NK cells, I depleted PBMCs of just CD4+ T cells, just CD8+ T cells, all a~TCR+ T 
cells or all y8TCR+ T cells and cultured the remaining PBMCs with Pf-RBC for 24 hrs (Fig. 
3.14D-G). All depletions reached levels of >97% efficiency. It was clear that the NK cell 
response to Pf-RBC was only completely ablated when all T cells were removed but that 
removal of any T cell subset significantly reduced the NK cell IFN-y response. Finally, to rule out 
any non-specific effects of magnetic bead treatment, unlabelled PBMC were incubated with anti-
PE microbeads and passed through the magnetic column (Fig. 3.14H); a robust IFN-y response 
was seen. 
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Figure 3.14 NK cell responses to Pf-RBC are dependent upon C04+ T cell help. 
Intact PBMC or PBMC depleted of various T cell subsets were incubated for 24 hours with (A) 
100ng/ml each of rh1L-12 + rh1L-18 or with (B-F) Pf-RBC, and the percentages of NK cells 
staining for intracellular IFN-1' were measured by flow cytometry. PBMC were depleted of (A,B) 
all CD3+ cells; (C) CD20+ B cells; (0) a~ T cells; (E) CD4+ T cells; (F) CD8+ T cells and (G) 1'8 T 
cells or (H) incubated with anti-PE microbeads (without antibody) and passed through the 
magnetic column. P-values in are for 2-tailed paired Wilcoxon tests, 95% CI, for 15 donors. 
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Figure 3.15 NK cell responses to M. bovis BeG are dependent upon e04+ T cell help. 
Intact PBMC or PBMC depleted of various T cell subsets were incubated for 24 hours with (A-F) 
BCG, and the percentages of NK cells staining for intracellular IFN-y were measured by flow 
cytometry. PBMC were depleted of (A) all CD3+ cells; (B) CD20+ B cells ; (e) a~ T cells ; (0) 
CD4+ T cells; (E) CD8+ T cells and (F) y'6 T cells. P-values in are for 2-tailed paired Wilcoxon 
tests, 95% CI, for 15 donors. 
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Figure 3.16 NK cell responses to LPS are independent of T cell help. Intact PBMC or 
PBMC depleted of all CD3+ cells were incubated for 24 hours with LPS, and the percentages of 
NK cells staining for intracellular IFN-y were measured by flow cytometry. P-values in are for 2-
tailed paired Wilcoxon tests , 95% CI , for 15 donors. 
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I also measured the effects of subset-specific T cell depletion on NK cells when co-incubating 
with BCG (Figure 3.15) as well as with LPS (Figure 3.16). In contrast to what was seen for NK 
cell responses to Pf-RBC, NK cell responses to BCG seem to be completely dependent upon 
ap+ T cells, but there was no obvious role for yo+ T cells. When depleting PBMC of all T cells 
(Fig. 3.15A) or just TCR-ap+ T cells or just CD4+ or CD8+ T cells, the NK cell response to BCG 
was significantly impaired. The NK cell response to BCG was, however, independent of yo-
TCR+ T cells (Fig. 3.15F). I also examined the T cell dependence of NK cell responses to LPS 
(Fig. 3.16). I found that only in one case was the NK cell response apparently dependent upon 
T cell help and overall there was no significant effect of T cell depletion on the NK celllFN-y 
response to LPS, suggesting an alternative pathway for NK cell activation by LPS. 
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Figure 3,17 Rapid IL-2 production by C04+ T cells after co-culture with Pf-RBC 
PBMC were incubated with Pf-RBC for up to 24 hours. (A) Median concentration of IL-2 in 
culture supernatants , determined by cytometric bead array, over time. N = 5 donors. (B) Gating 
strategy for identification and phenotypic characterisation of IL-2-producing cells . (C) The total 
number of IL-2+ lymphocytes at each time point. N = 10 donors . (0) The proportion of aIlIL-2+ 
lymphocytes that are either NK cells or are y'{/ T cells, CD4+ T cells or CD8+ T cells when 
comparing responses over 24 hours. Data are presented for 10 donors at all time point except 
at 12 hours for which data from 14 donors are shown. Horizontal lines indicate median values. 
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Figure 3.18. Early IL-2 production is highly correlated with NK cellIFN-y production in 
response to Pf-RBC. PBMC from 10 donors were co-incubated with Pf-RBC for up to 24 hours. 
2-tailed Spearman correlation tests were performed to compare IL-2 responses at various time 
points with the peak NK cell IFN-y response (at 24 hours). Solid lines represent the best fit line 
and dotted lines represent 95% confidence intervals. 
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3.3.4 CD4+ T cells produce IL-2 within 12 hrs of co-culture with Pf-RBC 
Since NK cells require both T cell help (this thesis) and IL-2 (Newman, Korbel et al. 2006) in 
order to respond to Pf-RBC, it seemed likely that T cells are an essential source of IL-2. I sought 
to determine the kinetics of IL-2 production in response to Pf-RBC and to identify the major 
source(s) of this cytokine (Figure 3.17). IL-2 was detected in culture supernatants within 3 
hours of PBMC-Pf-RBC co-culture, peaked at 4 hrs and remained detectable for at least 24 
hours (Fig. 3.17A). In parallel cultures, intracellular IL-2 in NK cells and in T cell subsets was 
analysed by flow cytometry (Fig. 3.178-0). All IL-2+ cells were gated (Fig. 3.178) and counted 
(Fig. 3.17C). IL-2+ cells were first detected at 3hrs after initiation of co-culture and their numbers 
peaked at 12 hrs; the discrepancy in timing between the accumulation of soluble IL-2 in culture 
medium (Fig. 3.17A) and the peak of IL-2 secreting cells (Fig. 3.17C) presumably reflects the 
balance between secretion and consumption of IL-2 in the culture. At all time points, the vast 
majority (>80%) of IL-2-producing cells were CD4+ T cells with only minor contributions from 
CD8+ T cells at 6 and 12 hours and from yoT cells and NK cells at 3hrs (Fig. 3.170). 
Interestingly, IL-2 responses were much less heterogeneous among the various donors than 
were IFN-y responses. 
I next wanted to see if the IL-2 response was correlated with the subsequent NK cell IFN-y 
response, i.e. how likely was it that the IL-2 was driving the NK cell response to Pf-RBC? I 
examined IL-2 responses from 10 donors (Figure 3.17) at various time points in culture side-by-
side with the NK cell IFN-y response at 24 hours using XY scatter plots with 2-tailed spearman 
correlations (Figure 3.18). These data show that IL-2, produced as early as 3 hours post-
incubation of PBMC with Pf-RBC, is highly correlated with the activation of NK cells. As the 
number of IL-2-producing lymphocytes increased, so did that number of IFN-y+ NK cells. 
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Figure 3.19 Rapid TNF production from macrophages and yB+ T cells in response to Pf-
RBC 
PBMC were incubated with Pf-RBC for up to 24 hours. (A) Median concentration of TNF in 
culture supernatants, determined by cytometric bead array, over time. N = 5 donors . (B) Gating 
strategy for phenotypic characterisation of TNF-producing macrophages (CD14+CD68+) and y'f/ 
T cells (TCR-y8+ TCR-aW when gated on all CD3+ cells) after 12hrs PBMC co-culture with Pf-
RBC. (C) Representative flow cytometry data from one donor showing the percentages of 
macrophages (top row) or y8+ T cells (bottom row) expressing intracellular TNF after 4 or 12 
hours. (0) PBMC from 8 donors were incubated for up to 24 hours with Pf-RBC and 
percentages of macrophages (light circles) and y8+ T cells (dark circles) producing TNF-a were 
measured by flow cytometry. Data represent medians (±SE). (E) PBMC from 8 donors with 
previously documented high IFN-y responses to Pf-RBC were incubated for 24 hours with Pf-
RBC in the presence of neutralising antibody to TNF or with an isotype-matched control 
antibody and the percentages of T cells (left side) and NK celis (right side) expressing IFN-y 
were measured. P-values are for 2-tailed paired Wilcoxon tests, 95% CI. 
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3.3.5 yJ T cells produce TNF in response to Pf-RBC but TNF is not required for NK cell 
or T cell IFN-yresponses 
Since yo TCR+ T cells seemed to be necessary for an optimal NK response to Pf-RBC 
(Figure 3.142 but did not seem to be significant producers of IL-2 (Figure 3.17) I 
considered whether other cytokines produced by yo T cells might contribute to NK cell 
activation. As Hensmann et al have previously shown that yoT cells represent a 
significant source of intracellular TNF during the early (18hr) response to Pf-RBC 
(Hensmann and Kwiatkowski 2001) and as Robinson et al concluded (from T cell subset 
depletion assays) that yo T cells are a significant source of TNF (Robinson, D'Ombrain et 
al. 2009), I considered the possibility that yo T cell-derived TNF might potentiate NK cell 
responses. TNF was detected in supernatants within 4 hrs of PBMC-Pf-RBC co-culture 
and peaked at approx. 12 hrs (Fig. 3.19A). In parallel, PBMCs from 8 malaria na'ive 
donors were incubated with Pf-RBC for up to 24hrs and then stained for intracellular 
TNF and for surface markers to identify macrophages (CD14+ CD68+) and yo T cells 
(Fig. 3.19B). When gating on all macrophages (Fig. 3.19C), TNF+ macrophages were 
detectable within 2 hrs of Pf-RBC co-culture, the response peaking (with >35% of all 
macrophages being TNF+) at 4hrs and declining to barely detectable levels by 24 hrs 
(Fig. 3.190). In comparison, TNF+ yo T cells were detected from approx 5-6 hrs after 
initiation of Pf-RBC stimulation and the response was maximal (with -30% of all y8T 
cells being TNF+) at 12-24hrs (Fig. 3.19C-0). However, I found no evidence that TNF 
was required for induction of an early IFN-y response since when I stimulated PBMC 
from the same donors with Pf-RBC in the presence of neutralising antibodies to TNF the 
NK cell and T cell I FN-y responses were unaffected (Fig. 3.19E). 
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Figure 3.20 T cell help for NK cell activation by Pf-RBC does not require NK cell-T 
cell contact. PBMC were placed in the lower well, and CD3-depleted PBMC were 
placed in the upper well of a transwell chamber separated by a semi-permeable 
membrane and cultured in the presence (+) or absence (-) of Pf-RBC, anti-IL-2 antibody 
or isotype-matched control antibody (rabbit IgG). The percentage of NK cells in each 
chamber expressing IFN -y was determined after 24 hrs. Data for each donor were 
normalised to the response given by their own PBMC cultured directly with Pf-RBC in 
the lower chamber (Pf-RBC: median 41 %, inter-quartile ranges 6%; BCG: median 27%, 
inter-quartile ranges 5%; and LPS: median 14%, inter-quartile ranges 3%) and are shown 
as medians and inter-quartile ranges for 5 donors. P-values are for 2-tailed paired 
Wilcoxon tests, 95% CI. 
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3.3.6 T cell help for NK cell activation by Pf-RBC does not require NK cell-T cell contact 
I have shown that T cell-derived signals are required for NK cell activation by Pf-RBC. 
One of these signals is clearly IL-2, emanating principally from CD4+ a~ T cells, but T 
cell depletion studies suggest that there may also be an, as yet undefined, role for y'fJ T 
cells in NK cell activation. We have previously shown that direct contact between NK 
cells and myeloid accessory cells is required for optimal NK cell responses to Pf-RBC 
(Newman, Korbel et al. 2006)and I therefore considered the possibility that T cells might 
also provide contact-dependent signals to NK cells (Figure 3.20). Intact PBMC and 
CD3-depleted PBMC were cultured in separate compartments of a transwell plate 
separated by a semi-permeable membrane; intact PBMC in the lower chamber and 
CD3-depleted PBMC in the upper chamber. When Pf-RBC (Fig. 3.20A) or BCG (Fig. 
3.208) were added to the CD3-depleted (upper) PBMC compartment but not to the 
intact PBMC (lower compartment), NK cells in neither compartment produced IFN-
y, suggesting that Pf-RBC/BCG need to be in the same compartment as the T cells in 
order for NK cells to become activated, consistent with a need for antigen presenting 
cells to take up antigen and present it to T cells in an MHC-Class II-dependent manner. 
However, if Pf-RBC/BCG were added to both compartments, NK cells in both the intact 
PBMC population and in the CD3-depleted NK cell population were able to respond fully, 
indicating that soluble T cell-derived signals passing through the semi-permeable 
membrane were sufficient to activate the NK cells. To determine if this soluble signal is 
IL-2, I added neutralising anti-IL-2 antibody to the CD3-depleted PBMCs in the upper 
chamber and added Pf-RBC/BCG to both compartments. In this case, the NK cell IFN-y 
response was significantly inhibited in both compartments. Having already learned that 
the NK cell response to LPS was T cell-independent, I also used LPS (Fig. 3.20C) to 
stimulate NK cells as an internal negative control. When comparing conditions where 
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LPS was added to both the top and bottom chambers with only adding LPS to the top 
chamber, I did not observe any significant decrease in the NK cell response. 
Interestingly, blocking IL-2 seemed to reduce the response, although did not reach a 
level of significance. 
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3.4 Discussion 
Whilst there is a general consensus that a rapid, cell-mediated, inflammatory response is 
required to contain the initial stages of human blood stage malaria infections there has 
been considerable debate over many years as to the key cellular effectors of this 
response (Stevenson and Riley 2004). I have therefore conducted a detailed kinetic 
analysis of all the likely sources of IFN-yand find that the very early « 24hrs) IFN-y 
response to Pf-RBC is dominated - in most PBMC donors - by NK cells, that NK cells 
and T cells contribute more-or-Iess equally to the response at 24hrs and that T cells 
. come to dominate the response from 48 hrs onwards. This rapid NK cell response to Pf-
RBC among PBMCs from malaria naive donors is in full agreement with both earlier 
studies from our laboratory (Artavanis-Tsakonas and Riley 2002) and others (Baratin, 
Roetynck et al. 2007). D'Ombrain et al (D'Ombrain, Hansen et al. 2007) concluded that 
NK cells do not contribute significantly to the innate IFN-y response to Pf-RBC however 
their studies did not include the very early time points (12-18 hrs) at which I observe 
maximal NK cell responses, suggesting that an NK response may have been present in 
their donors but was missed, although it is surprising that D'Ombrain et al report so few 
IFN-y+ NK cells at 24hrs. Although Hensmann et al (Hensmann and Kwiatkowski 2001) 
stained for CD3, CD56 and IFN-y after 18hrs co-culture with Pf-RBC they studied only 4 
donors and did not explicitly report the NK cell IFN-y response; from the data presented 
in their paper it is possible that between 10 and 40% of IFN-y+ cells in their donors could 
have been NK cells, which is well within the range that we have observed in our much 
larger donor panel. 
More problematic is our observation that the vast majority of IFN-y-producing T cells (at 
all time points from 6 hrs to 6 days of Pf-RBC co-culture) are TCR a~+ and CD4+; this 
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finding is in direct contradiction to the findings of both Hensmann et a/ (Hensmann and 
Kwiatkowski 2001) and D'Ombrain et a/ (D'Ombrain, Hansen et al. 2007) which 
suggested that y'f/ T cells are the major producers of I FN-y in response to Pf-RBC 
stimulation. The reason for these conflicting results is unclear. It is possible that there 
are technical explanations. The three studies used different P. fa/ciparum clones, which 
might differ in their production of the phosphorylated nonpeptidic antigens which are 
believed to be the ligands for Vy9+ T cells (Behr, Poupot et al. 1996) although our 
observation of very robust TNF response to Pf-RBC by yaT cells tends to argue against 
this explanation. We have previously observed that yaT cells require quite considerable 
amounts of IL-2 in order to proliferate in response to Pf-RBC (Waterfall, Black et al. 
1998); I do not routinely add exogenous IL-2 or other co-stimulatory agents to my 
cultures which may explain the lack of yaT cell IFN-y responses in my experiments, but 
again the robust ya T cell TNF response suggests that this is not the explanation. Lastly, 
I have taken great care to avoid misclassification of lymphocyte populations by (i) using 
simUltaneous 7-colour analysis of CD3, CD56, a~TCR, yaTCR, CD4 and CD8 and IFN-y 
expression, (ii) by inclusion of anti-CD3 in the intracellular mix to identify activated T 
cells which may have down-regulated surface expression of CD3 and (iii) by using a 
biotinylated anti-yaTCR antibody which does not suffer from the tendency that we have 
observed of some supposedly yaTCR-specific antibodies to stain both CD3- and 
a~ TCR+ cells. I note with some concern that the majority of the IFN-y+ yaTCR+ cells in 
the study by D'Ombrain et al (D'Ombrain, Hansen et al. 2007) also express NK cell 
markers, raising interesting questions as to the true identity of these cells. Alternatively, 
the differences seen in the various studies may reflect genuine heterogeneity in ,,(aT cell 
responses between individuals or popUlations, reflecting the known inter- and intra-
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population diversity in numbers and TCR repertoires of y'tt T cells (Carding and Egan 
2002). 
The strong a~TCR+ CD4+ T celllFN-y response that I observed after 2-6 days of Pf-RBC 
activation is highly consistent with previous reports in na'lve humans (Currier, 
Sattabongkot et al. 1992; Fell, Currier et al. 1994; Dick, Waterfall et al. 1996), with 
evidence for cross-reactive priming of malaria-reactive T cells by a diverse array of 
commonly encountered micro-organisms (Currier, Sattabongkot et al. 1992) and with 
data from murine infections indicating that a~+ T cells can playa crucial role in the IFN-y 
response to primary infections (Lertmemongkolchai, Cai et al. 2001; Berg, Crossley et al. 
2005; Le-Barillec, Magalhaes et a!. 2005). It is difficult to predict whether or not such 
cross-reactive responses would be beneficial should these individuals become infected 
with malaria; na'ive adults show very variable responses to primary malaria infections 
with some making a very rapid - and partially protective - pro-inflammatory responses 
whilst others make little or no inflammatory response and develop rapidly escalating 
parasitaemia (Walther, Tongren et a!. 2005; Walther, Woodruff et a!. 2006). 
A somewhat unexpected finding of this study was the absolute dependency of NK cells 
on CD4+ T cell-derived IL-2 for their response to Pf-RBC. With hindsight, this should not 
have been a surprise. We have previously shown that NK cell responses to Pf-RBC 
depend upon cytokine and contact-mediated signals from myeloid cells (Newman, 
Korbel et al. 2006) and we did notice in those experiments that NK responses were 
diminished by anti-IL-2 and that adding purified adherent accessory cells to isolated NK 
cells did not fully restore the NK response seen in intact PBMCs (Newman, Korbel et al. 
2006). Moreover, T cell and IL-2 dependency has previously been reported for NK cell 
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activation by influenza virus (He, Draghi et al. 2004) and, in mice, NK cell cytotoxicity 
against some tumour cells is apTCR+ T cell dependent (Arina, Murillo et al. 2007; 
Shanker, Verdeil et al. 2007) but the possibility that this is IL-2-mediated remains to be 
formally tested. However, although it has long been taken for granted that antigen-
specific T cells mediate some of their anti-microbial effects by activation of innate cells 
such as macrophages, the possibility that antigen-specific T cells might interact with 
other cells of the innate response, in particular with NK cells, has largely been ignored. 
My current hypothesis is that, on exposure to cognate antigen presented by MHC Class 
II, TCR ap+ T cells secrete IL-2, which - in combination with essential signals from 
myeloid accessory cells - activates NK cells. The preponderance of CD4+ T cells among 
the IL-2+ cell population is consistent with the very marked effect on the NK cell 
response of MHC-Class II blockade. The transwell experiments indicate that the IL-2 is 
secreted from the T cells and diffuses in solution towards the NK cells; there is no 
apparent requirement for contact between the T cell and the NK cell nor for the focal 
secretion of IL-2 into an immune synapse. However, it is likely that T cells also provide 
other NK cell potentiating signals. For example, although I found no evidence that Pf-
RBC-activated y8 T cells produced significant amounts of IL-2, depletion of y8 T cells 
from PBMCs substantially reduced the NK cell IFN-y response. I do not believe that this 
is simply due to a reduction in the proportion of T cells in the cultures since y8 T cells 
represent a very small proportion of the total T cell pool and an equally small proportion 
of the IL-2+ T cells,J have not yet identified the y8 T cell contribution to the NK response 
but it does not appear to be TNF. 
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My data suggest that full reactivation of IFN-y-producing T cells also requires IL-2-
mediated signals since the peak of the T cell IL-2 response preceded the peak of the T 
cell IFN-y response and neutralisation of IL-2 markedly reduced IFN-y responses of T 
cells as well as NK cells. However, NK cell IFN-y responses peaked within 6 hrs of the 
peak IL-2 response whereas T cell IFN-y responses did not peak until -36 hrs after the 
peak IL-2 response suggesting that T cells may require higher concentrations of IL-2, or 
more sustained IL-2 signalling, to become fully activated than do NK cells. 
My observations imply that enhancing T cell responses to malaria (i.e. by vaccination) 
should also enhance the NK cell response. Given its speed (which precedes the bulk of 
the T celllFN-y response by hours or days) the NK IFN-y response may represent an 
important determinant of vaccine efficacy and the ability of vaccine-induced T cells to 
support NK cell effector function might be an important biomarker of an effective T cell 
response to the vaccine. Finally, my demonstration that NK cell responses to Pf-RBC 
are so highly dependent on T celllL-2 may necessitate reconsideration of data based 
simply on T cell-depletion of PBMC; the possibility that the IFN-y-producing cells might 
be NK cells - and that the main role of T cells might be to secrete IL-2 - needs to be 
considered and IFN-y ELISA, CBA or ELiSPOT data need to be confirmed by 
intracellular cytokine staining and flow cytometry. 
The following two chapters describe the activation of NK cells and T cells during recall 
responses to vaccine antigens. 
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Chapter 4: Markers of T cell and NK cell 
recall responses to vaccine antigens in a 
Phase lib trial of the malaria vaccine 
RTS,S/AS01 E in Tanzanian children 
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4.1 Introduction 
Malaria remains a major cause of human disease and deaths in the developing world 
(WHO 2008). Whilst recent reports of declining malaria morbidity in several African 
countries suggest that concerted control efforts may be having an impact on malaria 
transmission (WHO 2008), it is generally agreed that a safe and effective malaria 
vaccine would make a SUbstantial contribution to sustainable control and elimination 
programmes. The most advanced malaria vaccine currently in human trials, RTS,S/AS, 
has been consistently found to confer partial protection against malaria infection and 
against clinical malaria episodes in multicentre phase" trials (Ballou 2009). RTS,S is a 
virus-like particle produced in Saccharomyces cerevisiae comprising the C terminus 
(amino acids 207-395) of the P. falciparum circumsporozoite (CS) protein fused to the 
Hepatitis B virus surface antigen (HBs) together with excess HBs (Figure 4.1). 
It has recently been reported that RTS,S administered with the GSK proprietary adjuvant 
AS01 (liposomes containing MPL [derived from lipid A] and OS21 [plant extract from 
Soap bark treeD to Tanzanian and Kenyan children aged 5-17 months has an efficacy 
against clinical malaria caused by Plasmodium falciparum of 53 % (95% confidence 
interval [CI], 28-69%) in children followed up for a mean of 8 months (Bejon, Lusingu et 
al. 2008), of 39% (95% CI 20-54%) in children followed for 12 months and of 46% (95% 
CI 24-61 %) in a subset of children followed for a mean of 15 months (Olotu, Lusingu et 
al. 2010). 
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Figure 4.1 Schematic of RTS,S malaria vaccine (adapted from Soares and 
Rodrigues 1998). (A) Schematic representation of the RTS protein, which contains a 
repeat region of the circumsporozoite protein chemically linked to the HBsAg protein and 
the S protein, which is free HBaAg protein. These proteins are then co-transfected into 
(8) a yeast hybrid system , producing the RTS,S malaria vaccine. 
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Several thousand individuals have been enrolled into clinical trials of RTS,S and it has 
taken almost 15 years to progress from the original successful phase Ib trials (Stoute, 
Siaoui et al. 1997) to the current multicentre phase III trials of RTS,S/AS01 which aims 
to enroll 16,000 infants and children in 7 sub-Saharan African countries. One reason that 
this has been such a long, drawn-out process is that there are no reliable immunological 
correlates of vaccine efficacy, meaning that each reformulation of the vaccine has had to 
be evaluated empirically, in clinical trials in malaria-exposed populations. Identifying 
immunological correlates of protection for RTS,S would not only speed up evaluation of 
future pre-erythrocytic vaccine formulations but would also allow us to engineer those 
new formulations to preferentially induce the most protective immune effector responses. 
To date, significant associations have consistently been observed between titres of IgG 
antibodies to the immunodominant, repetitive (NANP)n epitope and resistance to 
infection and current best estimates suggest that the threshold IgG concentration 
required for protection is something in excess of 20IJg/mi (Moorthy, Diggs et al. 2009). 
Serum antibodies have been less consistently associated with protection against clinical 
episodes of malaria but it has recently been calculated that anti-(NANP)n antibody titres 
of approx 40 ELISA Units/ml (EU/ml) are associated with a highly significant step-
change in risk of clinical malaria (Olotu, Lusingu et al. 2010). The contribution of cellular 
immune responses to RTS,S induced immunity has been less extensively studied. 
Preclinical data are strongly suggestive of protective roles for IFN-y-producing CD8+ T 
cells (Moorthy and Ballou 2009). Among malaria na'ive vaccinees, activation of both 
CD4+ and CD8+ T cells has been observed (by IFN-y ELiSPOT and by flow cytometric 
analysis of IFN-y, TNF, IL-2 and CD40L expression) after in vitro restimulation of 
peripheral blood mononuclear cells (PBMC) with peptides representing known T cell 
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epitopes from the CS protein (Lalvani, Moris et al. 1999; Sun, Schwenk et al. 2003; 
Kester, Cummings et al. 2009) and there has been a consistent (and, in one case, 
statistically significant) trend for individuals who were subsequently protected against 
challenge infection to have stronger responses than individuals who were not protected. 
Importantly, in a recent trial of RTS,S administered with AS02 (an oil-in-water version of 
the MPLI QS21 adjuvant) to infants in Mozambique has revealed marginally statistically 
significant associations between protection from infection, CS-specific IL-2 secretion 
(detected by cytometric bead array) and CD8+ T cell IFN-y production (detected by 
intracellular staining and flow cytometry) in whole blood assays (Barbosa, Naniche et al. 
2009). 
In this chapter, I will report the results of a detailed analysis of the post-vaccination 
cellular immune responses of children (aged 5-17 months at enrolment) enrolled in the 
Phase I/lIb trial of RTS,S/AS01 E in Korogwe, Tanzania. Although the number of clinical 
cases of malaria among the cohort of children studied was too low for any meaningful 
analysis of correlates of protection, I have identified additional very sensitive markers of 
CS-specific T cell recall responses (CD69 and CD25 expression) and a previously 
unrecognised response by natural killer (NK) cells. In addition to facilitating the search 
for sensitive and specific immunological correlates of vaccine efficacy, these newly 
identified markers of cellular immune responses to RTS,S reveal a potential new 
pathway of vaccine-induced pre-erythrocytic immunity, namely rapid activation of NK 
cells by antigen-specific secretion of IL-2. 
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4.2 Materials and methods 
4.2.1 Study subjects and vaccinations 
Four hundred and forty seven, 5- to 17-month old Tanzanian children were enrolled in a 
Phase lib, randomised, double blind, controlled trial of RTS,S/AS01 E (ClinicaITrials.gov 
registration number NCT00380393); the trial is described in detail elsewhere (Bejon, 
Lusingu et al. 2008). Children received either 3 doses of RTS,S/AS01 E (n = 224) or 3 
doses of human diploid cell rabies vaccine (Sanofi-Pasteur) (n = 223) at approximately 4 
week intervals (acceptable range 20-60 days). Venous blood samples for assessment of 
cellular immune responses and antibody titres were collected approximately 4.5 months 
after the third vaccination from 93 recipients of the RTS,S/AS01 vaccine and 121 
recipients of the rabies vaccine. Subjects to be included in this study were selected from 
health care centres close to the lab in order that blood could be processed within 2 hours 
of collection. A full blood count was made for each child and Giemsa-stained thick blood 
films were examined for malaria parasitaemia. The characteristics of the children 
included in this analysis are shown in Table 1. Ethical approval for the trial, including this 
immunological assessment, was obtained from the Tanzanian Medical Research 
Coordinating Committee, the London School of Hygiene and Tropical Medicine Ethics 
Committee and the Western Institutional Review Board, Seattle, USA. Independent 
Data Safety Monitoring Board and Local Safety Monitors were appointed. The trial was 
sponsored by GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative. 
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Characteristic RTS,SIAS01 E Rabies 
(N=119, (N=146) 
Mean age months)a 11.9(tO.22) 12(tO.24) 
(tjb 19ldL a 10.5 to.074) 10.6(tO.06.) 
wac (x 10·'mL 9.4S(tO.17) IAS(d.1') 
Sex 
MIlle 47 as 
Femal. 72 61 
an1i-HBaAg Ab titre. (Unitstmt) 
Pre-vaccinationaa 161 (60 .... 93) 290 (103-630) 
Post-wccination (Month 3ra 61.51' (11 ,503.140.007) 215(79-483) 
Post-vaccination (Month 12)U 12,.472 (5367-28015) 157 (3'''27) 
P. felc#perum positive (blood smear 2 4 
Clinical malaria cases 3 13 
Table 4.1. Baseline characteristics of subjects according to vaccine group 
* Data are presented as mean values ± SE 
** Data are presented as median values plus inter-quartile ranges (25%-75%) 
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4.2.2 PBMC preparation and culture 
Venous blood was collected into vacutainers containing sodium heparin (10iu/ml blood, 
CP Pharmaceuticals) and peripheral blood mononuclear cells (PBMC) were isolated by 
Histopaque 1077 (Sigma) density gradient centrifugation as described in Chapter 2. 
Cells were resuspended at a concentration of 2 x 106 cells/ml in complete cell growth 
medium (GM; RPMI-1640 with 10% heat-inactivated human AB serum, 100 Units/ml 
penicillin, and 1 OO~g/ml streptomycin) in U-bottom 96-well tissue culture plates (total 
volume = 2001J1) and incubated, with or without antigenic or mitogenic stimulation, at 
37°C in 5% CO2 for 24 hours. All assays were performed on freshly isolated cells. PBMC 
were stimulated with a pool of peptides (n = 53, 15 mers, overlapping by 11 amino acids, 
each peptide at a final concentration of 1 IJg/ml, purity> 85%) representing the vaccine 
sequences of the hepatitis B surface antigen (HBs), or with a similar pool (n = 31 
peptides) representing the vaccine sequence of the CS protein (both peptide pools 
manufactured by Eurogentec), or with rhIL-12+IL-18 (0.1 ~g/ml) as a positive control for 
NK cell and T cell activation. Negative control cultures contained growth medium (GM) 
alone. Due to insufficient numbers of PBMCs from some children, the numbers of 
samples tested varies among the assays performed. 
4.2.3 Antigens: HBs and CS pep tides 
Peptides representing CS and HBs sequences were provided by GSK Biologicals and 
were frozen in dimethylsulfoxide (DMSO) at a concentration of 1 mg/ml. 
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4.2.3 Cell surface and intracellular staining for flow cytometry 
Surface and intracellular staining was performed using standard protocols as described 
previously (Chapter 2). The antibodies/reagents used were: anti-CD3 PerCP (BD 
Biosciences); anti-CD56 APC (Beckman Coulter); anti-CD69 PE (Serotec) and anti-IFN-
y FITC (Serotec); anti-CD4 FITC, and anti-CD25 APC (eBioscience). All antibodies were 
mouse monoclonals. Flow cytometric data were acquired using a Becton Dickinson 
FACSCalibur and analyses were performed using FloJo analysis software (TreeStar). 
4.2.4 Cytokine secretion assays 
Secreted IL-2, IFN-yand IL-10 were measured, according to the manufacturer's 
instructions, by Luminex (Millipore). All samples were acquired using the Luminex 
analyzer® and analysis was performed using Luminex xPONENT® software (Millipore). 
4.2.5 Serology 
Antibodies to the CS protein were assessed by ELISA at CEVAC, Ghent, Belgium using 
as antigen the recombinant antigen R32LR that contains the sequence 
[NVDP(NANP)1sh. The method has been reported in detail elsewhere (Macete, Sacarlal 
et al. 2007). Antibody titres are reported in EU/mL. 
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4.2.5 Hepatitis B antibody measurement 
In accordance with Tanzanian Ministry of Health policy for implementation of the 
expanded programme of childhood immunisations, all children were assumed to have 
received Hepatitis B vaccinations at 6, 10 and 14 weeks of age. HBV vaccination 
responders were confirmed based on anti-HbsAg antibody titres from samples collected 
at the baseline timepoint (i.e. at enrolment into the study). Anti-HBsAg antibody titres 
were measured by ELISA at GSK Biologicals, Belgium. 
4.2.6 Statistical analysis 
Values for each antigen stimulated well were divided by values for their respective 
negative control well (GM) for each assay. Geometric mean responses by vaccination 
group were calculated and students t test on log-transformed values was used to 
determine statistical significance. Stata version 10 was used. For cytokine secretion 
assays, Luminex xPONENT software was used to export data and then students t test 
was used to determine statistical significance using GraphPad Prism version 5. 
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4.3 Results 
4.3.1 T cell responses to HBs and CS pep tides in RTS,SIAS01E vaccinated 
subjects 
PBMC isolated from RTS,S/AS01 E-vaccinated and rabies-vaccinated children were 
cultured for 24 hours without stimulation (GM) or with HBs or CS peptide pools in order 
to quantify systemic effector memory T cell responses to each of the vaccine antigen 
components. Cell surface expression of the early activation marker CD69 and 
intracellular expression of IFN-y were analysed in all CD3+ T cells and cell surface 
expression of the high affinity IL-2 receptor a chain (CD25) was analysed in all CD4+ 
lymphocytes. A representative example of IFN-y, CD69 and CD25 expression in PBMC 
cultured in GM, HBs or CS from one child vaccinated with RTS,S is shown in Fig. 4.2A. 
Aggregated data from 93 RTS,S/AS01 E-vaccinated and 121 rabies-vaccinated children 
are shown for the three different parameters in Fig. 4.28-0; data for HBs- and CS-
stimulated cells are presented as fold-change (also known as the stimulation index) 
compared to GM cultures. 
IFN-y responses to HBs were significantly higher (p<O.0001) among RTS,S-vaccinated 
children than among the rabies-vaccinated children (Fig. 4.2C) indicating that, even in 
this recently vaccinated cohort, revaccination with HBs in AS01 significantly enhances 
the anti-HBs effector memory T cell response. By contrast, IFN-y responses to CS 
peptides did not differ significantly between RTS,S-vaccinated and rabies-vaccinated 
children and, among RTS,S-vaccinated children, anti-CS responses were significantly 
lower than responses to HBs. Thus, despite being administered as part of a highly 
immunogenic HBs vaccine, the CS protein did not appear to induce a sustained 
systemic effector memory T cell response. 
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Figure 4.2. After RTS,S/AS01 E vaccination, T cells upregulate expression of C069 
and C025 and produce IFN-y in response to vaccine antigens 
PBMC were isolated and cultured in vitro for 24 hours in growth medium (GM) or with 
peptide pools representative of either Hepatitis B surface antigen (HBs) or 
circumsporozoite (CS) proteins and analyzed by flow cytometry for surface expression of 
CD69 and CD25 and intracellular IFN-y. T cells were defined as all CD3-expressing 
lymphocytes (A) and then stained for (B) expression of CD69 and intracellular IFN-y (top 
row) or expression of CD4 and CD25 as a marker of activation (bottom row). Proportion 
of either (C) IFN-y+ T cells, (0) CD69+ T cells and (E) CD25+CD4+ T cells represented 
as fold change increases relative to activation response when cultured in GM. Grey bars 
represent median responses from RTS,S/AS01 E-vaccinated children and open bars 
represent median responses from rabies vaccinated children (NRTS ,S/AS01E = 93; Nrabies = 
121). P values are derived from unpaired Mann Whitney test. The horizontal line within 
each box represents the median; the top and bottom of each box represent the 25th and 
75th percentiles, respectively, and the "I" bars represent the upper and lower limits with in 
1.5 times the interquartile range. Circles denote outliers, 
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To determine whether other markers of antigen-specific memory T cell responses might 
be more sensitive than IFN-y secretion, T cell expression of the early activation marker 
CD69 (Fig. 4.20) and the high affinity IL-2R a chain (CD25) (Fig. 4.2E) was compared 
between the two vaccine groups. The fold change in both CD69 and CD25 expression 
was significantly greater among RTS,S-vaccinated children than among rabies-
vaccinated children after restimulation with either HBs or CS peptides, indicating that 
these markers are able to identify T cell memory responses that are not evident by I FN-y 
secretion. The fact that 24 hour restimulation with CS peptides induced CD69 and CD25 
expression but not IFN-y secretion suggests that the circulating CS-specific T cells in 
RTS,S vaccinated individuals are central memory cells rather than effector memory 
cells. 
4.3.2 NK cells are also activated by HBs and CS peptides in RTS,SIAS01E 
vaccinated children 
Whilst analysing T cell IFN-y responses (above) we noticed a population of CD3- but 
IFN-y+ cells (Fig. 4.3A), which we suspected might be natural killer (NK cells). To 
explore this further, we compared IFN-y and CD69 expression in CD3- CD56+ NK cells 
between the two groups of vaccinated children. Representative flow cytometry plots for 
NK cell responses in one RTS,S vaccinee are shown in Fig. 4.38; aggregate data for 93 
RTS,S-vaccinated and 121 rabies-vaccinated children are shown in Fig. 4.3C (IFN-y) 
and Fig. 4.30 (C069). 
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Figure 4.3 NK cells upregulate expression of C069 and produce IFN-y in response 
to RTS,S-vaccine antigens . 
PBMC were isolated and cultured in vitro for 24 hours in growth medium (GM) or with 
peptide pools representative of either Hepatitis B surface antigen (HBs) or 
circumsporozoite (CS) proteins and analyzed by flow cytometry for surface expression of 
CD3 and IFN-y (A) or CD69 and intracellular IFN-y when gating on all NK cells (B). 
Proportion of either (C) IFN-y+ NK cells cells , (0) CD69+ NK cells represented as fold 
change increases relative to activation response when cultured in GM. Grey bars 
represent median responses from RTS ,S/AS01 E-vaccinated children and open bars 
represent median responses from rabies vaccinated children (NRTS,S/AS01 E = 93 ; Nrabies = 
121). P values are derived from unpaired Mann Whitney test. The horizontal line within 
each box represents the median; the top and bottom of each box represent the 25th and 
75th percentiles, respectively, and the "I" bars represent the upper and lower limits within 
1.5 times the interquartile range. Circles denote outliers. 
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Somewhat surprisingly, we observed significant upregulation of NK cell IFN-y secretion 
and NK cell CD69 expression after 24 hour restimulation of PBMCs with HBs peptides. 
Among RTS,S-vaccinated children the percentage of NK cells expressing IFN-y was, on 
average, 3.5 fold higher (mean = 3.5, SE = 0.5) among HBs-restimulated PBMCs than 
among PBMCs incubated in growth medium alone and this difference was highly 
statistically significant (P < 0.0001); similarly, the mean fold change in median 
fluorescence intensity for CD69 expression was 2.S (SE = 0.16) and this was again 
highly significant (P < 0.0001). Within the rabies vaccinated (control) group, the was no 
significant increase in either NK celllFN-y or expression of CD69 relative to GM controls. 
Moreover, as for the T cell responses, NK cell IFN-y and CD69 responses to HBs 
restimulation were significantly greater among RTS,S vaccinees than among rabies-
vaccinated children, suggesting that the NK cell responses are also, in some undefined 
way, antigen-specific and indicative of a memory response. 
Significant NK cell responses to CS peptides were also observed in RTS,S-vaccinated 
children (mean [SE] fold changes in IFN-y and CD69 expression in CS stimulated cells 
versus growth medium incubated cells were 2.24 [±0.3S] p = O.OOOS and 1.4 [[±0.06] p < 
0.0001, respectively). Similar trends, however, were observed in rabies-vaccinated 
children (mean [SE] fold changes in IFN-yand CD69 expression in CS stimulated cells 
versus growth medium incubated cells were 1.4 [±0.07] P < 0.0001 and 1.02 [±0.03] p < 
0.0001, respectively) and, as for T cell responses, CD69 but not IFN-y NK cell responses 
were significantly higher among RTS,S-vaccinated than among rabies-vaccinated 
children (p = 0.0001 and p = 0.09, respectively). 
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4.3.3 NK cells and T cells contribute equally to RTS,S-vaccine antigen recall 
responses 
Since there are far greater numbers of T cells than NK cells circulating in the peripheral 
blood (-10 T cells: 1 NK cell) when I gated on all IFN-y producing lymphocytes, I 
observed that NK cells and T cells contributed equally to the IFN-y response. I performed 
a similar analysis to compare the IFN-y responses among the RTS,S- and rabies-
vaccinated children in response to HBs and CS peptides and found nearly identical 
trends (Figure 4.4). Interestingly, when gating on all IFN-y+ lymphocytes, we noticed a 
significant population that was neither T cells nor NK cells (CD3-CD56-). I assume that 
these are most probably T cells that have down regulated TCR expression as a result of 
antigen engagement (CD3 was stained extracellularly only). If we are to assume that this 
double-negative population really are CD3+ T cells then these data demonstrate that NK 
cells and T cells are contributing equally to the IFN-y-producing pool of lymphocytes. 
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Figure 4.4 NK cells and T cells contribute equally to the IFN-y recall response to 
RTS,S vaccine antigens 
PBMC were isolated and cultured in vitro for 24 hours with peptide pools representative 
of either Hepatitis B surface antigen (HBs) or circumsporozoite (CS) proteins and 
analyzed by flow cytometry for intracellular expression of IFN-y. All IFN-y+ lymphocytes 
were gated on and surface expression of CD3 and CD56 were measured to determine 
the proportions made up of T cells (black), NK cells (white) or CD3-CD56- lymphocytes 
(grey). Numbers outside of pie charts represent the mean of IFN-y+ cells ± SE. 
NRTS,S/AS01E = 93; Nrabies = 121. 
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We also assessed the proportion of individuals within each vaccination group that 
mounted recall responses to HBs and CS peptides. As shown in Table 4.2, we observed 
a significantly higher proportion of RTS,S/AS01 E vaccinees that mounted responses to 
HBs peptides than did the rabies vaccinated controls based on the expression of CD69 
and IFN-y in NK cells as well as for expression of CD25, CD69 and IFN-y in T cells. For 
responses to CS peptides, the proportion of RTS,S/AS01 E vaccinees expressing CD69 
in NK cells and T cells and CD25 in T cells was significantly higher than the proportion of 
rabies vaccinated controls making such responses. We did not observe any significant 
difference in the proportion of individuals within each group that mounted NK and T cell 
recall IFN-y responses to the CS peptides. Responders were defined as having at least 
twice as many NK cells or T cells expressing CD25, CD69 or IFN-y after restimulation 
with HBs or CS than after culture in GM alone. 
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Table 4.2 The proportion of vaccinated children whose PBMCs made an NK or T cell 
response to vaccine. All responders are defined as expressing CD25, CD69 or 
producing IFN-y at levels 2-fold greater than respective GM values. P values are derived 
from unpaired Mann Whitney test. 
4.3.4 Detection of soluble cytokines in culture supernatants from PBMC in 
response to RTS,S vaccine antigens 
We collected supernatants from the PBMC cultures described above and measured 
secreted levels of various cytokines by luminex assay. We measured the secretion of 
IFN-y, IL-2 and IL-10 by PBMCs in response to HBs and CS. As shown in Fig. 4.SA, we 
observed significantly greater amounts of secreted IFN-y in culture supernatants of 
RTS,S vaccinees in response to HBs as compared to rabies vaccine controls. 
Consistent with our flow cytometric data , no sign ificant difference in the levels of CS-
specific IFNy secretion was observed between RTS,S- and rabies vaccinees (Fig. 4.SA). 
Furthermore, IFN-y levels in response to CS peptides for both RTS,S- and rabies 
vaccinees were not significantly higher than in cultures with just GM. 
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Figure 4.5 Cytokines secreted in response to RTS,S vaccine antigens 
PBMC were isolated and cultured in vitro for 24 hours in GM or with peptide pools 
representative of either HBs or CS proteins. Culture supernatants were collected and 
analyzed by luminex for concentrations of (A) IFN-y, (B) IL-2 and (C) IL-10. Grey bars 
represent median responses from RTS ,S/AS01 E-vaccinated children and open bars 
represent median responses from rabies-vaccinated children. P values are derived from 
unpaired Mann Whitney test. IFN-y. (HBs): NRTS,S/AS01E = 43; Nrabies = 60; (CS): 
NRTS,S/AS01E = 44; Nrabies = 61. IL-2: (HBs): NRTS,S/AS01E = 47; Nrabies = 60; (CS): NRTS,S/AS01E 
= 48; Nrabies = 61. IL-10: (HBs): NRTS.S/AS01E = 43; Nrabies = 60; (CS): NRTS,S/AS01E = 44; 
Nrabies = 61. The horizontal line within each box represents the median; the top and 
bottom of each box represent the 25th and 75th percentiles, respectively, and the "I" bars 
represent the upper and lower limits within 1.5 times the interquartile range. Circles 
denote outliers . 
Strikingly, we observed very robust production of IL-2 in response to both HBs and CS in 
RTS,S-vaccinees (Fig. 4.5B). These responses were significantly greater, both relative 
to their respective GM values (p < 0.0001) and significantly higher than in the rabies 
vaccinated controls. Interestingly, we also observed that rabies vaccinees still mounted 
an IL-2 response to HBs peptides that was significantly greater than in cultures with GM 
(p=0.01). This significant difference can be accounted for by previous priming of HBV-
specific CD4+ T cells after HBV vaccination. Similarly, in response to CS peptides, 
RTS,S/AS-vaccinated children mounted strong IL-2 responses which were significantly 
greater than their respective GM values (p < 0.0001) as well as significantly higher than 
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among the rabies vaccinated controls. There were no significant differences between 
levels of IL-2 in rabies vaccinees in response to CS peptides and in cultures with GM. 
For IL-10 responses, we only observed significant differences between RTS,S- and 
rabies vaccinees in response to HBs peptides (Fig. 4.SC). Unfortunately, we were not in 
the position to phenotype the source of cells responsible for the production of IL-1 O. 
We also compared the proportion of RTS,S- and rabies- vaccinees that produced 
detectable levels of IFN-y, IL-2 and IL-10 in response to HBs and CS peptides (Table 
4.3). In response to HBs peptides, there was a significantly greater proportion of RTS,S 
vaccinees that mounted detectable IFN-y, IL-2 and IL-10 as compared to the proportion 
of rabies vaccinees that mounted positive responses. Interestingly, in response to CS 
peptides we only observed a significantly greater proportion of RTS,S vaccinees in the 
production of IL-2 as compared to rabies vaccinees. 
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Antigen : Group: IFN-., IL-2 IL-10 
HBS RTS,SlAS01E % Positive 53. 893 59 7 
Number Positive 23 42 30 
N = 43 47 43 
Rabies % Positive 11 6 633 216 
Number Positive 7 38 13 
N = 60 60 60 
P < 0.0001 0.002 < 0.0001 
CS RTS,S/AS01 E % Positive 136 604 11 3 
Number Positive 6 29 5 
N = 4. 48 4. 
Rabin % Positive 196 131 32 
Number Positive 12 8 2 
N = 61 61 61 
P 0 418 < 0.0001 10 
Table 4.3 The proportion of vaccinated children whose PBMCs secreted cytokines in 
response to RTS,S-vaccine antigens. All responders are defined as expressing CD25, 
CD69 or producing IFN-y at levels 2-fold greater than respective GM values. P values 
are derived from unpaired Mann Whitney test. 
4.3.5 Production of IL-2 is correlated with activation of NK cells in RTS,S 
vaccinees in response to HBs and CS peptides 
Based on the ability of NK cells to respond to RTS,S vaccine antigens in a recall-specific 
manner (Figure 4.3) and the robust production of IL-2 in response to RTS,S vaccination 
(Figure 4.5), we wanted to determine whether the same individuals that had strong 
activation of NK cells in response to HBs and CS peptides also mounted robust IL-2 
responses. We performed spearman correlation tests on all vaccinees for HBs and CS 
responses where data was available for both IL-2 production and IFN-y-producing NK 
cells as well as for IL-2 production and CD69-expressing NK cells . Data is shown for 
responses to HBs peptides in Figure 4.6 and for responses to CS peptides in Figure 
4.7. While there were no significant correlations observed between IFN-y+ NK cells and 
IL-2 production in RTS,S vaccinees, there was a strong correlation between CD69-
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expressing NK cells and IL-2 production in response to HBs peptides. Significant 
correlations were seen for RTS,S vaccinees but not for rabies vaccinees. 
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Figure 4.6 Correlations between expression levels of CD69 on NK cells and levels 
of secreted IL-2 in RTS,S/AS01 E-vaccinated children in response to HBs peptides 
PBMC were isolated and cultured in vitro for 24 hours in GM or with HBs peptides and 
analyzed by flow cytometry for surface expression of CD69 and intracellular IFN-y. 
Culture supernatants were collected and analyzed by luminex for concentrations of 
secreted IL-2. Circles represent individual children in the RTS,S/AS01 E-vaccinated 
group (left side) and rabies-vaccinated group (right side) (NRTS.S/AS01 E = 39; N rabies = 56). 
P values are derived from non-parametric spearman correlation test and dashed lines 
represent 95% confidence intervals. 
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Data are shown for responses to CS peptides in Figure 4.7. Similarly to responses to 
HBs peptides; we observed a strong correlation between the percentage of NK cells 
expressing CD69 and IL-2 production and this response was only observed in RTS,S 
vaccinees. These data suggest that antigen-specific IL-2 is directly involved in driving 
the early activation of NK cells by upregulating expression of CD69; however, it may not 
be sufficient to drive the downstream IFN-y response. It is possible that by incubating 
PBMC with vaccine antigens for longer (30-48 hours) that I would have observed more 
IFN-y production. Alternatively, additional signals such as IL-12 and IL-18 may be 
required for full activation of NK cells and these signals are not expected to be provided 
by HBs or CS peptides. 
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Figure 4.7 Correlations between expression levels of CD69 on NK cells and levels 
of secreted IL-2 in RTS,S/AS01 E-vaccinated children in response to CS peptides 
PBMC were isolated and cultured in vitro for 24 hours in GM or with CS peptides and 
analyzed by flow cytometry for surface expression of CD69 and intracellular IFN-y. 
Culture supernatants were collected and analyzed by luminex for concentrations of 
secreted IL-2. Circles represent individual children in the RTS,S/AS01 E-vaccinated 
group (left side) and rabies-vaccinated group (right side) (NRTS,S/AS01E = 39; Nrabies = 56) . 
P values are derived from non-parametric spearman correlation test and dashed lines 
represent 95% confidence intervals. 
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4.4 Discussion 
Vaccination has had a very large impact on a wide range of infectious diseases. Attenuated or 
inactivated pathogens, pathogen-derived toxins and recombinant proteins have been used as 
vaccines. Nevertheless, our current understanding of how any particular vaccine works on a 
mechanistic level is extremely limited. 
There is no clear understanding of natural immunity to P. fa/ciparum infection, which has 
hampered the progress of vaccine development with respect to choosing a model target 
antigen. Despite intensive efforts in the development of a vaccine for malaria, the only truly 
effective approach has been the use of irradiated sporozoites (Clyde 1975). 
The prevalence of malaria infection peaks during the first 5 years of life. A significant proportion 
of deaths and severe clinical malaria occur in infants < 18 months (Saute, Aponte et al. 2003). 
Thus, one of the major tasks of the Clinical Development Plan (COP) of RTS,S malaria vaccine 
for Africa has been to collaborate with the efforts of the WHO EPI to administer the vaccine as 
early as possible in infants in order to prevent malaria-induced mortality during the first few 
years of life. 
In this study, I investigated the cell mediated immune responses to the RTS,S/AS01 E 
(paediatric formulation)-adjuvanted sub-unit vaccine in infants 5-17 months of age. I 
characterised expression of CD69 and production of IFN-y in NK cells and T cells and 
expression of CD25 in T cells. My data demonstrate that robust recall NK cell and T cell 
responses are mounted during in vitro re-stimulation with the RTS,S vaccine antigen, HBs 
peptides and while CS-induced IFN-y responses were not as strong, expression of CD25 in T 
cells and CD69 in NK cells and in T cells were significantly higher in RTS,S vaccinated children 
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than in rabies vaccinated controls. Furthermore, nearly half of the IFN-y production is derived 
from NK cells. I also measured secreted levels of IFN-y, IL-2 and IL-10 in culture supernatants. I 
observed high levels of secreted IFN-y in culture supernatants of RTS,S/AS01 E vaccinated 
PBMC only in response to HBs peptides. Furthermore, I observed strong vaccine antigen-
specific IL-2 production to both HBs as well as CS peptides, which was significantly more robust 
in the RTS,S/AS01 E vaccinees than in the rabies vaccinated controls. Where IL-2 levels in 
response to HBs peptides were significantly higher than respective GM negative controls among 
RTS,S and rabies vaccinees, IL-2 responses to CS peptides were significantly higher relative to 
GM in RTS,S recipients but not in rabies vaccinees. 
That NK cells did not mount as robust a response to CS peptides as to HBs peptides seems to 
be correlated with significantly lower levels of IL-2 secreted in response to CS as compared to 
HBs as IL-2 secretion in response to HBs and CS peptides was highly correlated with the early 
activation of NK cells (expression of CD69). 
My data presented in Chapter 3 suggest that optimal indirect activation of NK cells requires 
whole pathogen, presumably triggering APC-derived signals such as IL-12, IL-18 and IFN-a due 
to recognition of pathogens via TLRs. It is difficult to accurately interpret these data when using 
overlapping peptides representing the CS protein as there are many different epitopes 
represented and of varying immunodominace relative to the array of MHC haplotypes in the 
RTS,S-vaccinated children. In this context, using live or killed sporozoites may have served as a 
more immunogenic "recall" antigen. The reason why NK cells responses to HBs peptides were 
significantly more robust than responses to CS peptides probably reflects the boosting effects of 
HBs from the RTS,S vaccine. Every child received a full course of HBV vaccine, but only the 
RTS,S recipients were re-exposed to HBs, as is clearly demonstrated in Table 4.1 which 
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compares anti-HBsAg antibody titres, following vaccination, in RTS,S/AS01 E and rabies 
vaccinees. Furthermore, based on the levels of secreted IL-2, both in response to HBs peptides 
in RTS,S recipients as well as by comparing these responses between RTS,S and rabies 
vaccinees, there is possibly a lower threshold for activation of NK cells in the presence of high 
dose IL-2. 
Recently completed trials have demonstrated the immunogenicity (superior CSP-specific IgG 
titres as well as induction of higher frequencies of CSP-specific CD4+ T cells producing ~ 2 
activation markers [e.g. IFN-y, TNF-a and I L-2]) , efficacy and safety of the RTS,S/AS01 B 
Iiposomal adjuvant system formulation. This formulation appears to be both more immunogenic 
and more efficacious than the AS02A [oil-in-water emulsion] formulation (Stewart, McGrath et 
al. 2006; Kester, Cummings et al. 2009). Similar to efficacy studies for RTS,S/AS01 B (adult 
formulation), efficacy rates for RTS,S/AS01 E (paediatric formulation), vary from 49% 
(unadjusted) to 56% (adjusted) (p < 0.0001), suggesting that the vaccine offers partial protection 
against re-infection and the development of severe disease (Bejon, Lusingu et al. 2008). The 
significant but modest protection offered by RTS,S vaccination suggests that insights regarding 
the mechanisms by which this vaccine works may allow the vaccine to be modified to be more 
protective. 
Single cell assays, which allow the enumeration as well as phenotype of responding cells, have 
been quite widely applied in field studies but they have been mostly focused on characterisation 
of antigen-specific effector T cell responses, overlooking the possibility that other cells may 
contribute to effector responses. A couple of recent studies have demonstrated this point. One 
study employing functional genomics, systems biology and the use of polychromatic flow 
cytometry to assess the global responses to yellow fever vaccination only characterised effector 
functions of CD4+ T cells by FACS and measured secretion of IFN-y in PBMC cultures. The 
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authors make the assumption that the IFN-y is derived from T cells without any further 
dissection of the response (Gaucher, Therrien et al. 2008). Similarly, another study analysed 
responses to yellow-fever vaccination but only examined correlates of CD8+ T cells and 
antibody responses (Querec, Akondy et al. 2009). 
My data presented in chapter 3 demonstrated that human NK cell responses to P. fa/ciparum-
infected RBC are markedly potentiated by CD4+ T cells, such that NK cells - rather than T cells 
- form the vast majority of IFN-y-secreting cells in the hours immediately following exposure to 
the infected RBC (Chapter 3). I described and defined the kinetics and cellular sources of the 
very early IFN-y response and believe that given its speed (which precedes the bulk of the T cell 
IFN-y response by hours or days) the NK cell IFN-y response may represent an important 
determinant of vaccine efficacy. Thus, the ability of vaccine-induced T cells to support NK cell 
effector function might be an important biomarker of an effective T cell response to the vaccine. 
It has been known for several years that NK cells may contribute to production of IFN-y during 
the initial stages of a recall response (Desombere, Clement et al. 2005) and that IL-2 can 
enhance NK cell activation (Malek 2008). Furthermore, NK cell responses to influenza virus 
have been shown to be dependent upon IL-2 from T cells (He, Draghi et al. 2004) and elevated 
frequencies of IFN-y-producing NK cells have been documented following influenza vaccination 
(Long, Michaelsson et al. 2008). The connection between the vaccine-induced activation of 
memory CD4+ T cells producing IL-2 leading to the recruitment of NK cells as effectors of the 
adaptive immune response and vaccination potentiating NK cell recall responses has been 
largely overlooked. From a practical vaccine development and testing perspective, my results 
indicate that NK cells are major contributors to the post-vaccination IFN-y responses and that 
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the contribution of these cells as well as IL-2-producing T cells needs to be considered when 
evaluating vaccine efficacy in clinical trials or in vaccine potency tests. 
In the following chapter, using rabies virus vaccination as a model, I will present data which 
conclusively demonstrate that NK cells may be recruited as effector cells by IL-2 secreting 
vaccine antigen-specific CD4+ T cells to amplify the adaptive effector response, following 
vaccination. 
113 
Chapter 5: NK cells as effectors of acquired 
immune responses: effector CD4+ T cell-
dependent activation of NK cells following 
Rabies virus vaccination 
Adapted from (Horowitz, Behrens et al., 2010) 
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5.1 Introduction 
My investigations of the pathways of NK cell activation by Plasmodium falciparum 
(malaria)-infected red blood cells revealed an essential role for IL-2 produced by 
CD4+ T cells. These observations are bolstered by reports of T cell and IL-2-
dependent activation of human NK cells (Fehniger, Cooper et al. 2003; He, Draghi et 
al. 2004). Furthermore, my characterization of the RTS,S malaria vaccine-specific NK 
cell recall responses to vaccine antigens demonstrated that NK cell activation was 
highly correlated with IL-2 production. These observations are also in line with a 
previous report demonstrating an increase in the frequency of IFN-y-producing NK 
cells among re-stimulated PBMCs after influenza vaccination (Long, Michaelsson et 
al. 2008). This led me to speculate that IL-2 from antigen-specific T cells might allow 
NK cells to contribute to the effector arm of adaptive immune responses and thus 
that NK cells may make a significant contribution to the cellular effector response to 
vaccination. 
In this chapter, I tested the hypothesis that NK cell responses are specifically 
enhanced, after vaccination, by IL-2 emanating from antigen-specific T cells. Using 
rabies virus vaccination as my model system (as inapparent exposure to rabies virus 
is likely to be extremely rare and my volunteers are thus expected to be fully na"ive 
prior to vaccination) I demonstrate that NK cells are the major contributors to the 
immediate vaccine-specific cytokine and cytotoxic recall response, that this response 
is dependent upon IL-2 from antigen-specific memory T cells and is associated with 
extensive NK cell proliferation. 
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5.1.1 The burden of rabies virus 
More than 55,000 people die of rabies each year and more than 95% of all rabies 
virus-related fatalities occur in developing countries within Africa and Asia, where 
most fatalities are directly attributed to bites from rabies-infected dogs (Figure 5.1) 
(WHO 2008). Of these, 30% to 60% are children under the age of 15. It is widely 
recognized that the number of fatalities, which are reported is a gross 
underestimation of the true incidence of rabies infections. There is minimal political 
commitment to controlling rabies infections, as there are no accurate data on the true 
public health impact of this disease. This can be attributed to poor surveillance as 
well as patients not presenting to health treatment centers. Even fewer reported 
cases ever get laboratory confirmation and clinical cases are often not officially 
documented with central authorities (WHO 1998; Cleaveland, Fevre et al. 2002). 
Perhaps the most accurate estimates to date on risk of clinical rabies developing in a 
person bitten by a dog suspected of infection with rabies have come from a study 
done in Tanzania based (WHO 1998; Cleaveland, Fevre et al. 2002; Cleaveland, 
Kaare et al. 2003). This group showed that dog bites are reported more frequently 
than human cases of rabies and could potentially provide a source of data from 
which to infer the incidence of human fatalities. Their data suggest that the death toll 
may be 100-fold greater than official reports declare. 
Education is a major factor in disease control. It has been shown that wound 
cleansing and immunizations immediately following 'unnatural' encounters with 
animals, nearly eliminates the chance of contracting the disease. Once bite victims 
become symptomatic, mortality is nearly 100%. Global vaccination strategies in dogs 
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are currently viewed as the most cost-effective strategy for rabies prevention in 
humans. There is a wide range of commercially available rabies vaccines marketed 
towards animals, both small and large. Table 1 provides a comprehensive listing of 
these vaccines, their manufacturers as well as their recommended dosage and 
booster regimens as deemed by the Centers for Disease Control. While effective and 
economical control measures are available, rabies virus infection remains a 
neglected disease throughout the developing world (WHO 1998). 
While the use of post-exposure treatment is effective if started early enough, its use 
is extremely cost-prohibitive in the developing world. A rabies immunization following 
exposure to animal suspected of rabies infection is US$40 in Africa and US$49 in 
Asia and 3 doses are recommended. 
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5.1.2 Rabies virus and pathogenesis 
Rabies virus belongs to the genus Iyssavirus and is in the Rhabdoviridae fam ily and 
this genus is made up of 10 other viruses as well (Hanlon , Kuzmin et al. 2005; Nadin-
Davis and Fehlner-Gardiner 2008). Genotype 1 is the classical rabies virus and is 
considered responsible for the vast majority of human and animal infections and 
deaths (Nadin-Davis and Fehlner-Gardiner 2008). Bat rabies virus (Genotype 2) is 
also responsible for a significant number of infections. The other 9 viruses all have 
caused or are capable of causing rabies virus in the human host. While they are less 
commonly encountered, all are highly infectious and require treatment with great 
urgency. Rabies virus is a single-stranded, negative sense, unsegmented and 
enveloped RNA virus which encodes 5 proteins. A schematic of a fully assembled 
rabies virus virion is shown in Figure 5.2. 
Glycoprotein Matrix protein 
Nucleoprotein Polymerase Phosphoprotein 
Figure 5.2 A schematic of a fully assembled rabies virus virion (Schnell , 
McGettigan et al. 2010). The RNA genome is tightly enclosed with in the 
nucleocapsid protein (yellow) - referred to as ribonucleoprotein or nucleocapsid 
protein (NCP). The polymerase (blue) and phophoprotein (orange) make up the 
internal capsid structure and associate with the RNP. The matrix protein (green) joins 
together the capsid and the viral membrane. The glycoprotein (pu rple) is a 
transmembrane protein which stretches into the matrix protein layer. 
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The rabies virus life cycle can be broken into 3 phases and a schematic is shown in 
Figure 5.3 (Schnell, McGettigan et al. 2010): 
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Figure 5.3 A schematic of the rabies virus life cycle (Schnell, McGettigan et al. 
2010). 
1) virus recognizes host receptor(s) and binds to host cell initiating endocytosis. 
2) Endocytosis is quickly followed by fusion between the endosomal and vi ral 
membrane proteins which releases the viral genome into the cytoplasm , a 
process known as 'uncoating'. The classical wild-type rabies virus enters the 
motor neuron at the neuromuscular junction, and rabies virus particles are 
shuttled - in a retrograde direction - through the axon of the infected neuron 
when they finally reach the neuron's cell body. 
3) The production of the virion components beg ins , wh ich includes transcription , 
replication and protein synthesis . 
4) Viral protein assembly begins , followed by transportation to the sites of viral 
budding , which releases mature rabies virus particles , each of which are capable 
of infecting a new cell. 
Ll 
This process is highly regulated , however, it is not fully understood . It has been 
suggested that the rabies glycoprotein is the viral protein responsible for ligation with 
host-cell receptors. Previous studies have demonstrated that deletions in the 
glycoprotein gene prevent mature virus particles spreading from an infected ce ll in 
vivo (Etessami, Conzelmann et al. 2000) and in vitro (Mebatsion , Konig et al. 1996). 
It has also been postulated that the nicotinic acetylcholine receptor (nAchR), located 
at the post-synaptic muscle membrane, allows for the accumulation of rabies virus at 
the neuromuscular junction leading to more efficient infection of the motor neurons 
(Lafon 2005). However, it has also been shown that rabies virus can replicate in 
striated muscle cells and that rabies virus uses the nAchRs to infect muscle cells 
(Murphy and Bauer 1974; Watson , Tignor et al. 1981). A schematic of this process is 
shown in Fig. 5.4. 
Figure 5.4 A schematic of rabies virus infecting a motor neuron (Schnell , 
McGettigan et al. 2010). Rabies virus is enriched for at the neuromuscular junction 
by nAchR, which are located on the postsynaptic muscle membrane. The rabies virus 
enters the cell via binding to the neural cell adhesion molecule (N CAM) and possibly 
through binding to unknown receptor(s) . 
Early diagnosis of rabies virus has proven very difficult. The current guidelines state 
that rabies should be treated for in the event of unexplained viral encephalitis with a 
known history of an animal bite. Non-vaccinated individuals require more time to 
develop neutralizing antibodies, and they usually do not develop until later in the 
course of disease after symptoms have begun. A conclusive diagnosis of rabies 
infection includes: 1) isolated virus from saliva; and 2) positive immunofluorescent 
skin biopsies or immunofluorescent neutralizing antibodies isolated from 
cerebrospinal fluid or from serum (WHO 2008). 
Virus may directly enter the peripheral nervous system and migrate to the brain or 
may replicate for a period in the muscle tissue. The latter creates a period of 
sequestration in close proximity to the entry site, and this period is referred to as the 
incubation period. Once completion of incubation period occurs, the virus can then 
spread into other organs. The duration of the incubation period has been noted 
between 5 days to more than 2 years. 
The clinical manifestations of the disease can be seen in 2 ways: 1) the furious 
(classical) form - accounts for 80% of infections; and 2) the numb (paralytic) form -
20% of infections. Furious infection is described as hydrophobia and defined as terror 
and excitation-induced spasm of inspiratory muscles, larynx and pharynx leading to 
an overwhelming need to drink (Warrell 1976). Hallucinations are commonly 
associated with the furious form of rabies virus infections. These symptoms often 
include extreme aggression leading to outburst attacks on other animals or humans. 
The numb form of infection is associated with weakness in the form of mild paralysis 
and is associated with a greater frequency of misdiagnoses at the onset of disease 
(Schnell, McGettigan et al. 2010). In both forms of infection, once symptoms begin, 
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there is an acute neurologic period which usually lasts up to 7 days and this then 
leads to coma (5-14 days) and finally death (Warrell 1976). 
5.1.3 Immunoprophylaxis 
Fortunately, post-exposure prophylaxis (PEP) is available for humans after having 
encounters with animals suspected of infection. Current guidelines in the United 
States for use of PEP in previously non-immunized people state to give 1 dose of 
rabies immunoglobulin (RIG) along with 5 doses of rabies vaccine (Manning, 
Rupprecht et al. 2008). There are clear disadvantages to this approach in developing 
countries as the cost of this is not sustainable and patient compliance and adherence 
to medication treatment regimes are often a concern. There are currently alternative 
approaches being investigated on behalf of the WHO which include the use of DNA 
vaccines (Lodmell, Ray et al. 1998; Lodmell, Ray et al. 1998; Lodmell and Ewalt 
2000; Lodmell, Ray et al. 2000; Lodmell and Ewalt 2001; Lodmell, Parnell et al. 2001; 
Lodmell, Parnell et al. 2002) and viral vectors (Vos, Neubert et al. 2001; Lees, Briggs 
et al. 2002; Ito, Sugiyama et al. 2005; Morimoto, Shoji et al. 2005; Cenna, Tan et al. 
2008). Studies have also begun to assess the safety, efficacy and cost-benefit for 
implementing pre-exposure vaccinations in children in areas of high endemnicity 
(Dodet, Adjogoua et al. 2008; Shanbag, Shah et al. 2008; Lang, Feroldi et al. 2009). 
As for many other vaccines, the mechanisms of vaccine-induced immunity to rabies 
virus infection remain unknown. Vaccination induces virus neutralising antibodies and 
it is widely assumed that this is how the vaccine protects. There is a great need to 
identify effective correlates of protection. However, there is very little known about 
the cell-mediated immune response to rabies vaccination or whether it contributes to 
protective immunity. 
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Rabies vaccination, however, serves as an excellent model in that screening for 
previous exposure to rabies virus can be performed with a relatively high degree of 
certainty. Furthermore, rabies virus can infect multiple species of animal other than 
homo sapiens, such as mice and dogs, which affords us the opportunity to study this 
virus in its native environment as compared to working with cultures and cell lines. 
Finally, the same vaccine, which elicits protection in humans, is also used in other 
animals. 
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5.2 Materials and Methods 
5.2.1 Vaccination of study participants 
Thirty healthy adult volunteers (median age = 28 yrs; i.q.r. = 26-31 yrs) received 
three doses (Days 0, 7 and 21) of 2.5 IU heat-inactivated rabies virus (Flury LEP 
strain) (RABIPUR, Novartis Vaccines) by intramuscular injection. All subjects gave 
fully informed, written consent and the study was approved by the London School of 
Hygiene and Tropical Medicine Ethics Committee. 
5.2.2 Blood sampling, PBMC preparation and cell culture 
PBMC collected immediately before the first and third vaccinations (i.e. Day 0, Day 
21) were cryopreserved in liquid nitrogen so that pre- and post-vaccination samples 
could be analyzed side-by-side at the end of the study. PBMC (2 x 106 cells/ml) were 
cultured in 96 well U-bottom plates for up to 7 days (with or without 25 ng/ml PMA 
(phorbol 12-myristate 13-acetate) plus 1 j..Jg/ml lonomycin (both Sigma) (P/I), rhIL-12, 
rh-IL-18 or rhlL-2 (0.1 j..Jg/ml) or 200 arbitrary units/ml inactivated rabies virus 07/162 
(5th International Standard; National Institute for Biological Standards and control, 
UK). Neutralizing anti-IL-2 (MQ1-17H12; BD Biosciences), or anti-IL-12 and anti-IL-
18 (R & 0 Biosystems) were each used at final concentrations of 10j..J.g/ml. 
Recombinant rabies virus nucleocapsid protein (rNCP) (M. Juozapaitis, Institute of 
Biotechnology, Vilnius, Lithuania) and was used at a final concentration of 10j..J.g/ml. 
Brefeldin A (3 j..Jg/ml) and monensin (1.33 j..Jg/ml) were added to all cultures for the 
last 5 hours of the culture. 
CD3+ cells were positively selected using FlowComp human CD3 Dynabeads and a 
Dynal Magnetic Particle Concentrator-2 (both Invitrogen), according to the 
manufacturer's instructions and purity confirmed with anti-human CD3 antibody 
(clone UCHT-1; BD Biosciences). Purity of both CD3+ and CD3- cell populations was 
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> 97%. T cell subsets were depleted on LD separation columns (Miltenyi Biotec) 
using monoclonal antibodies to CD4 (BD Biosciences) or CD8 (Caltag) or anti-
CD45RO-coated microbeads (Miltenyi Biotec). 
PBMC labeled with 10IJM carboxyfluorescein diacetate, succinimidyl ester (CFSE) 
(Invitrogen) were cultured at 3TC with 5% CO 2 for up to 7 days with or without heat-
killed rabies virus 07/162 and analyzed by flow cytometry. 
5.2.3 Cell surface and intracellular staining for flow cytometry 
Surface and intracellular staining was performed as previously described (Korbel, 
Newman et al. 2005). Antibodies used were: CD56 PE (N901), CD56 APC (N901) 
(both Beckman Coulter), CD56 PE-Cy7 (B159), CD45RO PE-Cy7 (UCHL 1), CD3-
PerCP (SK7), CD4 APC-Cy7 (RPA-T4), CD4 PE (RPA-T4), CD8 PE (SK1), LAMP-1 
biotin (H4A3), Perforin PE (OG9), IL-2 APC (MQ1-17H12), Streptavidin-PerCP (all BD 
Biosciences), anti-CD69 PE (CH/4) and CD3 PE-Texas Red (S4.1) (both 
Caltag/lnvitrogen), CD8 Pacific Blue (L T8; eBiosciences) andlFN-y FITC (D9D10; Ab 
Serotec). 
5.2.4 Statistical analysis 
Data analyses were performed using prism5 (GraphPad) or Stata10 (StataCorp). To 
estimate the proportion of the precursor lymphocyte population proliferating through 
each division the number of CFSE-diluted cells in each division was divided by , 
2(number of divisions + 0.5) (Hawkins, Hommel et al. 2007). 
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5.3 Results 
5.3.1 T cells and NK cells upregulate CD69 and produce IFN-yin response to 
rabies antigen, after rabies vaccination 
PBMC isolated from vaccinees immediately before their 1 st and 3rd vaccinations (Day 
o and Day 21) were cultured for 21 hours without stimulation (GM), with PII (positive 
control) or with heat-inactivated rabies virus (07/162) as the specific recall antigen. 
Cell surface expression of CD69 and intracellular expression of IFN-ywere analyzed 
in CD3+ CD4+ and CD3+ CD8+ T cells and in CD56+ CD3- NK cells (Fig. 5.5a). A 
representative example of IFN-y and CD69 expression before (left panels) or after 
(right panels) two doses of rabies vaccine is shown in Fig. 5.5b. and data from 5 
individual vaccinees are shown in Figs. 5.5c and 5.5d. In the pre-vaccination 
samples, PII induced upregulation of both IFN-yand CD69 in CD4+ and CD8+ T cells 
and in NK cells but none of these cells responded to rabies virus 07/162. By contrast, 
in the post vaccination (Day 21) samples, rabies virus 07/162 induces highly 
significant upregulation of IFN-y and CD69 in CD4+ and CD8+ T cells and in NK cells. 
Moreover, among NK cells the IFN-y responses are as high as those induced by the 
polyclonal stimulator PII (with at least 30% of all NK cells staining positively for IFN-y) 
. and the MFI for IFN-y staining is significantly higher among NK cells than among T 
cells (Figs. 5.5b and 5.5d). Both CD56bright and CD56dim NK cells produce IFN-y in 
response to rabies virus 07/162 and although a higher percentage of CD56bright NK 
cells than CD56dim cells make IFN-y (-50% vs. -20%) (Figure 5.6), since CD56bright 
cells make up only a small proportion of the NK cell population, the majority (>75%) 
of the IFN-yr NK cells are in fact CD56dim. Furthermore, there was no significant 
difference in the amount of IFN-y being produced by CD56bright and CD56dim NK cells 
as judged by MFI. 
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Figure 5.5 After rabies vaccination, T cells and NK cells upregulate CD69 and 
produce IFN-y in response to rabies virus 
PBMC were isolated before (pre) and after (post) 2 doses of rabies vaccine , cultured 
in vitro for 21 hours in growth medium alone (GM) or with PMA and lonomycin (P/I) 
or heat-inactivated rabies virus (07/162) and analyzed by flow cytometry for surface 
expression of CD69 and intracellular IFN-y. (a) Lymphocytes (identified by 
characteristic FSC and SSC) were identified as NK cells (CD56+ CD3-) , CD4+ CD3+ T 
cells or CDB+CD3+ T cells. (b) Representative flow cytometry plots for PBMC 
obtained before or after rabies vaccination from one donor, showing IFN-yand CD69 
expression in CD4+ T cells , CDB+ T cells and NK cells after restimulation in vitro with 
rabies virus 07/162. (c) Percentages of IFN-y+ cells (left plots) and MFI of CD69 
expression (right plots) among CD4+ T cells, CDB+ T cells and NK cells isolated from 
5 subjects, before (open circles) and after (filled circles) vaccination , and restimulated 
in vitro. (d) MFI of IFN-y+ CD4+ T cells , CDB+ T cells and NK cells among post-
vaccination PBMCs from 5 subjects cultured with (07/162 ; filled circles) or without 
(GM; open circles) inactivated rabies virus. P values are derived from 2-tailed paired 
Wilcoxon test. 
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Figure 5.6 Comparison of IFN-y production between CD56bright and CD56dim NK 
cell subsets. NK cells were divided into CD56bright and CD56dim and all IFN-y+ NK 
cells within each population were gated on separately. Numbers are presented are 
mean ± SE. P values are derived from 2-tailed paired Wilcoxon test. N = 5. 
1 0 
5.3.2 Post-vaccination, NK cells make both early and sustained IFN-r 
responses to vaccine antigens 
Having found that vaccination primes NK cells to make a robust and immediate IFN~y 
recall response to vaccine antigen, I sought to determine how quickly this NK 
response develops and for how long it is sustained, by sampling cultured PBMCs at 
intervals over a 7 day period (Figure 5.7). Restimulation of post-vaccination PBMC 
with rabies virus 07/162 leads to an initial, modest peak in IFN-y production from both 
CD4+ and CD8+ T cells at 18-24 hours but there is a second much more robust 
response that begins on day 5 and which is still increasing on Day 7 (Fig 5.7a). By 
contrast, a very robust NK cell recall response is clearly underway within 12 hrs and 
peaks at 18 hrs; however there was also a second wave of NK cell IFN-y production -
coinciding with the secondary wave of the T cell response - such that -30% of NK 
cells were still making IFN-y 7 days into the recall response. This biphasic NK cell 
and T cell response may reflect an initial responding population giving rise to a 
second generation of responsive cells or providing essential stimuli for further cell 
activation. In either case, it is apparent that NK cells are not only the earliest 
contributors of IFN-yto the post-vaccination recall response but also contribute to this 
response for a protracted period of time. 
Although the proportion of NK cells producing IFN-y in the restimulated post-
vaccination samples was much higher than the proportion of T cells producing IFN-y, 
circulating T cells outnumber NK cells by approx 10: 1. I therefore calculated the 
contribution of NK cells to the total pool of IFN-y-producing cells (Fig. 5. 7b). Twelve 
and 18 hrs after in vitro re-stimulation with rabies virus 07/162, more than 70% of all 
IFN-y+ cells were NK cells. Although this dropped to -40% by 24 hours, NK cells 
continued to represent 30-50% of all IFN-y+ cells until at least 7 days after re-
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stimulation. Thus, not only are NK cells readily activated post-vaccination , but they 
contribute very significantly to the total effector cell pool during the first 7days of the 
recall response. When taken together with the very high MFI for IFN-y staining 
among NK cells (Figure 5.5d) these data suggest that the overwhelming majority of 
the early IFN-y emanates from NK cells. 
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Figure 5.7 Post-vaccination, NK cells make both early and sustained IFN-y 
responses to vaccine antigens. PBMC from 5 subjects were isolated before (pre) 
and after (post) 2 doses of rabies vaccine, analyzed immediately (ex vivo) or cultured 
in vitro for up to 7 days in growth medium alone (GM) or with heat-inactivated rabies 
virus (07/162) and analyzed by flow cytometry for intracellular IFN-y. (a) The 
percentage of IFN-y+ CD4+ T cells, CD8+ T cells and NK cells detected in PBMC 
cultures at each time point. The vertical dashed line separates data from a short-term 
restimulation (up to 18 hours) and a long-term restimulation experiment. (b) The 
absolute number of IFN-llymphocytes was calculated at each time point and 
stratified according to whether these were NK cells or CD4+, CD8+ or CD4-CD8- T 
cells. Numbers above each column indicate the proportion of all the IFN-y+ cells that 
are NK cells (mean ± SE). 
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5.3.3 NK cells degranulate and release perf orin in response to rabies antigen 
after rabies vaccination 
One of the hallmarks of NK cells is their ability to rapidly detect and kill (within 
minutes) infected, transformed, or non-self cells by releasing pre-formed cytolytic 
molecules, such as perforin and granzymes, stored in secretory granules. Whilst 
CD8+ T cells kill in a similar manner, their stores of cytolytic granules are very limited 
and CD8+ T cells thus need time, after reactivation, to synthesize cytolytic granules 
and become fully cytotoxic (Chavez-Galan, Arenas-Del Angel et a!. 2009). To 
determine whether NK cytotoxic responses are enhanced post-vaccination and 
whether NK cells might thus represent the first wave of actively cytotoxic cells during 
the recall response, I cultured pre- and post-vaccination PBMCs with P/I or rabies 
virus 07/162 and measured surface expression of CD1 07a/LAMP-1 (as an indicator 
of degranulation) and intracellular levels of perforin. 
Representative flow cytometry plots for CD1 07a/LAMP-1 and perforin staining of 
CD8+ T cells and NK cells from pre- and post-vaccination PBMCs are shown in 
Figure 5.8; data from 5 individual vaccinees are shown in Fig. 5.9a. As expected, 
resting (GM) NK cells do not express surface CD1 07a/LAMP-1 but resting CD56dim 
(but not CD56bri9ht) NK cells do contain pre-formed perforin; 12 hrs polyclonal (P/I) 
stimulation results in increased surface expression of LAMP-1 and complete loss of 
intracellular perforin, consistent with NK cell degranulation. On the other hand, 
resting CD8+ T cells do not contain perforin but do synthesize perforin and upregulate 
LAMP-1 in response to P/I stimulation. Importantly, stimulation with rabies virus 
07/162 also causes marked degranulation (upregulation of LAMP-1 and loss of 
perforin) of CD56dim NK cells in the post-vaccination but not in the pre-vaccination 
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samples. Degranulation in 07/162-restimulated post-vaccination CD8+ T cells is less 
marked but there is clear induction of perforin synthesis. 
mlgG2b Ex vivo GM 07/162 - Pre-vacc. 07/162 - Po t.vacc. 
LAMP-1 
mlgG1 
Perforin 
Figure 5.8 Representative staining of LAMP-1 and perforin expression in CD8+ 
T cells and NK cells. Representative flow cytometry plots showing CD8+ T cell 
expression of LAMP-1 and perforin (upper panels) and LAMP-1 (middle panels) and 
perforin (lower panels) expression in NK cells isolated from one donor data before 
and after rabies vaccination (ex vivo) and after culture in vitro in growth medium (GM) 
or with rabies virus 07/162 for 12 hours. Isotype matched control antibodies (mlgG2b 
or mlgG1; left panels) were used to establish background levels of staining . 
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Figure 5.9 Post-vaccination, NK cells degranulate and release perforin in 
response to rabies virus. PBMC were isolated from 5 subjects before (pre) and 
after (post) 2 doses of rabies vaccine , analyzed immediately (ex vivo) or cultured in 
vitro for up to 72 hrs in growth medium alone (GM) or with PMA and lonomycin (P/I) 
or heat-inactivated rabies virus (07/162) and analyzed by flow cytometry for surface 
expression of LAMP-1 and intracellular perforin. (a) Percentages of LAMP-1 + (left 
plots) and perforin+ (right plots) NK cells (upper plots) and CD8+ T cells (lower plots) 
isolated before (open circles) and after (filled circles) vaccination , and restimulated in 
vitro for 12 hrs. Data represent mean ± SE. P values are derived from 2-tailed paired 
Wilcoxon test. (b) The percentages of LAMP-1+ (left plots) and perforin+ (right plots) 
NK cells (upper plots) and CD8+ T cells (lower plots) detected in PBMC cultures at 
each time point. (c) Pie charts showing the proportion of all LAMP-1 (top row) 
expressing lymphocytes and all perforin (bottom row) express ing lymphocytes that 
are either NK cells (light grey) or CD8+ T cells (black) among post-vaccinated PBMC 
stimulated in vitro for up to 72 hours with rabies virus 07/162 . The size of the circles 
is proportional to the absolute numbers of LAMP-1+ or perforin+ cells per 106 PBMC. 
Data represent mean values from 5 subjects. 
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To determine whether NK cells or CD8+ T cells were the major contributors to the 
early cytotoxic response we analyzed the degranulation response of the two cell 
populations over time (up to 72 hours) (Fig. 5.9b) and calculated the absolute 
number of degranulating cells that were either NK cells or CD8+ T cells at each time 
point (Fig. 5.9c). There was rapid (within 6 hrs) and sustained (at least 72 hrs) 
upregulation of surface LAMP-1 expression in rabies virus re-stimulated, post-
vaccination, NK cells and CD8+ T cells. In NK cells, LAMP-1 upregulation was 
evident by 6 hrs, peaked (at> 25% of all NK cells) at 12 hrs and then gradually 
declined whereas in CD8+ T cells LAMP-1 expression was maximal by 6 hrs (at -4% 
of all CD8+ T cells) and was sustained at this level for the duration of the experiment. 
The kinetics of the perforin' response in post-vaccination NK cells mirrored the LAMP-
1 response, with the proportion of perforin+ cells falling significantly within 6 hrs and 
reaching its lowest point at 12 hrs, indicating perforin release by degranulation in 
post-vaccination NK cells within 6 hrs of re-exposure to the vaccine antigen. 
However, perforin took up to 12 hrs to accumulate in re-stimulated post-vaccination 
CDS+ T cells suggesting that the 6hrs burst of T cell degranulation may not lead to an 
optimal cytotoxic response. 
The degranulation response was antigen-specific since LAMP-1 expression 
remained at baseline levels in all unstimulated cells and in rabies virus re-stimulated 
pre-vaccination NK and CD8+ T ceUs. Perforin levels remained at baseline in 
unstimulated and pre-vaccination CD8+ T cells. There was a gradual loss of perforin 
over time in pre-vaccination NK cells and in unstimulated post-vaccination NK cells, 
presumably reflecting non-specific leakage of perforin. 
The relative contributions of NK cells and CD8+ T cells to the pool of cytotoxic 
effectors are shown in Fig. 5.9c. NK cells represent the majority of both LAMP-1+ 
137 
and perforin+ cells 6 hrs after antigen stimulation. The marked decrease at 12 hours 
in the proportion of perforin+ cells that are NK cells, together with the increased 
proportion of the LAMP-1 + cells that are NK cells, provides further evidence of a 
wave of NK cell degranulation between 6 and 12hrs. On the other hand, although 
CD8+ T cells represent the majority of all perforin+ cells from 12hrs onwards, they do 
not represent the majority of degranulating, LAMP-1+ cells, until 48-72 hrs into the 
recall response. 
5.3.4 Antigen-specific IL-2 production from CD45RO+ CD4+ T cells is required 
for NK cell recall responses 
Our previous data (Newman, Korbel et al. 2006) and that of others (He, Draghi et al. 
2004) indicating a role for IL-2 and CD4+ T cells in NK cell activation, led us to 
speculate that IL-2 from antigen-specific T cells drives the recall response of NK cells 
after vaccination. I therefore analyzed the kinetics of IL-2 and IFN-y production by 
CD4+ T cells among pre- and post-vaccination PBMC re-stimulated in vitro with 
rabies virus 07/162 for up to 24 hrs. Representative flow cytometry plots for one 
vaccinated subject are shown in Fig. 5.10a and post-vaccination data from 4 subjects 
are summarized in Fig. 5.10b. 
Pre-vaccination, CD4+ T cells produce neither IL-2 nor IFN-y in response to rabies 
virus 01/162. Post-vaccination, a clear population of IL-2+ CD4+ T cells can be 
distinguished, peaking as early as 6 hrs after re-exposure to rabies virus and 
declining to negligible values within 24 hrs. Very few of the IL-2+ cells produced IFN-y 
(Fig. 5.10a) suggesting that at this early stage they are ThO rather than Th1 effector 
cells. In line with my hypothesis, the peak of T cell IL-2 production (6 hrs) preceded 
the onset of NK cell IFN-y production (12 hrs; Fig 5.7a). 
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To determine whether this CD4+ T cell IL-2 response contributed to the post-
vaccination NK cell response, post-vaccination PBMCs from 5 subjects were cultured 
overnight with rabies virus 07/162 in the presence or absence of rh-IL-2 or a 
neutralizing antibody to IL-2 and analyzed for intracellular IFN-y, intracellular perforin 
or cell surface expression of LAMP-1 (Fig. 5.1 Oc; statistical analysis is shown in 
Table 5.3.1). In parallel experiments, PBMCs were depleted of all CD3+ T cells, just 
CD4+ T cells, just CD8+ T cells or just CD45RO+CD3+ T cells. In the intact PBMC 
cultures, as before, there were potent NK cell IFN-yand degranulation (decreased 
intracellular perforin and increased surf~ce expression of LAMP-1) responses to the 
recall antigen. Anti-IL-2 antibody completely ablated both the IFN-y response and 
degranulation. Moreover, NK cells among PBMC depleted of CD3+, CD4+, or 
CD45RO+CD3+ T cells did not mount any significant IFN-y or degranulation 
responses; depletion of CD8+ T cells, on the other hand, had no significant 
detrimental effect on the NK cell recall response. In support of my hypothesis, 
however, NK cells among CD4+ T cell-depleted and CD45RO+ T cell-depleted 
PBMCs were able to make robust IFN-y and degranulation responses when cultures 
were supplemented with rhIL-2. 
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Figure 5.10: Antigen-specific IL-2 production from CD45RO+ CD4+ T cells is 
required for NK cell recall responses. Pre- and post-vaccination PBMC from 4 
subjects were cultured for periods of up to 24 hrs without stimulation (GM) or with 
rabies virus (07/162) and analyzed by flow cytometry for intracellular IL-2 and IFN-y. 
(a) Representative flow cytometry plots showing IL-2 and IFN-y expression in pre-
(upper plots) and post- (lower plots) vaccination CD4+ T cells from one donor in 
response to 07/162 stimulation over 24 hours. (b) Percentages of CD4+ T cel ls 
expressing intracellular IL-2 in response to 07/162 restimulation over time; post-
vaccination samples from 4 subjects. (c) Post-vaccination PBMCs from 4 subjects 
were cultured for 12 hrs (perforin and LAMP-1 expression) or 24hrs (IFN-
y expression) with rabies virus 07/162 in the presence or absence of rh-IL-2 or a 
neutralizing antibody to IL-2 and analyzed for intracellular IFN-y (left panel) , 
intracellular perforin (middle panel) or cel l surface expression of LAMP-1 (right 
panel). Parallel experiments were carried out using PBMCs that had been depleted 
of all CD3+ T cells , just CD4+ T cells , just CDS+ T cells or just CD45RO+CD3+ T cells . 
Data represent mean ± SE. Statistical analysis is presented in Table 5.3.1. 
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C045RO+ 
PBMC+ C03-depleted C04-depleted CDS-depleted C03-depleted 
anti-IL-2 Ab PBMC PBMC PBMC PBMC 
IFN-y 
*p= < 0.0001 < 0.0001 < 0.0001 0.53 < 0.0001 
t= 27.42 38.33 38.59 0.68 37.42 
df= 4 4 4 4 4 
LAMP-1 
*p= 0.004 0.005 0.005 0.006 0.004 
t= 6.037 5.699 5.684 5.81 5.831 
df= 4 4 4 4 4 
C045RO+ 
PBMC+ C03·depleted C04·depleted CDS-depleted C03-depleted 
anti·IL·2 Ab PBMC + rhlL·2 PBMC + rhlL-2 PBMC + rhlL-2 PBMC + rhlL-2 
Perforin 
*p= 0.0008 0.0003 < 0.0001 < 0.0001 < 0.0001 
t= 9.075 11.83 19.44 16.23 20.67 
df= 4 4 4 4 4 
* 2 tailed paired students t test; CI = 95% 
Table 5.2. Statistical analysis of data presented in Figure 5.1 Dc 
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5.3.5 Extensive NK cell proliferation during post-vaccination recall response 
To determine whether IL-2 produced by T cells during the post-vaccination recall 
response induced NK cell proliferation - which might potentiate the NK cell effector 
response andlor replenish the NK cell pool after activation-induced cell death of the 
first wave of effector response - I labeled pre- and post-vaccination PBMC from 4 
donors with CFSE, cultured them for 7 days without stimulation (GM) or with rabies 
virus 07/162 and then analyzed CFSE expression separately in CD4+ T cells, CD8+ T 
cells and NK cells (Fig. 5.11 a) and in both CD45RO+ and CD45RO- populations of T 
cells (Fig. 5.11 b). Cells cultured without antigen did not proliferate. Extensive 
proliferation was observed in post-vaccination T cells and NK cells after 7 days 
restimulation with the recall antigen, rabies virus 07/162. The CFSE dilution patterns 
(Fig. 5.11 a) suggested that a higher proportion of NK cells than T cells were 
proliferating and that NK cells were going through more rounds of proliferation than 
the T cells. Indeed, we were unable to see any undivided NK cells and we could 
discern at least 7 distinct CFSE peaks among the NK cells whilst a substantial 
proportion of T cells remained undivided and only -4 peaks of divided cells could be 
seen; this was confirmed by detailed analysis of samples from 4 vaccinees (Figs. 
5.11 c and 5.11 d). The average number of divisions undergone by NK cells 
(mean/SE: 2.55/0.01) was significantly higher than for CD8+ T cells (mean/SE: 
1.1210.18; p < 0.001), CD4+ T cells (mean/SE: 0.9610.07; p < 0.001); P = 0.31) or 
CD45RO+CD4+ T cells (1.2010.37; p = 0.005). Analysis of the proportion of the initial 
cell population that had gone through one or more divisions confirmed that, after 7 
days all NK cells had divided at least once but only -30% of all CD45RO+ CD4+ T 
cells and less than 10% of CD8+ T cells or CD45RO- CD4 T cells had done so (Fig. 
5.11 d) however the time to first cell division did not differ between NK cells and the 
CD4+ and CD8+ T cells. 
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Figure 5.11 Extensive NK cell proliferation during post-vaccination recall 
response 
Pre- and post-vaccination PBMC from 4 donors were labeled with CFSE, cultured for 
7 days with rabies virus (07/162) and analyzed by flow cytometry. (a) Representative 
flow cytometry plots of CFSE dilution (left plots) in post-vaccination CD4+ T cells 
(upper plots), CD8+ T cells (middle plots) and NK cells (lower plots) after 7 days 
incubation with 07/162. Histogram overlays (right plots) compare CFSE dilution in 
post-vaccination cells either ex vivo (dark fill) or after 7 days restimulation with 
07/162 (light fill). (b) Representative flow cytometry plots of CFSE dilution and 
CD45RO expression (left plots) after 7 days restimulation with rabies virus (07/162) 
in post-vaccination CD4+ (upper plots) and CD8+ (lower plots) T cells . Histogram 
overlays (right plots) compare CFSE dilution in CD45RO+ (dark fill) or CD45RO' (no 
fill) CD4+ or CD8+ T cells. (c) The percentage of CD4+ T cells , CD8+ T cells or NK 
cells in the post-vaccination , 7 day-restimulated PBMC population that had not 
divided, or had divided 1 or more times. Data represent mean + SE for 4 donors. (d) 
Estimated proportions of the precursor populations of NK cells and CD45RO+ or 
CD45RO' T cells that did not divide, or that divided 1 or more times during the 7 day 
restimulation assay. Data represent means for 4 donors. 
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5.3.6 IL-12 and IL-18 synergize with IL-2 to activate NK cells after vaccination 
To determine whether IL-2 alone is sufficient for NK cells to show a "recall" response 
to rabies virus after vaccination or whether other signals (e.g. from myeloid 
accessory cells) are also required for optimal NK cell responses, I compared the 
recall response to structurally intact but heat-killed rabies virus (07/162) with that to 
purified recombinant rabies virus nucleocapsid protein (rNCP) and I investigated the 
effect on the NK cell recall response of adding or neutralizing IL-12 and IL-18 in the 
presence or absence of r1L-2 (Figure 5.12). Suboptimal concentrations of rhIL-12, 
IL-18 and IL-2 - that do not, alone or in combination, induce NK cell activation - were 
determined by titration; for each cytokine a concentration of 0.01 ng/ml was selected. 
NK cells, among post-vaccination PBMC incubated with rNCP alone, did not produce 
IFN-y or upregulate CD69 (t = 2.1, df = 4, p = 0.6), but when cultured with rNCP plus 
0.01 ng/ml rhIL-12, rh1L-18 and rhlL-2 they responded strongly (t = 8.94, df = 4, P = 
0.0009) (Figs. 5.12a and 5.12b). No NK cell response was seen in pre-vaccination 
PBMCs with any of the combinations of stimuli tested (Fig. 5.12b). Neutralizing 
antibodies to IL-12 and IL-18 completely ablated the rabies virus 07/162-induced NK 
celllFN-y response in post-vaccination PBMCs (t = 8.5, df = 4, P = 0.001) (Fig. 
5.12c), in a very similar manner to IL-2 neutralization. I conclude that signals from 
two accessory cell populations (myeloid cells and T cells) are required for the recall 
response of NK cells and that inactivated virus but not rNCP (which presumably lacks 
the TLR-activating ligands present in whole virus) is able to induce a recall response 
in NK cells. 
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Figure 5.12: IL-12 and IL-18 synergize with IL-2 to activate NK cells after 
vaccination 
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Pre- and post-vaccination PBMCs from 5 donors were restimulated in vitro with 
inactivated whole rabies virus (07/162) or with purified recombinant viral 
nucleocapsid protein (rNCP), in the presence or absence of recombinant human IL-2 
or IL-12 plus IL-18, or in the presence or absence of neutralizing antibodies to IL-2 or 
IL-12 plus IL-18, for 24 hours and analyzed by flow cytometry for CD69 and IFN-'Y 
expression. (a) Representative flow cytometry plots showing IFN-'Y production and 
CD69 expression in post-vaccination NK cells cultured with or without rNCP in the 
presence or absence of rhIL-2, rh1L-12 and rhIL-18. (b) Percentage of NK cells 
producing IFN-'Y+ after restimulation with rNCP in the presence or absence of 
recombinant cytokines. Data represent mean ± SE of 5 subjects. P values are 
derived from 2-tailed paired Student's t test. (c) Percentage of NK cells producing 
IFN-'Y+ after restimulation with rabies virus 07/162 in the presence or absence of 
neutralizing antibodies to IL-2, IL-12, IL-18. Data represent mean ± SE. 
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5.3.7 The recall NK cell response to rabies virus is augmented in the presence 
of rabies immune serum 
Having shown that T cell- and myeloid accessory cell-med iated stimuli lead to NK cell 
activation after vaccination , I wondered whether this NK cell response could be 
further enhanced in the presence of rabies antibodies. It is well established that NK 
cells can bind immune-complexed IgG through recognition by FcyRlllA (CD16) 
receptors on their surfaces and that this receptor-ligand interaction induces cytolytic 
killing functions as well as production of effector molecules (Perussia 1998; Niwa , 
Hatanaka et al. 2004; Bryceson, March et al. 2005). In preliminary experiments I 
have observed that rabies virus restimulation of post-vaccination PBMCs in the 
presence of autologous serum (i.e. containing anti-rabies antibodies) leads to even 
more florid NK cell responses (Figure 5.13). 
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Figure 5.13 Immune serum enhances the recall NK cell resp~ns.e to rabies 
virus. Post-vaccination PBMC from 4 donors were restimulated In vitro with whole 
rabies virus (07/162) , in the presence of heat-inactivated fetal calf serum (HI F~S) , 
pre-immune or post-immune autologous serum. Data represent mean of 4 subjects. 
P values are derived from 2 tailed paired Wilcoxon test. 
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While rabies virus clearly induces activation of post-vaccination NK celllFN-y when 
cultured with pre-immune autologous serum or with HI FCS, this response is 
markedly enhanced when cells are cultured with the post-immune serum. It is not 
possible from these data to infer whether this enhanced state of NK cell activation is 
due to a synergistic effect of the IL-2/IL-12 + CD16 pathways or whether there are 2 
independent pathways, where the enhanced NK cell response is a cumulative effect. 
I therefore compared the kinetics of the NK cell IFN-y response in autologous rabies 
immune serum versus HI FCS (Figure 5.14). 
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Figure 5.14 Measuring the effects of immune serum on NK cells in resp~ns~ to 
rabies virus over time. Post-vaccination PBMC from the same 4 donors as In Figure 
5.13 were cultured with rabies virus in the presence of HI FCS or autologous post-
vaccination serum for up to 18 hours. Data represent mean of 4 subjects. P values 
are derived from 2 tailed paired students t test. 
As early as 6 hours post-incubation, there is a very noticeable difference between NK 
cell responses in post-immune serum and HI FCS. While the slope of the NK cell 
response when cultured with HI FCS seems to be quite linear, there is a much 
steeper slope for the post-immune serum suggesting that the pathways maybe 
synergistic rather than simply additive, but further work is required to test this. 
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5.3.8 Pre-vaccination NK cells respond to rabies virus 071162 when cultured 
with primed (post-vaccination) T cells 
Recent reports suggest that exposure to haptenated proteins, cytomegalovirus or 
cytokines can enhance the subsequent response of murine NK cells to reactivation 
by the same stimuli, raising the possibility that NK cells can acquire a "memory" 
phenotype (O'Leary, Goodarzi et al. 2006; Cooper, Elliott et al. 2009; Sun, Beilke et 
al. 2009). To determine whether the enhanced anti-viral response of post-vaccination 
NK cells results from such an "adaptive" response to prior antigen exposure, I 
compared the 07/162-induced IFN-y, CD69 and LAMP-1 responses of pre- and post-
vaccination PBMCs with the responses of pre-vaccination, CD3 T cell- depleted 
PBMC to which purified post-vaccination T cells had been added; as a control, CD3-
depleted post-vaccination PBMCs were mixed with purified pre-vaccination T cells 
(Figure 5.15). I observed that pre-vaccination NK cells responded vigorously to 
inactivated rabies virus 07/162 when cultured together with post-vaccination T cells 
and the magnitude of the NK response was proportional to the number of T cells 
added to the culture. Conversely CD3-depleted post-vaccination NK cells cultured 
with na'ive T cells were fully responsive to high dose IL-12/18 but were unable to 
respond to rabies virus. These data suggest that there are no intrinsic differences 
between pre-vaccination and post-vaccination NK cells and that post-vaccination NK 
cells are simply responding to the high levels of cytokines emanating from rabies 
virus-specific CD4+ T cells and myeloid accessory cells. 
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Figure 5.15 Pre-vaccination NK cells respond to rabies virus 07/162 when 
cultured with post-vaccination T cells. PBMC, collected either before (white bars) 
or after (black bars) vaccination, were cultured without stimulus (GM) or with rh1L-12 
+ rhIL-18, or with 07/162 for 24 hours and stained for intracellular IFN-y (a) ; CD69 
(b); and LAMP-1 (c) . Responses of whole PBMC were compared with those of CD3-
depleted post-vaccination PBMC to which na"ive (pre-vaccination) T cells had been 
added (diagonally cross-hatched bars) and with those of CD3-depleted pre-
vaccination PBMC to which varying numbers of memory (post-vaccination) T cells 
had been added (horizontally cross-hatched bars) ; post-vaccination T cells were 
added to pre-vaccination PBMCs at ratios of 1 T cell per PBMC, or 1 T cell per 2, 5 or 
10 PBMCs. 
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5.4 Discussion 
The purpose of vaccination is to expand and differentiate small populations of na'ive, 
antigen-specific T and B lymphocytes into larger populations of memory cells with 
enhanced effector function, in order to accelerate the clearance of pathogenic 
microorganisms. Evaluation of vaccine-induced immune responses typically includes 
measurement of antibody titers and some assay of cell-mediated immunity, such as 
lymphocyte proliferation, cytokine secretion or cytotoxicity, Although bulk assays (in 
which the responding cell type is not known) can now be supplemented by single cell 
assays (such as flow cytometry; which allow both the number and phenotype of 
responding cells to be assessed), these assays are typically designed - and their 
outputs interpreted - on the assumption that differences in cell-mediated effector 
responses post-vaccination, and especially after recall antigen stimulation of cells in 
vitro, are due solely to the actions of antigen-specific effector cells, Two recent 
examples, from otherwise groundbreaking studies, serve to illustrate the 
pervasiveness of these assumptions. In a study using functional genomics, 
polychromatic flow cytometry and systems biology to evaluate the global response to 
yellow fever vaccination, only the effector functions of CD4+ T cells were 
characterized at the single cell level and IFN-y secreted by PBMC cultures was 
assumed to be derived from Th-1 cells, despite evidence that NK cells - a well-
documented source of IFN-y - were proliferating in the first 7 days after vaccination 
(Gaucher, Therrien et al. 2008). A similar analysis of yellow fever vaccine-induced 
responses examined correlates only of CD8+ T cell and antibody responses (Querec, 
Akondy et al. 2009). 
Here I compare, for the first time, pre- and post-vaccination NK cell effector 
responses (IFN-y production and exocytosis of cytotoxic granules), demonstrate that 
these responses are augmented in an antigen-specific manner by vaccination and 
demonstrate that NK cells contribute significantly to the post-vaccination response, 
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especially - but not exclusively - during the first hours and days after re-exposure to 
the vaccine antigen. Moreover, and again for the first time, I have elucidated the 
activation signals required for this post-vaccination NK cell "recall" response. My 
findings indicate that IL-2-mediated NK activation should be considered as an 
additional - and potentially very important - indicator of vaccine efficacy. 
In many ways, my findings are not surprising. It has been known for several years 
that NK cells can represent a significant proportion of IFN-y+ cells in the initial stages 
of a classical recall response (Desombere, Clement et al. 2005), that IL-2 can 
augment NK cell responses (Malek 2008; Sutlu and Alici 2009), that the NK cell 
response to influenza virus depends upon IL-2 and T cells (He, Draghi et al. 2004), 
and that increased numbers of IFN-y-producing NK cells can be detected after 
influenza vaccination (Long, Michaelsson et al. 2008). However, the logical 
conclusion of these observations - that antigen-specific IL-2 secretion from memory 
T cells may recruit NK cells as effectors of adaptive immunity and, thus, that NK cell 
responses can be potentiated by vaccination - has not previously been made explicit 
and has not been formally tested. Indeed, our collective fixation on NK cells as cells 
that can mediate effector function without prior sensitization (Trinchieri 1989; Moretta, 
Bottino et al. 2002) has blinded us to the notion that they may perform their effector 
functions even more effectively after sensitization. 
By detailed analysis of the response to rabies vaccination, I have shown that antigen-
specific, CD45RO+ CD4+ T cells secrete IL-2 within 6hrs of re-exposure to antigen 
and that this IL-2 - in combination with IL-12 and IL-18 induced by the interaction of 
whole virus with other accessory cells - activates NK cells to produce IFN-y and to 
degranulate, releasing perforin. A proposed schematic for the NK recall response is 
shown in Figure 5.16. 
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Figure 5.16: Schematic representation of suggested pathway for "recall" NK 
cell responses (a) On first exposure, pathogens bind to macrophages/DC pattern 
recognition receptors (PRR) (either on the cell surface or within various intracellular 
compartments) (I), leading to cytokine secretion and upregulation of co-stimulatory 
molecules (II). Pathogen uptake and peptide presentation by DCs will prime na"lve T 
cells (III). However, in the absence of a source of IL-2, NK cells will not become 
activated. (b) On re-exposure to the same pathogen , PRR binding , cytokine secretion 
and peptide antigen presentation will again take place (I , II , III). In addition, IL-2 from 
primed effector T cells (IV) provides signals, which allow NK cells to secrete 
cytokines, become cytotoxic and proliferate. In the presence of ongoing antigen 
presentation, a second wave of activation may provide for a sustained NK cell 
response. 
Importantly, these NK effector responses occur extremely rapidly, starting within 6 
hours (i.e. significantly earlier than the equivalent T cell responses), and are very 
robust, with 30-40% of all NK cells responding. Consequently, in the first 12-18 
hours after re-exposure to antigen, more than 70% of all IFN-y-producing cells are 
NK cells. Importantly, however, NK cells also show a marked and prolonged 
proliferative response to the vaccine antigen and they continue to contribute to the 
effector cell population for at least 7 days after antigen re-exposure; indeed the 
secondary peak in the NK IFN-y response may well represent maturation and 
activation of cells that have divided during the first few days of the response. Lastly, 
the durability of the recall NK cell response needs to be thoroughly characterized, but 
I have repeated this analysis, in 1 donor, more than 4 months after the last 
vaccination without any noticeable decline in the response (data not shown). 
My finding that, in the absence of T cells, r1L-2 is sufficient to restore NK recall 
responses indicates that IL-2 is the only T cell-derived signal that is essential for the 
NK recall response. In support of this scenario, I have shown that although T cells 
are required for optimal activation of NK cells by malaria-infected red blood cells 
there is no requirement for NK cell-T cell contact and that the T cell-dependent signal 
can be delivered to the NK cells via a semi-permeable membrane (Horowitz, 
Newman et al. 2010). My data therefore reveal an important new role for vaccine-
induced IL-2-secreting memory T cells and may, in part, explain the emerging 
consensus that polyfunctional T cells, which secrete IL-2 in addition to IFN-y or TNF-
ex, are associated with positive outcomes of viral infection (Ciuffreda, Comte et al. 
2008; Nebbia, Mattes et al. 2008; Ferre, Hunt et al. 2009) and with particularly 
effective vaccination regimes (Harari, Dutoit et al. 2006; Aagaard, Hoang et al. 2009). 
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It was noticeable that whichever parameter I assayed (CD69 upregulation, IFN-y 
production, degranulation) the NK cell response to rabies vaccination among the 
vaccinees was remarkably homogeneous. Overall, for different parts of the study, I 
assayed responses from 30 individuals and in every case there was a robust and 
persistent NK cell recall response. This is in marked contrast to our previous findings 
for NK cell responses to malaria-infected red blood cells, Mycobacterium bovis BCG 
and bacterial lipopolysaccharide where NK IFN-y responses are extremely 
heterogeneous, but similar (in homogeneity, if not magnitude) to responses we 
observed to high dose rhIL-12+IL-18 (Korbel, Norman et al. 2009). We have 
proposed that heterogeneity in NK cell IFN-y responses to pathogens reflects both 
differences in the strength of accessory stimuli and variable expression of 
polymorphic NK cell receptors (which fine-tune the degree of activation) (Korbel, 
Norman et al. 2009). The results of this vaccination study suggest that if the 
accessory cell stimulus is sufficiently strong (which may require synergism of signals 
from myeloid cells and T cells) then the effect of NK cell regulatory receptors may be 
overcome. If so, genetic diversity in NK cell regulatory receptors may not represent a 
major hurdle to effective vaccination. 
The indirect route of NK cell activation has largely been overlooked until recently but 
it is now clear that inflammatory cytokines (IL-12, IL-18, IFN-a) and co-stimulatory 
signals from myeloid accessory cells are essential for optimal NK cell responsiveness 
to a wide range of viral, bacterial and protozoal infections (Newman and Riley 2007). 
My finding that intact rabies virus, but not purified recombinant protein, was able to 
activate NK cells after vaccination in an IL-12- and IL-18-dependent manner, is 
consistent with a requirement for myeloid accessory cell-derived as well as T cell-
derived signals for induction of recall NK responses. Neither the rabies virus encoded 
ligands for pattern recognition receptors (PRR) nor the PRRs themselves are known. 
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Although TLR3 is upregulated in brains of RV infected mice (McKimmie, Johnson et 
al. 2005; Mansfield, Johnson et al. 2008) and humans (Jackson, Rossiter et al. 
2006), TLR3 preferentially recognises dsRNA rather than ssRNA and is thus not an 
obvious candidate for recognition of RV. Human TLR8/murine TLR7 are receptors 
for some ssRNAs (Diebold, Kaisho et al. 2004; Heil, Hemmi et al. 2004) and may 
thus be more likely innate receptors for RV. One practical implication of the need for 
myeloid acessory cell stimuli for induction of recall NK responses is that evaluation of 
vaccine-induced immune responses by restimulation of PBMCs with purified protein 
antigens or synthetic peptides may not reveal the full extent of the NK recall 
response that may occur after exposure to whole pathogens. 
Although there are superficial similarities between the "recall" NK response that I 
have described and the "memory-like" NK cells recently described in mice (O'Leary, 
Goodarzi et al. 2006; Cooper, Elliott et al. 2009; Sun, Beilke et al. 2009), there are 
important differences between the cytokine-driven response described here and 
some of the mouse studies. In mice infected with murine cytomegalovirus (MCMV), 
NK cells proliferate, persist at higher than normal frequencies for several months and 
show enhanced cytokine and degranulation responses on reactivation (Sun, Beilke et 
al. 2009) however NK cell activation in this model is driven by binding of the 
activating NK Ly49H receptor to the m157 viral protein expressed on MCMV-infected 
cells (Arase, Mocarski et al. 2002) and may thus occur independently of accessory 
cell stimuli. 
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Figure 5.17 Schematic 
representation of proposed 
interactions between N K cells 
and T cells after vaccination. 
(a-I) Contact hypersensitivity 
model for sensitization of Thy-
1 +Ly49C-I+ NK cells by hapten-
specific challenge. (a-II) Upon 
re-treatment of tissues with 
same hapten, NK cells bearing 
the same hapten-specific Thy-
1 +Ly49C-I+ phenotype undergo 
rapid expansion and infiltrate to 
the site of challenge. (b-I) 
Activation of na"lve NK cells with 
IL-12, low-dose IL-15 and IL-18 
triggers robust NK cell IFN-y 
production . (b-II) After 7 days 
post-transfer of pre-activated 
NK cells into Ragr'- mice, 
activation of NK cells with IL-12 
and IL-15 or by using plate 
bound antibodies targeting 
Ly49H or NK1 .1 activating 
receptors , a significantly 
enhanced NK cell response is 
observed as well as sustained . 
(c-I) Prior sensitization of na"lve 
NK cells by route of vaccination 
with heat-killed rabies virus is 
phagocytosed by antigen 
presenting cells and processed 
intracellularly. (c-II) Viral ligands 
binding to TLR3 and TLR9 lead 
a. 
c. 
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to production of IL-12 and IL-18 as well as direct contact between NK cells and APC. 
(c-III) Peptide antigen is presented by MHC class II molecules on the surface of the 
plasma membrane and recognised by antigen-specific memory CD4+ T ce lls causing 
them (c-IV) to secrete IL-2. (c-V) Production of IL-2, IL-12 and IL-1 8 seem to have a 
synergistic effect leading to effective NK cell IFN-y production as wel l as 
degranulation responses. (c-VI) NK cell activation as defined by IFN-y prodction, 
degranulation, and robust proliferation is also sustained well after the adaptive T ce ll 
response is initiated . (c-VII) NK cell derived IFN-y may promote differentiation of 
CD4+ T cells from ThO to Th1 effectors . 
Indeed, expansion of the Ly49H+ NK cell subset in MCMV+ mice is reminiscent of the 
expanded population of NKG2C+ NK cells in individuals seropositive for human MCV 
(Guma, Angulo et al. 2004). Similarly, the original description of murine memory-like 
NK cells - in a contact hypersensitivity model- specifically involved Ly49C+/Ly491+ 
cells which might conceivably be activated by haptenated MHC Class 1 molecules 
and, at least inasmuch as T cells were not required, would appear to be IL-2 
independent (O'Leary, Goodarzi et al. 2006) (Figure 5.17). 
Importantly, the "memory" component of the post-vaccination NK response to rabies 
virus described here appears to lie entirely within the T cell population: NK cells from 
unvaccinated individuals were fully able to respond to the virus when mixed with 
autologous memory T cells. It is not known whether nonspecific inflammatory stimuli 
can maintain human NK cells in a prolonged hyper-reactive state, as recently 
described for murine NK cells activated in vitro with a cocktail of accessory cell-
derived cytokines (Cooper, Elliott et al. 2009), but this might be interesting to explore 
in the context of vaccine adjuvants. 
Our study raises interesting questions regarding the functional significance of 
enhanced NK cell responses after immunisation. For infections where a protective 
role for NK cells is established, evaluation of NK responses post-vaccination is likely 
to be a useful indicator of vaccine efficacy but for other infections the implications are 
less clear and further studies are required. In the case of rabies virus vaccination it is 
widely accepted that neutral ising antibody is essential for protection (Johnson, 
Cunningham et al. 201 O), but experimental infections in mice suggest that cell-
mediated immune responses (including signalling through the IFN-yR) are required 
for efficient viral clearance (Hooper, Morimoto et al. 1998) and that pro-inflammatory 
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cytokines (IFN-y and IL-2) enhance vaccine immunogenicity, leading to significantly 
higher neutralising antibody titres (Claassen, Osterhaus et al. 1998). The potential for 
NK cell IFN-y responses to contribute to the efficacy of rabies vaccines thus deserves 
to be evaluated. The role of the degranulation response is less obvious. In these 
particular experiments, using killed virus, it is unlikely that NK cells are degranulating 
in response to infected cells and degranulation may simply be a marker of NK cell 
activation. 
In summary, I have demonstrated that NK cells are major contributors to the effector 
lymphocyte population during the recall response to rabies vaccination. This should 
lead us to reconsider the precise roles of antigen-specific memory T cells in vaccine-
induced immunity. Assays of CD4+ T cell IL-2 production, NK celllFN-y production 
and NK cytotoxicity need to be included in the arsenal of tools for evaluating 
correlates of vaccine-induced immunity. 
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Chapter 6: Final Discussion 
_-------------~=~~c, 
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6.1 Study significance 
The conventional view of acquired immunity to infection is that it is mediated by 
numerous, small populations of effector and memory Band T lymphocytes 
expressing antigen receptors with high affinity for the particular pathogen. Upon re-
exposure to an antigen, these populations undergo rapid clonal expansion. Antigen-
specific CD4+ T helper cells augment B cell, CD8+ T cell and macrophage-mediated 
effector functions. These interactions and their downstream responses, i.e. the 
production,of antibodies, cytotoxic T lymphocyte (CTL) killing and phagocytosis, form 
the basis for evaluation of vaccine-induced immunity. 
Vaccination is the most sustainable and cost-effective way to reduce the global 
burden of many infectious diseases. New vaccines are urgently needed for complex 
infections such as malaria, HIV and TB. Rational design of such vaccines might be 
informed by comparison with existing effective vaccines but these were, in the main, 
developed empirically and we have a very incomplete understanding of how they 
work. Expensive and time-consuming clinical trials remain the only way to evaluate 
vaccines for most human diseases; correlates of protection - which might allow 
triage of candidate vaccines - are lacking in most cases. Recently, CD4+ T cell-
derived IL-2 has emerged as a potential correlate of protection in several disease 
and vaccine studies (Harari, Dutoit et al. 2006; Beveridge, Price et al. 2007; Darrah, 
Patel et al. 2007; Ciuffreda, Comte et al. 2008; Kamath, Rochat et al. 2008; Nebbia, 
Mattes et al. 2008; Aagaard, Hoang et al. 2009; Barbosa, Naniche et al. 2009; Ferre, 
Hunt et al. 2009; Lindenstrom, Agger et al. 2009). 
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In this thesis, I have investigated an additional, little-appreciated but potentially very 
important, function of CD4+ T cells, namely their ability to activate NK cells in an IL-
2-dependent manner. I have thoroughly characterised human NK cell responses to 
Plasmodium falciparum malaria (Pf-RBC) (Chapter 3 and Chapter 4), 
Mycobacterium bovis BCG (BCG) (Chapter 3) and rabies virus (Chapter 5). My data 
demonstrate that antigen-specific CD4+ T cell-derived IL-2 is an essential component 
of the cocktail of cytokines required for the activation of NK cells to secrete IFN-y and 
release cytotoxic granules, and that vaccination-primed effector/memory CD4+ T 
cells lead to rapid and potent activation of NK cells upon re-exposure to the 
pathogen. I hypothesize that IL-2-driven NK cell effector functions may contribute to 
containment and elimination of certain pathogens in vaccinated individuals. If this 
holds true, IL-2-driven NK cell activation may represent a novel correlate of vaccine-
induced immunity and designing vaccines to optimize this response may enhance 
their efficacy. Furthermore, NK cell recall responses may provide a new tool for rapid 
evaluation of vaccine efficacy, screening of new antigens and adjuvants, optimising 
dosing schedules and determining duration of protection. Where appropriate, 
vaccines could be designed to induce NK cell responses. 
NK cells are classically thought of as innate immune effectors that, by cytokine 
production or cytotoxicity, help to contain an infection (or limit tumour growth) until an 
effective adaptive response is mounted. NK cells become activated when the 
balance of activating and inhibitory signals that they receive is disturbed (Newman 
and Riley 2007). Direct NK cell activation follows interaction with transformed or 
infected cells, which lack ligands for inhibitory NK cell surface receptors for self-MHC 
(the "missing self' phenomenon) and/or express stress-induced ligands for NK cell 
activating receptors. Indirect NK cell activation occurs following microbial ligation of 
pattern recognition receptors on myeloid accessory cells and is mediated by 
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cytokines (IL-12, IL-18, IFN-a) and by contact-dependent stimuli from myeloid cells 
(e.g. ICAM-1/LFA-1). Whether NK cell regulatory functions, such as secretion of IL-
10 (Maroof, Beattie et al. 2008), are induced in a similar manner remains to be 
determined. Recently, it has become clear that bi-directional interactions between NK 
cells and T cells are also vital for the activation of NK cells (He, Draghi et al. 2004; 
Newman, Korbel et al. 2006). IL-2 is produced predominantly from effector memory 
CD4+ T cells and is secreted very early in the secondary response to antigens. 
The quality of the antigen-specific CD4+ T cell response after vaccination is 
increasingly recognized as being as important as, or perhaps even more important 
than the size of this response. Specifically, induction of multifunctional CD4+ T cells 
secreting several cytokines (IFN-y, TNF-a, IL-2) and/or expressing ligands for co-
stimulatory receptors (e.g. CD154/CD40L) correlates with protection in murine 
vaccination models of, for example, leishmaniasis (Darrah, Patel et al. 2007) and 
tuberculosis (Forbes, Sander et al. 2008) and in human malaria vaccine trials 
(Roestenberg, McCall et al. 2009). Retention of secretory IL-2 is assumed to endow 
IFN-yITNF-secreting effector CD4+ T cells with long-term memory potential (Darrah, 
Hegde et al. 2010), but the possibility that IL-2 is an effector molecule in its ownright 
is rarely considered (Rochman, Spolski et al. 2009). 
6.2 Key findings and future perspectives 
(i) Malaria 
My research, presented in Chapter 3 of this thesis, has indicated that T cell-derived 
IL-2 is an essential component of the cocktail of cytokines that activates NK cells to 
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secrete IFN-y and release cytotoxic granules upon exposure to Pf-RBC. Of note, a 
weak but significant association between the proportion of CD4+ T cells making IL-2 
and protection against challenge infection in malaria-vaccinated humans has been 
reported and was accompanied by expansion of the circulating NK cell pool and 
increased NK cell perforin expression (Berthoud, Fletcher et al. 2009). These 
observations suggest that T cell-derived IL-2 may contribute to the immediate 
effector response by inducing NK cell-mediated Iysis/apoptosis of infected cells or by 
inducing NK cells to secrete IFN-y and thereby enhancing phagocytosis and 
destruction of malaria-infected red blood cells. 
Our group has been characterizing the pathways of NK cell activation by Pf-RBC for 
many years now, and our investigations have revealed essential roles for IL-12 and 
accessory cell contact as well as necessary roles for IL-18 and IFN-a (Artavanis-
Tsakonas, Eleme et al. 2003; Korbel, Newman et al. 2005; Newman, Korbel et al. 
2006). These studies also demonstrated that IL-2 was necessary for optimal 
activation of NK cells in response to Pf-RBC (Newman, Korbel et al. 2006) and 
although the data demonstrated that myeloid accessory cells were also crucial for the 
NK cell response, our group was never able to recapitulate the NK cell response in 
mixed PBMC by simple addition of myeloid cells and purified NK cells. In this thesis, I 
have now demonstrated that NK cell responses (CD69 and CD25 expression, 
proliferation, secretion of IFN-y, mobilization of cytolytic granules and release of 
perforin/granzyme) to Pf-RBC and to Mycobacterium bovis BCG are crucially 
dependent on IL-2 secreted (in an MHC class II-dependent manner) by CD4+ T cells, 
indicating that the "innate" response to malaria infection actually relies upon complex 
interactions between NK cells, antigen-specific T cells and accessory cells (Figure 
5.16). In the case of Pf-RBC, antigen recognition is thought to be mediated by TLR 
pattern recognition. Specifically, ligands for myeloid accessory cells include 
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glycosylphosphatidylinositols (GPI) derived from the glycolipid anchors of parasite 
surface proteins which signal through TLR2 (Gowda 2007) and parasite DNA trapped 
within hemozoin (the insoluble breakdown product of haemoglobin) which is carried 
into the cytosol and binds to TLR-9 (Parroche, Lauw et al. 2007). In malaria na"lve 
donors (such as those used throughout Chapter 3 of this thesis) CD4+ T cells are 
believed to recognise Pf-derived peptides, which cross-react with those on commonly 
encountered micro-organisms, vaccines or environmental antigens (Currier, Beck et 
al. 1995). 
These observations with Pf-RBC, bolstered by reports of T cell and IL-2-dependent 
activation of human NK cells (Fehniger, Cooper et al. 2003; He, Draghi et al. 2004) 
and of an increase in the frequency of IFN-y-producing NK cells among restimulated 
PBMCs after influenza vaccination (Long, Michaelsson et al. 2008) led us to 
speculate that IL-2 from antigen-specific T cells might allow NK cells to contribute to 
the effector arm of adaptive immune responses and thus that NK cells may make a 
significant contribution to the cellular effector response to vaccination. Our first 
evidence to support this hypthesis comes from a phase lib clinical trial of the RTS,S 
malaria vaccine in children (Chapter 4). RTS,S comprises a chimaeric recombinant 
protein [malaria circumsporozoite surface protein (CS) fused to hepatitis B surface 
antigen (HBs)] formulated with excess free HBs and adjuvant (Casares and 
Brumeanu 2010). PBMC isolated 4.5 months after vaccination from RTS,S 
vaccinated children and from controls (who received rabies virus vaccine instead of 
RTS,S) were restimulated for 24 hours with CS or HBs and analyzed by flow 
cytometry for NK cell activation (CD69 expression and IFN-y production) and T cell 
activation (CD69 and CD25 expression, IFN-y production and secretion of IL-2). 
HBs-induced IL-2 secretion, NK cell CD69 expression and IFN-y production were all 
Significantly higher among RTS,S vaccinated children than in controls and similar 
results were obtained for responses to CS. Importantly, NK cell responses were 
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significantly correlated with secreted IL-2, and after 24 hour stimulation, >50% of all 
IFN-y-secreting cells were NK cells. 
Whilst my data presented in this thesis demonstrate very clearly that NK cells can 
respond to malaria-infected red blood cells as well as malarial antigens, in vitro, the 
next steps will be to determine if NK cells actually make any significant contribution to 
malaria-induced immunopathology or protection from developing clinical disease, in 
vivo, using experimental malaria infections. In order to do so, more detailed stUdies in 
mouse models of malaria infections are needed. Specifically, 
• To investigate the role of NK cells in experimental cerebral malaria using the 
P. berghei ANKA model in C57/BL6 mice; 
• To investigate protective immune mechanisms and non-cerebral forms of 
malaria using the P. yoellii model in C57/BL6 mice; 
• To investigate potential roles for NK cells in prevention of clinical disease' 
using novel in vivo NK cell depletion techniques comparing the use of new 
depletion antibodies (targeting NKp46) (Walzer and Biery 2007) and "E4BP4"-
NK cell deficient mice (Gascoyne, Long et al. 2009) or NKG20-deficient mice 
(Guerra, Tan et al. 2008). 
(ii) Vaccination 
Whilst highly supportive of my hypothesis, the cross-sectional RTS,S data do not 
formally prove that vaccination can induce potent NK cell effector responses in that 
we did not have access to cells collected prior to vaccination. Thus, as a direct test of 
the hypothesis, I compared NK cell responses to inactivated rabies virus before and 
after rabies virus vaccination (Chapter 5) (Horowitz, Behrens et al. 2010). Inapparent 
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exposure to rabies virus is extremely rare and our volunteers were thus expected to 
be fully na'ive prior to vaccination. Prior to vaccination, NK cells were unresponsive to 
inactivated rabies virus whereas potent NK cell responses were observed 21 days 
after first dose (14 days after the 2nd dose). The NK cell response was completely 
dependent upon IL-2 from antigen-specific memory (CD45RO+) CD4+ T cells and 
did not require differentiation of NK cells to a "memory" phenotype (as described for 
mouse NK cells (Sun, Beilke et al. 2009)) since pre-vaccination NK cells responded 
as efficiently as post-vaccination NK cells when co-cultured with post-
vaccination/primed CD4+ T cells (Horowitz, Behrens et al. 2010). Importantly, in the 
first 12-18 hours of the recall response, >70% of all IFN-y-secreting cells were NK 
cells. However, extensive NK cell proliferation and IFN-y secretion continued for at 
least 7 days, suggesting that NK cells make a major contribution to both immediate 
and sustained effector responses. 
Whilst IL-2 is clearly essential for these "recall" responses, there do seem to be some 
differences between the different pathogens in terms of the other stimuli that are 
required and ultimately the magnitude of the downstream NK cell response. For Pf-
RBC response, IL-12 is also essential and IL-18 and IFN-a are beneficial (Artavanis-
Tsakonas and Riley 2002; Artavanis-Tsakonas, Eleme et al. 2003; Newman, Korbel 
et al. 2006). For rabies virus, whole (inactivated) virus induced NK cell activation but 
recombinant ribonucleocapsid protein antigen did not (Horowitz, Behrens et al. 2010) 
and the anti-viral response was blocked by anti-IL-12 and anti-IL 18 antibodies. In 
RTS,S recipients, CS peptide antigens were able to induce partial activation of NK 
cells (CD69 was significantly upregulated but IFN-y production was not) but HBs 
peptides induced very potent NK cell responses. More detailed analyses focusing 
more specifically on antigen recognition/processing by accessory cells and how 
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these synergize with T cell-derived IL-2 to trigger NK cell activation will need to be 
investigated before we can accurately define appropriate vaccine design strategies. 
It will be necessary to explore the potential for NK cells to contribute to the effector 
phase of adaptive (acquired) immune responses to infection following vaccination 
and to define the pathways by which this occurs. This needs to be tested in the 
setting of a large and very well defined vaccine trial. Specifically, it will be very 
interesting to test: 
• If NK cell "recall" responses are naturally induced by infection and whether 
these responses can be recapitulated by vaccination while comparing 
different types of vaccines (i.e. live attenuated, inactivated, recombinant 
protein or polysaccharide vaccines) as well as if different vaccine delivery 
systems with and without the use of adjuvants may augment these 
responses; 
• If the post-vaccination NK cell "recall" responses depend upon, and correlate 
with, CD4+ T cell IL-2 responses; 
• If the durability of the NK cell "recall" responses is linked to the durability of 
the CD4+ T cell IL-2 responses and if these responses are boosted by 
infection/vaccination; 
• 
If the quality of the NK cell "recall" responses, induced by vaccination, is age-
dependent at the time of immunisation; 
• 
If the NK cell response differs both phenotypically and functionally during 
primary and secondary "recall" responses, following infection/vaccination; 
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• And if the NK cell "recall" responses may contribute to protective immunity 
following vaccination by secretion of IFN-y (enhancing macrophage activity), 
cytotoxicity, and/or by direct induction of apoptosis of infected cells. 
All of the assays presented in this thesis were performed using heat-inactivated fetal 
calf serum (HI-FCS) in the culture in lieu of autologous serum. Protective responses 
to rabies virus infection have largely been associated with the presence of 
neutralising antibodies (specific isotypes remain unknown). Strikingly, when 
comparing the use of autologous immune serum with HI-FCS in the cultures, the NK 
cell response was dramatically enhanced both in the speed as well as in the 
magnitude of their response to inactivated rabies virus. In many ways, this 
observation was not completely surprising. Celis et al. first demonstrated that 
antigen-antibody immune complexes (specifically anti-rabies IgG with rabies vaccine 
as a recall antigen) induced enhanced proliferation in culture (Celis and Wiktor 1985). 
This study predates the implementation of multi-colour flow cytomtery techniques to 
identify specific populations of proliferating lymphocytes but the authors -
understandably - concluded that this proliferation was due exclusively to T cells as 
they were using T cell lines. However, the cell lines were generated by culturing 
PBMC from vaccinated donors with rabies vaccine (inactivated virus) and 
recombinant IL-2 for 1 week and then further expanding antigen-reactive cells by 
limiting dilution assays and stimulating with irradiated PBMC as a source of antigen. 
Based on my observations, NK cells were highly responsive to rabies vaccine as a 
recall antigen and proliferated in a far more robust manner than either CD4+ or CD8+ 
T cells; it is quite likely that NK cells were also responding in these assays. 
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Based on my observations, one hypothesis that needs to be tested in the presence of 
immune serum could be that immune complex recognition through CD16 lowers the 
threshold for NK cell activation. In other words, there are two potential pathways by 
which NK cell responses can be potentiated by vaccination: IL-2/CD4+ T cell-
mediated and immune complexlCD16-mediated. This hypothesis of CD16-mediated 
activation of NK cells could be tested alongside the characterisation of IL-2/CD4+ T 
cells in a vaccine study setting. Specifically, it will be very interesting to test: 
• If post-vaccination NK cell "recall" responses are further augmented by 
vaccine antigen-specific antibodies targeting CD16 by way of antigen-
antibody immune complexes. 
• If the durability of the NK cell "recall" responses is linked to the durability of 
serum antibodies as well as if these responses can also be boosted by 
infection/vaccination. 
6.3 Concluding remarks 
It is increasingly clear over the last 5 years that the dichotomy drawn between innate 
and adaptive immune responses to antigen has become skewed. Interactions 
between conventionally defined innate cells and adaptive "recall" immune responses 
seem to be very different to the interactions between these two arms of the immune 
response during primary responses to the same pathogens. 
My observations with protozoan (Pf-RBC), bacterial (BCG) and viral (rabies) 
pathogens, together with the observations of others on influenza virus (He, Draghi et 
al. 2004; Long, Michaelsson et al. 2008), suggest that NK cell activation is 
augmented as a consequence of T cellllL-2 responses to infection. Moreover, I have 
validated (in collaboration with Dr. Anthony Fooks, rabies and wildlife zoonoses 
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group, VLA) the rabies vaccination model in mice (unpublished), observing very 
similar NK cell "recall" responses as in humans and essentially identical observations 
have very recently been reported for interactions between murine NK cells and T 
cells and the protozoan parasite Leishmania major (Bihl, Pecheur et al. 2010), 
indicating that this pathway of NK cell activation is conserved between humans and 
mice. 
I hypothesize, therefore, that an important function of effector/memory CD4+ T cells 
may be to secrete IL-2, activating NK cells to secrete cytokines and become cytolytic. 
The size, speed and duration of this "recall" NK cell response suggests that it may 
represent a critical component of the immediate and the sustained effector response 
to reinfection or infection post-vaccination. However, despite interest in the 
phenotypic characteristics of "memory" NK cells (Sun, Beilke et a!. 2009), the 
functional importance of NK cells during secondary immune responses is not known. 
Testing the hypothesis that T ceII/IL-2-driven NK cell responses contribute to post-
vaccination immunity and protection from development of disease will certainly 
warrant further investigation in a larger setting as well as by comparing numerous 
types of vaccines, i.e. whole organism versus DNA sub-unit as well as clinically 
effective vaccines versus vaccines which have not been shown to elicit protection 
from disease (e.g. HBV versus HIV). 
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Appendix 1 
The Journal of Immunology 
Cross-Talk between T Cells and NK Cells Generates Rapid 
Effector Responses to Plasmodium Jalciparum-Infected 
Erythrocytes 
Amir Horowitz,* Kirsty c. Newman,* J. Henry Evans,t Daniel S. Korbel,* 
Daniel M. Davis, t and Eleanor M. Riley* 
Rapid cell-mediated immune responses, characterized by production of proinfiammatory cytokines, such as IFN-y, can inhibit 
intraerythrocytic replication of malaria parasites and thereby prevent onset of clinical malaria. In this study, we have charac-
terized the kinetics and cellular sources of the very early IFN-y response to Plasmodium Jalciparum-infected RBCs among human 
PBMCs. We find that NK cells dominate the early (12-18 h) IFN-y response, that NK cells and T cells contribute equally to the 
response at 24 h, and that T cells increasingly dominate the response from 48 h onward. We also find that although yo T cells can 
produce IFN-'Y in response to P. Jalciparum-infected RBCs, they are greatly outnumbered by 0'/3 T cells, and thus, the majority of 
the IFN-'Y+ T cells are 0'/3 T cells and not 'Yo T cells; 'Yo T cells are, however, an important source of TNF. We have previously 
shown that NK cell responses to P. Jalciparum-infected RBCs require cytokine and contact-dependent signals from myeloid 
accessory cells. In this study, we demonstrate that NK cell IFN-y responses to P. Jalciparum-infected RBCs are also crucially 
dependent on IL-2 secreted by CD4+ T cells in an MHC class II-dependent manner, indicating that the innate response to infection 
actually relies upon complex interactions between NK cells, T cells, and accessory cells. We conclude that activation of NK cells 
may be a critical function of IL-2-secreting CD4+ T cells and that standard protocols for evaluation of Ag-specific immune 
responses need to be adapted to include assessment of NK cell activation as well as T cell-derived IL-2. The Journal oj 
Immunology, 2010, 184: 6043-6052. 
The optimal immune response to a malaria infection likely comprises rapid induction of inflammatory antiparasitic responses followed by equally rapid resolution of in-
flammation (mediated by anti-inflammatory cytokines) to prevent 
immunopathology (1). Rapid and robust cell-mediated immune 
responses can inhibit intraerythrocytic replication of malaria par-
asites and thereby prevent onset of clinical malaria (2). This process 
can be primed by ultra-low-dose infection/vaccination (3, 4) but 
has yet to be mimicked by subunit vaccines. Understanding the 
cellular and molecular pathways of this very early cellular response 
may allow the design of new approaches to vaccination, but there is 
still considerable debate over the precise sequence of events. In 
particular, the timing and magnitude of IFN-')' secretion are thought 
to be pivotal in determining the outcome of disease, and it is thus of 
importance to identify the major cellular sources of IFN-y, the 
kinetics of its production, and the pathways by which it is induced 
and regulated. 
IFN-')' can be produced by both innately activated cells and cells 
of the adaptive immune system. We have previously found that a/3 
T cells, ')'8 T cells, and NK cells all contribute to the IFN-y response 
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of PBMCs from malaria-naive donors cocultured for 18-24 h with 
live Plasmodium Jalciparum-infected RBCs (5). but we also found 
that the magnitude of the response, as well as the proportion of 
responding cells in each subset, varies among individuals (5, 6). In 
some individuals. there is little or no evidence of an NK cell re-
sponse to P. Jalciparum-infected RBCs, whereas in other in-
dividuals, NK cells comprise", 70% of IFN-,),-producing cells (5). 
We have identified variation in the strength of costimulatory signals 
from myeloid accessory cells (7) as well as polymorphism among 
NK cell regulatory receptors (8) as two components of this varia-
tion. Others, however, have concluded that ')'8 T cells are the major 
population of IFN--y-producing lymphocytes when PBMCs from 
naive individuals are incubated with P. Jalciparum-infected RBCs 
(9, 10) and that NK cells make no major contribution to the innate 
response to P. Jalciparum (9), although comparison of data from 
different studies is complicated by substantial differences in ex-
perimental protocols. 
In this study, we have carefully compared the magnitude and the 
timing of T cell and NK cell responses to P. Jalciparum-infected 
RBCs in a large cohort of malaria-naive donors. We find that NK 
cells dominate the early (12-18 h) IFN-y response. that NK cells 
and T cells contribute approximately equally to the response at 24 h. 
and that T cells then increasingly dominate the response from 48 h 
onward. We also find that although -y8 T cells can produce IFN-')' in 
response to P. Jalciparum-infected RBCs, they are greatly out-
numbered by al3 T cells. and thus, contrary to previous reports. the 
majority of the IFN--y + T cells are 0.13 T cells and not ')'0 T cells; ')'0 
T cells are, however. an important source of TNF. Importantly. 
however. we find that the NK cell IFN--y response to P. Jalciparum-
infected RBCs is crucially dependent on IL-2 secreted. in an ~fHC 
class II-dependent manner. by CD4 + T cells. These data corroborate 
our recent observations that NK cells may be recruited by Ag-
specific IL-2-secreting CD4+ T cells to act as effector cells during 
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the recall response to vaccine Ags (A. Horowitz, R.H. Behrens, 
L. Okell, A.R. Fooks, and E.M. Riley, submitted for publication) and 
indicate that the innate response to infection actually relies upon 
complex interactions between NK cells, T cells, and accessory cells. 
Materials and Methods 
Blood donors 
Adult blood donors were recruited at the London School of Hygiene and 
Tropical Medicine through an anonymous blood donation system. All 
donors were malaria naive and healthy and gave fully informed consent for 
their blood to be used in this study. Ethical approval was given by the 
London School of Hygiene and Tropical Medicine Ethics Committee 
(application number 805). 
PBMe preparation and culture 
Venous blood was collected into sodium heparin (10 IV/ml blood; CP 
Pharmaceuticals, London, U.K.), and PBMCs were isolated by Histopaque 
1077 (Sigma-Aldrich, St. Louis, MO) density gradient centrifugation as 
described previously (11). Cells were resuspended at a concentration of 2 X 
106 cells/ml and cultured in flat-bottom 24-well plates or U-bottom 96-well 
plates for periods of up to 6 d. 
Recombinant human IL-12 (rhIL-12; PeproTech, Rocky Hill, NJ) and 
rhIL-18 (MBL International, Woburn, MA) were each used at 0.1 J.Lg/ml. 
P. fa1ciparum parasites 
P. /alciparum parasites (strain 3D7) were grown in ORh- human eryth-
rocytes (National Blood Service, London, U.K.) in RPMI 1640 (Life 
Technologies, Rockville, MD) supplemented with 25 mM HE PES (Sigma-
Aldrich), 28 mM sodium bicarbonate (BDH Prolabo Chemicals, London, 
U.K.), 20 j.Lg/l hypoxanthine (Sigma-Aldrich), and 10% normal human AB 
serum (National Blood Service). Cultures were gassed with 3% O2, 4% CO2, 
and 93% N2 and incubated at 37"C. Parasite cultures were routinely shown 
to be free from MycoplasmalAcholeplasma species contamination using an 
ELISA-based Mycoplasma Detection Kit (Roche, Basel, Switzerland) in-
corporating polyclonal Abs against Mycoplasma arginini, Mycoplasma 
hyorhinis, Acholeplasma laidlawii, and Mycoplasma orale. Highly pure 
(>95%) mature schizonts were harvested from cultures of 5-8% para-
sitaemia by adherence to an LD separation column (Miltenyi Biotec, Au-
burn, CAl. Columns were washed thoroughly with PBS to remove 
uninfected erythrocytes pre-elution. Schizont-infected (P. Jalciparum-
infected RBC) or uninfected erythrocytes were added at a ratio of 3 RBC/ 
mononuclear cell. 
Depletion oj T cell subsets 
PBMC were stained for CD3-expressing cells using a T cell selection kit 
(StemCelI Technologies, Vancouver, British Columbia, Canada); CD4-
expressing cells using a Dynal bead-conjugated mAb to CD4 (Invitrogen, 
Carlsbad, CAl; CD8-expressing cells using aPE-conjugated mAb to CD8 
(Caltag Laboratories, Burlingame, CAl and anti-PE MicroBeads (Miltenyi 
Biotec); ,/0 TCR-expressing cells using PE-conjugated mAb to 'Yo TCR 
(Cal tag Laboratories) and anti-PE MicroBeads (Miltenyi Biotec); and ctr3 
TCR-expressing cells using aPE-conjugated mAb to ctr3 TCR (BD Bio-
sciences, San Jose, CAl and anti-PE MicroBeads (Miltenyi Biotec). De-
pletion of CD4 cells was carried out using a Dynal Magnetic Particle 
Concentrator-2 (Invitrogen). All other depletions were carried out using LD 
separation columns (Miltenyi Biotec) according to the manufacturer's in-
structions. Postdepletion, the PBMC concentration was readjusted to 2 X 
106, and cells were cultured with P. Jalciparum-infected RBCs at a ratio of 
1:3 (as previously) and also at a ratio of I: I 0 to ensure that changing the ratio 
of NK cells and accessory cells to P. Jalciparum-infected RBCs did not 
adversely affect the outcome of the experiments. No significant differences 
were seen between the 1:3 and I: 10 cultures, so only data from the 1:3 
cultures are presented. 
Blocking experiments 
Two million PBMCs were cultured overnight in 2-1-well flat-bottom plates in 
the presence of purified blocking/neutralizing Abs or appropriate isotype 
control Abs for the following cytokines, cytokine receptors, and MHC 
molecules (all BD Biosciences): anti-IL-12 (p40/p70; clone C 11.5), anti-IL-
18n-chain (clone H44), anti-IL-2 (clone MQ I 17H 12), anti-IFNR-ct [2b] 
(clone 7N4-1), anti-TNF (clone MAbl), anti-MHC class I (HLA-A, -B, -C; 
clone W6132), and anli-MHC class II (HLA-DR, DP, DQ; clone Tii-39). 
T CELL-NK CELL CROSS-TALK AND ~IALARIA 
Cell sUrface and intracellular staining Jar flow cytomerry 
Surface and intracellular staining was performed as described previouslv 
(6) .. The Abs/~a~ents used were: anti-CD3 PerCP, anli-n~ TCR-FITC, 
antl-'Yo TCR (~lOtInylate~), streptavidin PerCP, anti-IFN--y APe, anti-CDol 
A~C-Cy7, an~I-CD8 PaCIfic Blue, and anti-CD3 PE-Texas Red (BD Bio-
sCIences); ~ntl-CD56 APC (Be:km~n Coulter, Fullerton, CAl. anti-IFN--y 
F~TC,. antl-IL-2 APC (BD Blosclences). and anti-CD56 PE-Cy7 (BD 
Blosclences). All ~bs were mouse monoclonals. Flow cytometric analyses 
w~re ~erformed usmg a BD FACSCalibur or BD Cyan flow cytometer (BD 
BlOsclences) an~ FlowJo ~nalysi.s software (TreeS tar, Ashland, OR). Anti-
CD3 Abs were mcluded In the mtracellular staining mixes to ensure that 
T cells that downregulated CD3 upon stimulation were not miscIassified. 
Multiplex assay 
~ecrete~ IL-2 and TNF-ct were measured, according to the manufacturer's 
m~tructIons, by cytometric bead array (CSA Thltrh2trhl7 kit; SD Bio-
sCIences). All sam~les were acquired using an FACSCalibur flow cy-
tometer, and analYSIS was performed using FCAP Array software (Soft 
Flow, SI. Louis Park, MN). 
Statistical analysis 
All statistical analyses were performed using Prism 5 software (GraphPad 
San Diego, CAl. ' 
Results 
T cells and NK cells both contribute to early IFN--y response to 
P. falciparum 
We have previously demonstrated that both NK cells and T cells can 
produce IFN-"{ following incubation for 18-24 h with P. Jalciparum-
infected RBCs (5), but others have concluded that "{8T cells are the 
only significant source of early IFN-"{ (9, 10). This discrepancy may 
reflect, in part, heterogeneity between human blood donors in the 
timing and magnitude of the response and in the source of IFN-"{ (6). 
We sought, therefore, to characterize more systematically the early 
IFN-"{ response to P. Jalciparum-infected RBCs (Fig. lA-E). Lym-
phocytes were identified as CD3+ T cells or as CD3 -CD56+ NK 
cells (Fig. IA). After 21 h coculture with P. Jalciparum-infected 
RBCs, the proportion of NK cells that contained intracellular IFN-"{ 
ranged from 0--81 % with a median of 4.65%. The proportion of 
T cells that were positive for IFN-"{ was significantly lower, ranging 
from 0--7% with a median of 0.82% (Fig. IB). However, because 
T cells outnumber NK cells by ~ 10: 1 among PBMCs, when we gate 
on all IFN-"{+ cells (Fig. 1 C), we find that T cells and NK cells con-
tribute approximately equally to the population of IFN-"{+ cells (Fig. 
ID). On the other hand, IFN-"{ staining intensity (mean fluorescence 
intensity [MFID is significantly higher for NK cells than for T cells 
(p < 0.0001) (Fig. IE), indicating that NK cells are producing more 
IFN-"{ per cell than T cells. 
To determine whether NK and T cells responded to P. Jalciparum-
infected RBCs with similar kinetics, we determined the proportion 
of all IFN-"{+ cells that were either NK cells or T cells after co-
culturing for periods from 6 h to 6 d (Fig. I F). Although there is 
heterogeneity in the response among donors, the distinct trend was 
for IFN-"{+ cells to be almost exclusively NK cells after 6 h of 
coculture and for NK cells to continue to dominate the IFN-"{ re-
sponse at 12 h. However, by 24 h, the response was evenly split 
between NK cells and T cells, and T cell responses gradually came 
to dominate the IFN-"{ response over the next 5 d. This observation, 
that the NK cell IFN-,,{ response is very rapid but transient, is not 
unexpected but does likely explain many of the apparent discrep-
ancies in the literature in which innate responses tend to have been 
assayed at a single point in time and frequently as long as 72 h 
postinitiation of P. Jalciparum-infected RBC stimulation. 
Because potent Ag-specific T cell responses to P. Jalciparum-
infected RBCs might not be expected among malaria-naive do-
nors, we next sought to identify which subsets of T cells were 
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lymphocytes) and Tcells (a ll CD3+ lymphocytes) and for detection of intracellular IFN--y after 24 h coculture with (right column ) or without (leJt column ; OM P 
Jalciparum-i nfecte d RBCs. B, The proportion of all NK cells or all T cells expressing intracellular IFN--y after 24 h cocultu re with PJalciparum-infected RBCs. 
II = 50 malaria-naive donors. C, Oating strategy for identification of all IFN--y+ lymphocytes and their subsequent identification as ei ther NK cell or T cells. D, 
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Numbers on x-axis identify individual blood donors , B, D, and E, Hori zontal lines represent medians . The p values are fo r two-tai led paired Wi lcoxon test 
with 95% CIs comparing NK cells with T cells from the same donor. CI, confidence interva l; OM, growth medium. 
produc ing IFN-,)" PBMCs from 14 donors were incubated wi th P. 
falc iparum-infected RBCs for 2 1 h and gated as NK, CD3+ 
),5TCR+, or CD3+ a (3TCR+ T cell s; at some key time points, a (3 
T cell s were gated as either CD4+ or CDS+ T ce ll s (Fig, 2A). When 
each lymphocyte population was separately analyzed for IFN-')' 
expression , we agai n found that, on average, a higher proportion 
of NK cells than T cells produce IFN-,)" but among the T cell 
populations, a significantly higher proportion of ,),oTCR+ T cell s 
were IFN-')'+ than either of the a(3TCR+ T cell subsets (Fig. 28). 
However, because the majority of circulating T cells are CD4+ and 
Cl~TCR+, when we gate on all IFN-')'+ cells (Fig. 2C), we find that 
the majority of [FN-,),+ T cells are CD4+ a(3TCR+ and that CD4+ 
Cl~TCR+ T cells and NK cells contJibute equally to the total IFN-')'+ 
POpulation, with CDS+ a(3TCR+ and ,),oTCR+ cells making only 
a minor contribution (Fig. 2D) , To make sure that we had not 
Illi ed the optimal timing for respon es of any particular T cell 
ubset, we repeated the kinetic analysis over 6 d (Fig . 2£) and 
found that a(3+ T cells were the major contlibuting T cell pop-
ulation throughollt the response. 
NK cell and T cell responses to P. fa lciparum-inJecred RBCs 
are both cytokine and MHC class II dependent 
We have previously shown that NK cell responses to P. JalciparulIl -
infected RBCs are absolutely dependent upon myeloid cell-
derived IL-1 2 (12) and partial ly dependent upon IL-IS, IF -a. 
and IL-2 (7), Moreover, we, and others, have previously hown 
that memory CD4+ T cells from malaria-naive individual are able 
to respond to P. Jalc iparum-infected RBC in a cia ical MHC 
class II-restricted manner (13- 15), and it i nOW generally ac-
cepted that these cell s have been primed by cro -reacti ng Ag 
(13, 16), To confirm and extend the e observation , PB C from 
10 malaria-naive donors (selected to represent a range of K re-
sponses from nonre ponders to high re ponder ) \ ere cullUred 
with P. Ja/ciparulll-infected RBC for 24 h in the pre en e of 
blockingorneutralizingAb toIL-1 2, IL-1 , IL-_. IF -a R, lH 
clas I, MHC cia s ll, or the rele ant i otype ontr lb . 
representative data set for one donor i ho, n in Fig. ; daw for nil 
10 donor are hO\ n in Fig. 4. e pe ted. K ell IF -')' 
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responses were markedly and significantly diminished by anti-IL-
12, anti-IL-2, and anti-IFN-o:R, although the effect of anti-IL-18 
was less obvious (Fig. 4A-D). Also, in confirmation of a previous 
study (8), blocking Ab to MHC class I had no effect on the NK 
cell response (Fig. 4£). Somewhat unexpectedly, however, NK 
cell responses to P jalciparum-infected RBCs were markedly 
reduced in the presence of MHC class II-blocking Ab (Fig. 4F). 
As expected, given the previously published data (7, 8, 12-16), 
the preponderance of CD4+ T cells in the IFN-)'-responding pop-
ulation, and the small but noticeable contlibution of CD8+ T cells, 
total T cell IFN-)' responses were markedly diminished in the 
presence of anti-MHC class II Abs (Fig. 4F) and significantly, but 
less markedly, dimini shed by MHC class f blockade (Fig. 4E). Total 
T cell responses were also significantly inhibited by neutralizing 
Abs to fL-12, IL-18, and IL-2, and there was a margi nally signifi-
cant effect of anti-fFN-aR (Fig. 4A- D), indicating that T cell s are 
also dependent upon accessory cell-delived cytokines. 
NK cell responses to P. falciparum-injecled RBCs are 
dependent upon T cell help 
The ob ervation that NK cell responses to P Jalciparum-infected 
RBCs were highly dependent upon both IL-2 and MHC class n 
raised the possibility that, as previously described for human NK 
cell responses to influenza (17, 18), NK cells require signals ( uch as 
IL-2) from Ag-specific CD4+ T cells to respond optimally to P 
jalciparum-infected RBCs. To test this hypothesis, we depleted 
PBMCs of various lymphocyte populations and tested the remaining 
PBMCs for their ability to make IFN-')' in 24-h cultures (Fi g. 5). NK 
cells among CD3-depleted PBMCs made strong re pon es to rhlL-
12 plus IL-18 (Fig. SA), indicating that these two cytokine (at op-
timal concentrations) are sufficient for NK cell activation. Con-
versely, NK cells among CD3-depleted P8MC were completely 
unable to make IFN-')' in response to P jalciparul1l -infected R8 C 
(Fig . 5B), but NK cells among CD20 (8 ce ll )-depleted P8MC made 
a robust IFN-)' response to P Jalciparum-in fected R8 C (Fig. 5C). 
To determine which subset(s) ofT cell provide help to K cell , e 
depleted PBMCs of just CD4+ T cell , ju t CD + T cell, all 
a[3TCR+ T ce ll s, or all ),oTCR+ T cells and cu ltured the remaining 
PBMCs with P Jalciparum -infected RBC for 24 h (Fig . 5D- C . It 
was clear that the NK cell re pon e to PJalciparulII-infected R8 
was only completely ablated when all T cell were rem ed but that 
removal ofanyTcellsub et ignificantl y redu edthe K ell lF -'( 
respon e. Finally, to rule out an non pecific effe f magnell 
bead treatment, unlabeled P8M ere incubated with ntl-P 
o 
o 
~ 
::s 
o 
~ [ 
::j> 
o 
3 
:3 
:l 
c 
:J 
o 
2 
rrJ 
o 
::s 
Z 
o 
< ~ 
3 
r:J 
~ 
., 
0\ 
N 
o 
o 
6048 
A NK cells T cells p = 0.002 p . 0.002 
~ 50 ~8 
B 40 116 ~ ~ Z 30 l-t- 20 t- 4 Z Z !:2 !!: 10 ~ ~ 0 0 
Isotype 
,, ·IL-12 Isotype ,,·IL-12 Contro l Control 
B p = 0.2 3 p" 0.01 
Y2 50 I , 8 ~ ~ B 40 B6 ~ ~ 30 ~::::::::o l-t- 20 .-.... t.4 Z ~ Z !!: 10 !:2 
~ ~ 0 0 
Isotype u -IL-18 Isotype (,·IL-18 Control Control 
C ~ 50 p" 0.002 8 , 
B 40 ~ 1l 6 ~ ~ 30 l-t- 20 1- 4 Z z !!: 10 !:!: 2 ~ .,.e 0 0 Isotype 
«·IL -2 Isotype n -IL·2 
Control Control 
0 50 8 P" 0.042 
<II ~ ~ 40 1l 6 F§§ " ~ 30 I-pO t· 4 z 
~ 10 !:!: 2 
.,.e 
'ifl 0 0 
Isotypo (, -IFN-uR[2b) Isotype n -IFN-" R[2b) 
Control Control 
E 50 p" 0.43 8 P = 0.022 
</I , , ~ ~ 40 ~~O 1l 6 ~ ~ 30 ~-__ ~il I-z ~ + 4 + 20 ~. i'- ~--o ~ 2 ~ 10 
'" tf!. 0 
.,.e 
0 
Isotype 
«·MHC class I Isotype u -MHC class I 
Control Control 
F 50 P = 0.002 8 P = 0.002 </I I I ~ ,...-, ~ 40 ~ 1l 6 ~ " ~ 30 I-pO \ . 4 z ~ 10 !:!: 2 .,.e ~ 0 0 
Isotype « -MHC class II Isotype ,,·MHC class II 
Control Control 
FIGURE 4. NK cell and T cell responses to P. !alciparum-infected 
RBCs are both cytokine and MHC class II dependent. PBMCs from 10 
donors were cultured with P. !alciparum-infected RBCs for 24 h in the 
presence of blocking Abs to cytokines, cytokine receptors, MHC mole-
cules, or with iso type-matched control Abs and the percentages of NK 
cell s (left columns) and T cell s (right columns) expressing intracellular 
IFN-'Y detemlined by flow cytometry. The p values are for two-tailed 
paired Wilcoxon test with 95% Cr. A, Anti-IL-12. B, Anti-IL-18. C, Anti-
IL-2. D, Anti-fFN-aR . E, Anti-MHC class r. F, Anti-MHC class II. 
microbeads and passed through the mag netic column (Fig. Sf{); 
a robust [FN--y response was seen. 
CD4+ T cells produce IL-2 within 12 h oj caculture with 
P. falciparum-in!ected RBCs 
Because NK ce\1 s require both T cell help and IL-2 to respond to 
P. fa lciparum-in fec ted RBCs, it seemed likely that T ce\1 s are an 
essenti al source of IL-2. We sought to determine the kinetics of 
T CELL-NK CELL CROSS-TALK AND ALARlA 
~L-2 ~roduction in response to P Jalciparum-infected RBC and to 
IdentIfy the major source(s) of this cytokine (Fig. 6). IL-2 \ a 
detected m culture supernatants wi thin 3 h of PBMC P fi 1 . 
. - . a ClparUIIl -
mfected RBC coculture, peaked at 4 h, and remained detectable 
for at least 24 h (Fig . 6A). [n parallel cultures, intracellular IL-2 in 
NK cells and T ~ell subsets was analyzed by flow cytometry (Fig. 
6B-D)~ All IL-2 cells were gated (Fig. 6B) and counted (Fig. 6C). 
[FN--y cells were first detected at 3 h posti niti ation of coculture 
and their numbers peaked at 12 h; the di screpancy in timing be~ 
tween the accumulation of so luble [L-2 in culture medium (Fig. 6A ) 
and the peak of IL-2-secreting cell s (Fig. 6C) pre umab ly reflect 
the balance between secretion and consumption of TL-2 in the cul-
ture. At all time points , the vast majority (>80%) of fL-2- producing 
cells were CD4+ T cells with only minor contributions from CD8+ 
T cells at 6 and 12 h and from -yoT cells and NK cells at 3 h (Fig. 6D) . 
Interestingly, IL-2 responses were much less heterogeneous among 
the various donors than were IFN--y responses . 
'Yo T cells produce TNF in response to P. fa1ciparum-in!ected 
RBCs, but TNF is not required Jar NK cell or T ceIlIFN-'Y 
responses 
Because -yo TCR+ T cells seemed to be necessary for an optimal NK 
response to P. Jalciparum-infected RBCs (Fig. 5) but did not seem 
to be significant producers of IL-2 (Fig. 6), we considered whether 
other cytokines produced by -yo T cell s might contribute to NK cell 
activation. As Hensmann et al. ( 10) have previously shown that 
-yoT cells represent a significant source of intracellular TNF during 
the early (18 h) response to P. Jalciparum-infected RBCs, and as 
Robinson et al. (19) concluded (from T cell subset depletion assays) 
that -yo T cells are a significant source of TNF, we considered the 
possibility that -yo T cell-derived TNF might potentiate NK cell 
responses . TNF was detected in supernatants within 4 h of PBMC-
P Jalciparum-infected RBC coculture and peaked at ~ 12 h (Fig . 
7A) . In parallel , PBMCs from eight malaria-naive donors were 
incubated with PJalciparum-infected RBCs for up to 24 h and then 
stained for intracellular TNF and surface markers to identify 
macro phages (CD 14 + CD68+) and -yo T cell s (Fig. 7 B). When 
gating on all macrophages (Fig . 7D), TNY macrophages were 
detectable within 2 h of P Jalciparum-infected RBC cocultu re , the 
response peaking (wi th >35% of all macrophages being TNY) at 
4 h and declining to barely detectable levels by 24 h. In com pari on, 
TNY -yo T cells were detected from ~5 to 6 h postinitiation of 
P. Jalciparum-infected RBC stimulation, and the response was 
maximal (wi th ~30% of all -yoT cell s be ing TNP) at 12-24 h. 
However, we found no evidence that TNF was required for in-
duction of an early IFN--y response, because when we stimulated 
PBMCs from the same donors with PJalciparum-infected RBCs in 
the presence of neutralizing Abs to TNF, the NK cell and T cell 
IFN--y responses were unaffected (Fig. 7 E). 
T cell help Jar NK cell activation by P. fa1ciparum-inJected 
RBCs does not require NK cell-T cell contact 
We have shown that T ce ll-derived signa ls are required for K cell 
activation by P JalciparLlm-infected RBCs. One of the e ignal i 
clearly IL-2 , emanating principally from CD4+ al3 T cell , but 
T cell depletion studies suggest that there may al 0 be an a yet 
undefined role for -yo T cells in NK cell activation . We ha e pre-
viously shown that direct contact between K cell and myel id 
accessory cells is required fo r optimal K cell re pon e t P. Jal-
ciparwn-infected RBCs (7), and we therefo re con idered the po -
sibility that T cells might also provide contact-dependent ignal to 
NK cell s (Fig. 8) . Intact PBMC and CD3-depleted PB 1 
cultured in separate compartment of a tran v ell pl ate eparated b ' 
a semipermeable membrane; intact PBMC in the 10 er chamber 
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magnetic column. The p values are for two-tailed paired Wilcoxon tests, 95% CI, for 15 donors. 
and CD3-depleted PBMCs in the upper chamber. When P. falci-
parum-infected RBCs were added to the CD3-depleted (upper) 
PBMC compartment but not to the intact PBMCs (lower compart-
ment), NK cells in neither compartment produced IFN-/" suggest-
ing that P. falciparum-infected RBCs need to be in the same 
compartment as the T cells in order for NK cells to become acti-
vated, consistent with a need for APCs to take up Ag and present it to 
T cells in an MHC class II-dependent manner. However. if P. fal-
ciparum-infected RBCs were added to both compartments, NK cell s 
in both the intact PBMC population and in the CD3-depleted NK 
cell population were able to respond fully, indicating that soluble 
T cell-derived signals passing through the semipermeable mem-
brane were sufficient to activate the NK cells . To determine if this 
soluble signal is IL-2, we added neutralizing anti-IL-2 Ab to the 
eD3-depleted PBMCs in the upper chamber and added P.falciparum-
A B I. II. 
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infected RBCs to both compartments. In this case, the NK celllFN--y 
response was significantly inhibited in both compartments. 
Discussion 
Although there is a general consensus that a rapid, cell-mediated. 
inflammatory response is required to contain the initi al stages of 
human blood-stage malaria infections. there has been considerable 
debate over many years as to the key cellular effectors of thi s re-
sponse (2). We have therefore conducted a detailed kinetic analys is 
of all the likely sources of IFN-/, and find that the very early «24 
h) IFN-/, response to P. faLciparum-infected RBCs is dominated. in 
most PBMC donors. by NK cell s, that NK cells and T cells con-
tribute more or less equally to the response at 24 h. and that T cell 
come to dominate the response from 48 h onward. This rapid NK 
cell response to P. faLciparum-i nfected RBCs among PBMCs from 
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malaria-naive donors is in full agreement with both of our own 
earlier studies (5) and others (20). D'Ombrain et al. (9) concluded 
that NK cells do not contribute significantly to the innate JFN--y 
response to Pjalciparum-infected RBCs; however, their studies did 
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FIGURE 8, T cell help for NK cell ac tivation by P falciparum-infected 
RBCs does not require NK cell-T cell contact. PBMCs were placed in the 
lower well and CD3-depleted PBMCs were placed in the upper well of 
a transwell chamber separated by a semipermeable membrane and cultured 
in the presence (+) or absence (-) of P falciparum-infected RBCs, anti-
IL·2 Ab, or isotype-matched control Ab (rabbit IgG). The percentage of 
NK cells in each chamber expressing IFN--y was determined after 24 h. 
Data for each donor were nonnali zed to the response given by their own 
PBMCs cultured directly with P fa lciparum-infected RBCs in the lower 
chamber (medi an 41 %, interquartil e ranges 6%) and are shown as medians 
and interquartil e ranges for five donors. The p values are fo r two- tail ed 
paired Wil coxon tes ts, 95% Cr. 
not include the very early time points (12- 18 h) at which we ob-
serve maximal NK cell responses, suggesting that an NK re pon e 
may have been present in their donors but was missed, although it i 
surprising that D'Ombrain et a!. (9) report so few IFN--y+ NK ce ll 
at 24 h. Although Hensmann et a!. (l0) stained for CD3, CD56, and 
IFN--y after 18 h coculture with P jalcipa rum-infected RBCs, they 
studied only four donors and did not explicitl y report the NK ce ll 
IFN--y response; from the data presented in their paper, it is pos ible 
that between 10% and 40% of IFN--y+ cells in their donors could 
have been NK cells , which is well within the range that we have 
observed in our much larger donor panel. 
More problematic is our observation that the vast majority of 
IFN--y-producing T cells (at all time points from 6 h to 6 d of 
Pjalciparum-infected RBC coculture) are TCR a [3+ and CD4+; thi 
finding is in direct contradiction to the findings of both Hen mann 
et al. (10) and D'Ombrain et a!. (9), who sugges ted that -y8+ T cell 
are the major producers of IFN--y in response to P Jalciparum-
infected RBC stimul ation . The reason fo r these confl icting re ult i 
unclear. It is possible that there are technical explanations. The three 
studies used different P Jalciparum clones, which might differ in 
their production of the phosphorylated nonpeptidic Ag , which are 
believed to be the ligands fo r V-y9+ T cells (2 1), although our ob-
servation of very robust TNF re pon e to P Jalciparw/I-infected 
RBCs by -y8T cells tends to argue against thi explanation . We have 
previously observed that -y8T cells require quite con iderable 
amounts of fL-2 to proliferate in respon e to P Jalciparulll-infe ted 
RBCs (22); we do not ro uti nely add e ogenou IL-_ or other 
timulatory agents to our culture , " hich may e pl ai n lh la k f 
-y8T cell IFN--y respon es in our experiment , but again the r bu t 
-y8 T cell TNF re pon e uggest th at thi i n t the e\pl 3natl n 
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Lastly, we have taken great care to avoid misclassification of lym-
phocyte populations by 1) using simultaneous seven-color ana-
lysis of CD3, CD56, a [3TCR, 'Y8TCR, CD4, CD8, and IFN-'Y 
expression; 2) inclusion of anti-CD3 in the intracellular mix to 
identify activated T cells that may have downregulated surface 
expression of CD3; and 3) using a biotinylated anti-'Y8TCR Ab 
that does not suffer from the tendency that we have observed of 
some supposedly 'Y8TCR-specific Abs to stain both CDr and a[3 
TCR+ cells. We note with some concern that the majority of the 
IFN-'/ 'YSTCR+ cells in the study by D'Ombrain et a1. (9) also 
express NK cell markers, raising interesting questions as to the true 
identity of these cells. Alternatively, the differences seen in the 
various studies may reflect genuine heterogeneity in 'YST cell re-
sponses among individuals or populations, reflecting the known 
inter- and intrapopulation diversity in numbers and TCR reper-
toires of 'YS+ T cells (23). 
The strong a [3TCR+ CD4+ T cell IFN-'Y response that we observed 
after 2-6 d of P Jalciparum-infected RBC activation is highly con-
sistent with previous reports in naive humans (13, 14,24), with evi-
dence for cross-reactive priming of malaria-reactive T cells by 
a diverse array of commonly encountered micro-organisms (13) and 
with data from murine infection models, indicating that a[3+ T cells 
can playa crucial role in the IFN-'Y response to primary infections 
(25-27). It is difficult to predict whether such cross-reactive re-
sponses would be beneficial should these individuals become in-
fected with malaria; naive adults show very variable responses to 
primary malaria infections with some making very rapid, and par-
tially protective, proinflanunatory responses, whereas others make 
little or no inflammatory response and develop rapidly escalating 
parasitemia (28, 29). 
A somewhat unexpected finding of this study was the absolute 
dependency of NK cells on CD4+ T cell-derived lL-2 for their 
response to P Jalciparum-infected RBCs. In hindsight, this should 
not have been a surprise. We have previously shown that NK cell 
responses to P. Jalciparum-infected RBCs depend upon cytokine 
and contact-mediated signals from myeloid cells (7), and we did 
notice in those experiments that NK responses were diminished by 
anti-IL-2 and that adding purified adherent accessory cells to 
isolated NK cells did not fully restore the NK response seen in 
intact PBMCs (7). Moreover, T cell and IL-2 dependency has 
previously been reported for NK cell activation by influenza virus 
(18), and, in mice, NK cell cytotoxicity against some tumor cells 
is a~TCR + T cell dependent (30, 31), but the possibility that this 
is IL-2 mediated remains to be formally tested. However, although 
it has long been taken for granted that Ag-specific T cells mediate 
some of their antimicrobial effects by activation of innate cells, 
such as macrophages, the possibility that Ag-specific T cells might 
interact with other cells of the innate response, in particular with 
NK cells, has largely been ignored. 
Our current hypothesis is that, on exposure to cognate Ag pre-
sented by MHC class II, TCR a[3+ T cells secrete IL-2, which, in 
combination with essential signals from myeloid accessory cells, 
activates NK cells. The preponderance of CD4+ T cells among the 
IL-2+ cell population is consistent with the very marked effect on 
the NK cell response of MHC class II blockade. The transwell 
experiments indicate that the IL-2 is secreted from the T cells and 
diffuses in solution toward the NK cells; there is no apparent re-
quirement for contact between the T cell and the NK cell or for the 
focal secretion of IL-2 into an immune synapse. However, it is 
likely that T cells also provide other NK cell-potentiating signals. 
For example, although we found no evidence that P. Jalciparum-
infected RBC-activated 'Y8 T cells produced significant amounts of 
IL-2, depletion of 'Y8 T cells from PBMCs substantially reduced the 
NK cell IFN-'Y response. We do not believe that this is simply due to 
6051 
a reduction in the proportion of T cells in the cultures because )'S 
T cells represent a very small proportion of the total T cell pool and 
~n e~ually small proportion of the IL-2+ T cells. We have not yet 
IdentIfied the )'8 T cell contribution to the NK response, but it does 
not appear to be TNF. 
Our data suggest that full reactivation ofIFN-),-producing T cells 
also requires IL-2-mediated signals because the peak of the T cell 
IL-2 response preceded the peak of the T cell IFN-)' response, and 
neutralization of IL-2 markedly reduced IFN-)' responses ofT cells 
as well as NK cells. However, NK cell IFN-)' responses peaked 
within 6 h of the peak IL-2 response, whereas Tcell IFN-)' responses 
did not peak until ~36 h after the peak IL-2 response, suggesting that 
T cells may require higher concentrations of IL-2 or more sustained 
IL-2 signaling to become fully activated than do NK cells. 
Our observations imply that enhancing T cell responses to ma-
laria (i.e., by vaccination) should also enhance the NK cell response. 
Given its speed (which precedes the bulk of the T cell IFN-)' re-
sponse by hours or days), the NK IFN-'Y response may represent an 
important determinant of vaccine efficacy, and the ability of vac-
cine-induced T cells to support NK cell effector function might be 
an important biomarker of an effective T cell response to the vac-
cine. Finally, our demonstration that NK cell responses to P. fal-
ciparum-infected RBCs are so highly dependent on T cell IL-2 may 
necessitate reconsideration of data based simply on T cell depletion 
of PBMCs; the possibility that the IFN-)'-producing cells might be 
NK cells, and that the main role ofT cells might be to secrete IL-2, 
needs to be considered, and IFN-'Y ELISA, cytometric bead array, 
or ELlS POT data need to be confirmed by intracellular cytokine 
staining and flow cytometry. 
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rK Cells as Effectors of Acquired Immune Responses: 
~ffector CD4+ T Cell-Dependent Activation of NK Cells 
'ollowing Vaccination 
mir Horowitz, * Ron H. Behrens, *,t Lucy Okell, * Anthony R. Fooks,* and 
leanor M. Riley* 
e characterized vaccine-indu~ed .cellular responses to rabies virus in naive adult volunteers. Contrary to current paradigms, we 
served potent and prolonged In vitro NK cell cytokine production and degranulation responses after restimulation ofPBMCs with 
lctivated rabies virus in vaccinated, but not in unvaccinated, individuals. This "recall" NK cell response was absolutely de-
ndent on Ag-specific IL-2 from CD45RO+ CD4+ T cells as well as IL-12 and !L-18 from accessory cells. Importantly, NK cells 
presented over 70% of all IFN-,),-secreting and degranulating cells in the first 12-18 h after virus rechallenge indicating they 
ly be required for rapid control of infection after vaccination. Activation of NK cells may be a critical function of IL-2-secreting 
'ector memory T cells. Although IL-2-dependent postvaccination NK cell activation has been reported previously, this is the first 
ne the magnitUde of this effect and its contribution to the overall vaccine-induced response has been appreciated and the 
~chanisms of NK activation postvaccination have been elucidated. Our data will allow standard protocols for evaluating vaccine-
iuced immunity to be adapted to assess NK cell effector responses. The Journal of Immunology, 2010, 185: 2808-2818. 
r he innate immune system is designed to provide rapid but generic responses to foreign organisms. Conversely, adaptive responses are slow (requiring clonal expansion of 
ive precursors to generate sufficiently large populations of ef-
:tor and memory cells) but highly specific. Bidirectional inter-
lions between innate and adaptive immune systems are essential 
. immunity to infection and for successful vaccination. Innate 
'ector cells amplify and direct the subsequent adaptive response 
-3), whereas effector T cells activate innate cells to kill pathogens 
pathogen-infected cells (4). 
NK cells are innate immune effectors that, by cytokine pro-
ction or cytotoxicity, help to contain an infection until an ef-
:tive adaptive response is mounted. NK cells become activated 
len the balance of activating and inhibitory signals that they 
:eive is disturbed (5). Direct NK cell activation follows in-
action with cells that (due to mutation or infection) lack ligands 
. inhibitory NK cell surface receptors for self-MHC (the "missing-
f" phenomenon) andlor express stress-induced ligands for NK 
II-activating receptors. Indirect NK cell activation occurs after 
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microbial ligation of pattern recogmtIon receptors on myeloid 
accessory cells and is mediated by cytokines (IL-12, IL-18, and 
IFN-a) and by contact-dependent stimuli from myeloid cells (e.g., 
ICAM-IILFA-l) (6). 
Our investigations of the pathways of NK cell activation by 
Plasmodiumfalciparum (malaria)-infected RBCs revealed essential 
roles for IL-12 and accessory cell contact as well as subsidiary roles 
for IL-18 and IFN-a (7-9). However, optimal NK cell responses to 
malaria-infected cells were also dependent on IL-2 (7) and although 
myeloid cells were essential (7), we were never able to fully recapit-
ulate the NK cell response of mixed PBMCs by addition of myeloid 
cells (plastic adherent monocytes. macrophages, and dendritic cells) 
to purified NK cells (A. Horowitz, unpublished data). These observa-
tions (A. Horowitz, unpublished data), bolstered by reports of T cell 
and IL-2-dependent activation of human NK cells (8. 9) and of an 
increase in the frequency of IFN-'Y-producing NK cells among 
restimulated PBMCs after influenza vaccination (10) led us to 
speculate that IL-2 from Ag-specific T cells might allow NK cells 
to contribute to the effector arm of adaptive immune responses and 
thus NK cells may make a significant contribution to the cellular 
effector response to vaccination. 
In this study, we tested the hypothesis that NK cell responses are 
specifically enhanced, after vaccination, by IL-2 emanating from 
Ag-specific T cells. Using rabies virus vaccination as our model 
system (as inapparent exposure to rabies virus is likely to be ex-
tremely rare and our volunteers are thus expected to be fully naive 
prior to vaccination), we demonstrate that NK cells are the major 
contributors to the immediate vaccine-specific cytokine and cyto-
toxic recall response, that this response is dependent on lL-~ from 
Ag-specific memory T cells and is associated with extensive 
NK cell proliferation. We conclude that NK cells represent an im-
portant, and underappreciated, component of the adaptive immune 
response; that activation of NK cells may be a critical function of 
IL-2 secreting effector memory T cells; and that protocols for eval-
uation of vaccine-induced immune responses need to include as-
sessment of NK cell activation as well as T cell IL-2 secretion. 
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Materials and Methods 
Vaccination of study participants 
Thirty health~ adult volunteers (median age = 28 y; intraquartile range = 
26-31 y) received three doses (days 0, 7, and 21) of 2.5 IU heat-inactivated 
rabies. virus (Flu~ LEP str~in) (RABIPUR, Novartis vaccines) by i.m. 
injectIOn. All subjects gave fully inform~d, w:itten consent, and the study 
was approved by the London School of Hygiene and Tropical Medicine 
Ethics Committee. 
Blood sampling, PBMC preparation, and cell culture 
PBMC collected immediately before the first and third vaccinations (i.e., 
day?, d~y 21) were cryopreserved in liq.uid nitrogen so that pre- and post-
vacclOatlOn samp!es could be analyzed slde-by-side at the end of the study. 
PBMCs (2 ~ 10 ce~ls/ml) were cultured in 96-well U-bottom plates for 
up to 7 d (with or without 25 ng/ml PMA plus 1 f.1g/ml ionomycin [both 
Sigma-Aldrich: St. Louis, M~] [P~], rhIL-12, rhIL-18, or rhIL-2 [0.1 f.1g/ 
mil or 200 arbitrary umts/mllOactlvated rabies virus 071162 [5th Interna-
tional Standard; National Institute for Biological Standards and Control 
Potters Bar, U.K.]). Neutralizing anti-IL-2 (MQl-17H12; BD Biosciences: 
San Jose, CA), or anti-IL-12 and anti-IL-18 (R&D Systems, Minneapolis, 
MN) were each used at final concentrations of 10 f.1g/ml. Recombinant 
rabies virus nucleocapsid protein (rNCP) (M. Juozapaitis, Institute of Bio-
technology, .vilnius, Lithuania) was used at a final concentration of 10 fJ-g/ 
ml. Brefeldm A (3 fJ-g/ml) and monensin (1.33 f.1g/ml) were added to all 
cultures for the last 5 h of the culture. 
CD3+ cells were positively selected using FlowComp human CD3 
Dynabeads and a Dynal Magnetic Particle Concentrator-2 (both Invitro-
gen, Carlsbad, CA), according to the manufacturer's instructions and pu-
rity confirmed with anti-human CD3 Ab (clone UCHT-l; BD Biosciences). 
Purity of both CD3+ and CD3 - cell populations was >97%. T cell subsets 
were depleted on LD separation columns (Miltenyi Biotec, Auburn, CA) 
using mAbs to CD4 (BD Biosciences) or CD8 (Caltag Laboratories, Bur-
lingame, CA) or anti-CD45RO-coated microbeads (Miltenyi Biotec). 
PBMCs labeled with 10 f.1M CFSE (Invitrogen) were cultured at 37'C 
with 5% CO2 for up to 7 d with or without rabies virus 071162 and ana-
lyzed by flow cytometry. 
Cell surface and intracellular staining for flow cytometry 
Surface and intracellular staining was performed as previously described 
previously (II). Abs used were as follows: CD56 PE (N901), CD56 APC 
(N901) (both Beckman Coulter, Fullerton, CA), CD56 PE-Cy7 (B 159), 
CD4SRO PE-Cy7 (UCHLl), CD3-PerCP (SK7), CD4 APC-Cy7 (RPA-
T4), CD4 PE (RPA-T4),CD8 PE (SKI), LAMP-l biotin (H4A3), Perforin 
PE (809), IL-2 APC (MQl-17H12), streptavidin-PerCP (all BD Bioscien-
ces), anti-CD69 PE (CH/4), and CD3 PE-Texas Red (S4.1) (both Caltag/ 
Invitrogen), CD8 Pacific Blue (LT8; eBiosciences, San Diego, CA) and 
IFN--y FITC (D9DlO; Ab Serotec). 
Data analysis 
Data analyses were performed using prismS (GraphPad, San Diego, CA) 
or StatalO (StataCorp, College Station, TX). To estimate the proportion 
of the precursor lymphocyte population proliferating through each di-
vision, the number of CFSE-diluted cells in each division was divided 
by inumhc)" of divisions + 0.5) (12). 
Results 
T cells and NK cells upregulate CD69 and produce IFN-y in 
response to rabies Ag, after rabies vaccination 
PBMCs isolated from vaccinees immediately before their first and 
third vaccinations (day 0 and day 21) were cultured for 21 h without 
stimulation (growth medium [GM]), with PII (positive control) or 
with inactivated rabies virus (071162) as the specific recall Ag. Cell 
surface expression of CD69 and intracellular expression of IFN--y 
were analyzed in CD3+ CD4+ and CD3+ CD8+ T cells and in CD56+ 
CDr NK cells (Fig. IA). A representative example of IFN--y and 
CD69 expression before (left panels) or after (right panels) two 
doses of rabies vaccine is shown in Fig. IB, and data from five 
individual vaccinees are shown in Fig. I C and ID. In the pre-
vaccination samples, P/I induced upregulation of both IFN--y and 
CD69 in CD4+ and CD8+ T cells and in NK cells but none of 
these cells responded to rabies virus 071162. By contrast, in the 
2809 
p?stvac~ina.tion (day 21) samples, rabies virus 071162 induces 
hIghly sIgmficant upregulation of IFN--y and CD69 in CD4+ d 
CD8+ T cells and i.n NK cells. Moreover, among ;-.,rK cells the IF~~-Y 
respo~ses are as hIgh as those induced by the polyc\onal stimulator 
PII (WIth at least 30% of all NK cells staining positively for IFN--y) 
and the mean fluorescence intensity (MF!) for IFN t" . 
. 'fi --y 5 atmng IS 
slgm cantly highe~ among NK cells than among T cells (Fig. IB, 
1D). Both CD56bnght and CD56dim NK cells produce IF;-.,r--y in 
response to rabies virus 071162 (data not shown) and although 
a higher percentage of CD56bright NK cells than CD56dim cells 
make IFN--y (",50 versus ",20%), because CD56bright cells make 
up only a small proportion of the NK cell population, the majority 
(>75%) of the IFN--y+ NK cells are in fact CD56dim . 
Postvaccination, NK cells make both early and sustained 
IFN-y responses to vaccine Ags 
Having found that vaccination primes NK cells to make a robust 
and immediate IFN--y recall response to vaccine Ag, we sought to 
determine how quickly this NK response develops and for how 
long it is sustained, by sampling cultured PBMCs at intervals over 
a 7-d period (Fig. 2). Restimulation of postvaccination PBMCs 
with rabies virus 071162 leads to an initial, modest peak: in IFN--y 
production from both CD4+ and CD8+ T cells at 18-24 h, but there 
is a second much more robust response that begins on day 5 and 
which is still increasing on day 7 (Fig. 2A). By contrast, a very 
robust NK cell recall response is clearly underway within 12 hand 
peaks at 18 h; however, there was also a second wave of NK cell 
IFN--y production, coinciding with the secondary wave of the 
T cell response, such that ",30% of NK cells were still making 
IFN--y 7 d into the recall response. This biphasic NK cell and T cell 
response may reflect an initial responding population giving rise 
to a second generation of responsive cells or providing essential 
stimuli for further cell activation. In either case, it is apparent that 
NK cells are not only the earliest contributors of IFN--y to the post-
vaccination recall response but also contribute to this response for 
a protracted period. 
Although the proportion of NK cells producing IFN--y in the 
restimulated postvaccination samples was much higher than the 
proportion of T cells producing IFN--y, circulating T cells out-
number NK cells by '" 1 0: 1. We therefore calculated the contribution 
of NK cells to the total pool of IFN--y-producing cells (Fig. 2B). 
Twelve and 18 h after in vitro restimulation with rabies virus 07/ 
162, >70% of all IFN--y + cells were NK cells. Although this dropped 
to ",40% by 24 h, NK cells continued to represent 30-50% of all 
IFN--y + cells until at least 7 dafter restimulation. Thus, not only are 
NK cells readily activated postvaccination, but they contribute very 
significantly to the total effector cell pool during the first 7 d of the 
recall response. When taken together with the very high MFI for 
IFN--y staining among NK cells (Fig. 1) these data suggest that the 
overwhelming majority of the early IFN--y emanates from NK cells. 
NK cells degranulate and release perforin in response to rabies 
Ag after rabies vaccination 
One of the hallmarks of NK cells is their ability to rapidly detect 
and kill (within minutes) infected, transformed, or nonself cells by 
releasing preformed cytolytic molecules, such as perforin and 
granzymes, stored in secretory granules. Although CD8+ T cells 
kill in a similar manner, their stores of cytolytic granules are very 
limited and CD8+ T cells thus need time, after reactivation. to 
synthesize cytolytic granules and become fully cytotoxic (13). To 
determine whether NK cytotoxic responses are enhanced post-
vaccination and whether NK cells might thus represent the first 
wave of actively cytotoxic cells during the recall response. we 
cultured pre- and postvaccination PBMCs with P/l or rabies virus 
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FIGURE 1. After rabies vaccination, T cell s and NK cells upregulate CD69 and produce rFN--y in response to rabies vin.1 . PBMCs were isolated before 
(pre) and after (post) two doses of rabies vaccine, cultured in vitro for 21 h in GM alone (GM) or with PMA and lonomycin (PIT) or heat-inactivated rabies 
virus (071162) and analyzed by flow cytometry for surface expression of CD69 and intracellular IFN--y, A, Lymphocytes (identified by characteri ti c 
fo rward light scatter and side light scatler) were identified as NK cells (C D56+ CDr), CD4+ CD3+ T cells , or CD8+CD3+ T cell s, B, Representati ve flow 
cytometry plots for PBMCs obtained before or after rabies vaccination from one donor, showing IFN--y and CD69 express ion in CD4+ T cells, CD8+ T cell , 
and NK cell s after restim ulation in vitro with rabies virtls 071162 , C, Percentages of IFN--y+ cell s (left plots) and MFI of CD69 expression (right plots ) 
among CD4+ T cells, CD8+ T cells, and NK cells isolated from five subjects, before (open circles) and after (fill ed circles) vaccination, and restimulated 
in vitro. D, MFr of IFN--y+ CD4+ T cell s, CD8+ T cells, and NK cells among postvaccination PBMCs from fi ve subj ects cultured with (071162; fi lled circles) 
or without (GM; open circles) inactivated rabies virus) . The p values are derived from two-tailed paired Wilcoxon test. 
071162 and measured surface expression of CDI07aJLAMP-I (as 
an indicator of degranulation) and intracellular levels of perforin . 
Representative flow cytometry plots for CDI07aJLAMP- l and 
perforin staining of CD8+ T cells and NK cells from pre- and 
postvaccination PBMCs are shown in Fig. 3; data from five in-
dividual vaccinees are shown in Fig . 4A . As expected, resting 
(GM) NK cells do not express surface CD 107aJLAMP-I but rest-
ing CD56dim (but not CD56bright) NK cel ls do contain preformed 
perforin ; 12 h polycJonal (P/I) stimulation results in increased 
surface expression of LAMP-I and complete loss of intracellular 
perforin, consistent with NK cell degranulation. In contrast, rest-
ing CD8+ T cells do not contain perforin but do synthesize per-
forin and upregulate LAMP-I in response to PII stimulation. 
Importantly, stimulation with rabies virus 07/162 also causes 
marked degranulation (upregulation of LAMP- I and loss of per-
forin) of CD56dim NK cells in the postvaccination but not in the 
prevaccination samples. Degranulation in 0711 62-restimulated post-
vaccination CD8+ T cells is less marked, but there is clear induction 
of perforin synthesis. 
To detemilne whether NK cells or CD8+ T cells were the major 
contributors to the early cytotoxic response we analyzed the de-
granulation response of the two cell popu lations over rime (up to 
72 h) (Fig. 4B) and calculated the absolute number of degranu-
lating cells that were either NK cells or CD8+ T cells at each time 
point (Fig. 4C) . There was rapid (within 6 h) and u tained (at 
least 72 h) upregulation of surface LAMP-I expre ion in rabie 
virus restimulated, postvacci nation, NK cells and CD8+ T cell . In 
NK cells, LAMP- I upregulation was evident by 6 h, peaked (at 
>25% of all NK cells) at 12 h and then gradually declined, 
whereas in CD8+ T cells, LAMP-I expre ion wa ma imal by 
6 h (at ~4% of all CD8+ T cell) and wa u tained at thi Ie el 
for the duration of the experiment. The kinetic f the perforin 
response in postvaccination NK cell mirrored the L MP-I re-
sponse, with the proportion of perforin+ cell falling ignifi ntl)' 
within 6 h and reaching its lowe t point at 12 h, indi ating perforlll 
release by degranulation in po t accination K cell within h 
of re-exposure to the vaccine g. However, perforin to k up t 
12 h to accumulate in re timulated po tvaccination D + T ell 
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FIGURE 2. Postvaccination, NK cells 
make both early and sustai ned IFN--y re-
sponses to vaccine Ags . PBMCs from five 
su bjects were isolated before (pre) and af-
ter (post) two doses of rabies vaccine, an-
alyzed immediately (ex vivo) or cultured 
in vitro for up to 7 d in GM alone (GM) or 
with heat-inactivated rabies virus (071162) 
and analyzed by flow cytometry for intra-
cellular IFN--y. A, The percentage of 
IFN-·t C04+ T cells , C08+ T cells, and 
NK cells detected in PBMC cultures at 
each time point. The vertical dashed line 
separates data from a short-term restim-
ulation (up to 18 h) and a long-term 
restimu lation experiment. B, The abso-
lute number of IFN-'l lymphocytes was 
calculated at each time point and stratified 
according to whether these were NK cells 
or CD4+, C08+, or C04- C08 - T cells. 
Numbers above each column indicate the 
proportion of all the IFN--y + cells that are 
NK cells (mean ± SE). 
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suggesting that the 6 h burst of T cell degranulation may not lead 
to an optimal cytotoxic response. 
The degranu lation response was Ag-specific because LAMP-I 
expression remained at baseli ne levels in all unstimulated cells 
and in rabies virus restimulated prevaccination NK and CD8+ 
T cells. Perforin level s remained at baseline in unstimul ated and 
prevaccination CD8+ T cells . There was a gradual loss of perfo rin 
over time in prevacc ination NK cells and in un timulated post-
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FIGURE 4. Postvaccination, NK cell s degranulate and release perforin 
in response to rabies virus. PBMCs were isolated from five subjects 
before (pre) and after (post) two doses of rabies vaccine, analyzed im-
mediately (ex vivo) or cultured in vitro for up to 72 h in GM alone (GM) or 
with PMA and ionomycin (P/I) or heat-inactivated rabies virus (071162) 
and analyzed by flow cytometry for surface expression of LAMP-I and 
intracellular perforin. A, Percentages of LAMP-I + (Ie/I pia IS) and perforin+ 
(righl plals) NK cells (upper plals) and CD8+ T cell s (lawer plOfS) isolated 
before (open circles) and after (filled circles) vaccination, and restimulated 
in vitro for 12 h. Data represent mean ± SE. The p values are derived from 
two-tailed paired Wilcoxon test. 8, The percentages of LAMP-I + (Ie/I 
plals) and perforin+ (righl plals) NK cells (upper plals) and CD8+ 
T cells (lawer plals) detected in PBMC cultures at each time point. C, 
Pie charts showing the proportion of all LAMP-I (top raw) expressing 
lymphocytes and all perforin (bollom raw) expressing lymphocytes that 
are either NK cell s (light gray) or CD8+ T cells (black) among postvacci-
nated PBMCs stimulated in vitro for up to 72 h with rabies virus 07/162. 
The size of the circles is proportional to the absolute numbers of LAMP-I + 
or perforin+ cells per 106 PBMC. Data represent mean values from five 
subjects . 
vacci nation NK cells, presumably reflecting nonspecific leakage 
of perforin . 
The relative contributions of NK cells and CD8+ T cells to 
the pool of cytotoxic effectors are shown in Fig. 4C. NK cells 
CD4+ T CELL-DEPENDENT NK CELL EFFECTOR FU CTIO 
represent the majority of both LAMP-I + and perforin + ell 6 h 
after Ag .s~mulation. The marked decrea e at 12 h in the proportion 
of perfonn cells that are NK cells, together wi th the increa ed pro-
pO.rtion of the LAMP-I + cells that are NK cell ,provide fu rther 
eVIdence of a wave of NK cell degranulation between 6 and 12 h. 
In co~tr+ast, although CD8+ T cells represent the majori ty of al l 
perfonn cells from 12 h onward, they do not repre ent the majori ty 
of degranulating, LAMP-I+ cells, until 48- 72 h into the recall 
response. 
Ag-specific IL-2 production from CD45RO+ CD4+ T cells is 
required for NK cell recall responses 
Our previous data (7) and that of others (9) indicating a role for 
IL-2 and CD4+ T cells in NK cell activation , led us to speculate 
that IL-2 from Ag-specific T cells drives the recall re pon e of 
NK cells after vaccination . We therefore analyzed the kinetic of 
IL-2 and IFN-'Y production by CD4+ T cells among pre- and po t-
vaccination PBMCs restimulated in vitro with rabie viru 071162 
for up to 24 h. Representative flow cytometry plot for one vac-
cinated subject are shown in Fig. SA and postvaccination data 
from four subjects are summarized in Fig. S8. 
Prevaccination, CD4+ T cells produce neither IL-2 nor IFN-'Y 
in response to rabies virus 011162. Postvaccination, a clear popula-
tion of IL-2+ CD4+ T cells can be distinguished , peaking as early 
as 6 h after re-exposure to rabies virus and declining to negligible 
values within 24 h. Very few of the IL-2+ cells produced IFN-'Y 
(Fig. SA) suggesting that at this early stage they are ThO rather 
than Th I effector cell s. In line with our hypothesis, the peak of 
T cell IL-2 production (6 h) preceded the on et of NK cell IFN-'Y 
production (12 h; Fig. 2A). 
To determine whether this CD4+ T cell IL-2 response contrib-
uted to the postvaccination NK cell response, postvaccination 
PBMCs from five subjects were cultured overnight with rabies 
virus 07/162 in the presence or absence of rhIL-2 or a neutralizing 
Ab to IL-2 and analyzed for intracellular IFN-'Y, intracellular 
perforin or cell surface expression of LAMP-I (Fig. SC; statis-
tical analysis is shown in Supplemental Table I). In parallel ex-
periments, PBMCs were depleted of all CD3+ T cells, just CD4+ 
T cells, just CD8+ T cells or just CD4SRO+CD3+ T cells. In the 
intact PBMC cultures, as before, there were potent NK cell IFN-'Y 
and degranulation (decreased intracellular perforin and increased 
surface expression of LAMP-I) responses to the recall Ag. Anti-
IL-2 Ab completely ablated both the IFN-'Y response and degranu-
lation. Moreover, NK cells among PBMCs depleted of CD3+, 
CD4+ or CD4SRO+CD3+ T cells did not mount any significant 
IFN-~ or degranulation responses ; depletion of CD8+ T cell , in 
contrast, had no significant detrimental effect on the NK cell reca ll 
response. In support of our hypothesi s, however, NK cell among 
CD4+ T cell-depleted and CD4SRO+ T cell-depleted PBMC were 
able to make robust IFN-'Y and degranul ation respon e when 
cultures were supplemented with rhIL-2. 
Extensive NK cell proliferation during posrvaccinaliol1 recall 
response 
To determine whether IL-2 produced by T ce ll duri ng the po tvac-
cination recall response induced K ce ll proliferation. \ hi h might 
potentiate the NK cell effector re pon e and/or repleni h the 
NK cell pool after activation-induced cel l death of the fir t \\ ave 
of the effector re pon e, we labeled pre- and po tvac ination PB 1 
from four donor with CFSE, cultured them for 7 d without tim-
ulation (GM) or with rabi e viru 07/162, and then anal zed F E 
express ion separately in CD4+ T cell , CD + T cel l and K ell 
(Fig. 6A ) and in both CD4SRO+ and CD4S RO- p pu lation of 
T cell (Fi g. 68 ). Cell cultured ith ut g did n t pr Itferate 
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FIGURE 5. Ag-specific IL-2 production from CD45RO+ CD4+ T cells is required for NK cell recalJ responses. Pre- and postvacc inat ion PBMCs from 
four subjects were cultured for periods of up to 24 h without stimulation (GM) or with rabies virus (071162) and analyzed by flow cytomeLry fo r intracellular 
IL-2 and IFN--y. A, Representative flow cytometry plots showing IL-2 and IFN--y expression in pre- (upper plots) and post- (lowe r plots) vaccinati on CD4+ 
T cells from one donor in response to 071162 stimulation over 24 h. B, Percentages of CD4+ T cells expressing intracellular rL-2 in response to 071162 
restimulation over time; postvaccination samples from four subjects . C, Postvaccination PBMCs from four subjects were cultured for 12 h (perforin and 
LAMP- l ex pression) or 24 h (IFN--y expression) with rabies virus 071162 in th e presence or absence of rhIL-2 or a neu tralizi ng Ab to IL-2 and analyzed for 
intracellular IFN--y (left panel), intracellular perfori n (middle panel), or cell surface expression of LAMP- l (right pallel). Parallel ex periment were carried 
out using PBMCs that had been depleted of all CD3+ T cell s, just CD4+ T cells, j ust CD8+ T cell s, or just CD45RO+CD3+ T cells. Data represent mean :t 
SE. Statistical ana lysis is presented in Supplementary Table I. 
(data not shown) . Extensive proliferation was observed in post-
vaccination T cells and NK cells after 7 d restimulation with the 
recall Ag, rabies virus 07/162, The CFSE dilution patterns (Fig. 
6A) suggested that a higher proportion of NK cells than T cells 
were proliferating and that NK cells were going through more 
rounds of proliferation than the T cells. Indeed, we were unable 
to see any undivided NK cells and we could discern at least seven 
distinct CFSE peaks among the NK cells, whereas a substantial 
proportion of T cells remained undivided and only approximately 
four peaks of divided cells cou ld be seen; thi s was confirmed by 
detailed analys is of samples from four vaccinees (Figs. 6C, 6D). 
The average number of divi sions undergone by NK cells (mean/ 
SE: 2.55/0.01) was significantly higher than for CD8+ T ce lls 
(meanlSE: 1.1 2/0.1 8; p < 0.001 ), CD4+ T cells (meanlSE: 0.96/ 
0.07 ; p < 0.001 ); p = 0.31) or CD45 RO+CD4+ T cells (1.20/0.37; 
p = 0.005). Analysis of the proportion of the initial cell popul ation 
that had gone through one or more division (12) confirmed that, 
after 7 d, all NK cells had divided at least once but only ",30% of 
all CD45RO+ CD4+ T cells and < 1 0% of CD8+ T cell or 
CD45RO- CD4 T cells had done so (Fig. 6D) ; howe er, the time 
to first cell division did not differ between NK cell and the CD4+ 
and CD8+ T cells (data not shown). 
IL-1 2 and IL-1 8 synergize with IL-2 to activate K ce lls after 
vaccination 
To determine whether IL-2 alone i ufficient for K ell t ho\\ 
a "recall " respon e to rabi es vi ru after vaccination or whether 
other ignal (e.g., from myeloid a ce ory ell ) are al 0 required 
for optimal NK ce ll re pon e \ e om pared the re all re p n e 
with tructurally intact but heat-killed rnbie lru 0711 _) wllh 
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FIGURE 6. Extensive NK cell pro liferati on during postvacci nati on recall response. Pre- and postvaccination PB MCs from four donors were labeled with 
CFSE, cultured for 7 d with rabies virus (0711 62) and analyzed by fl ow cytometry. A, Representative flow cytometry plots of CFSE di luti on (lefl plOls) in 
postvacci nati on CD4+ T cells (upper pIOIS), CD8+ T cells (middle plols) , and NK cell s (lower p/OIS) after 7 d incubation with 071162 . Hi togram overl ay 
(right plots) compare CFSE diluti on in pos tvaccination cell s either ex vivo (dark fi ll ) or after 7 d restimulati on with 071162 (light fi ll ). S, Representati ve 
How cytometry plots of CFSE dilution and CD45RO expression (left plots) after 7 d restimulation with rabies virus (071162) in postvaccination CD4+ (upper 
plots) and CD8+ (lowe r plots) T cell s. Histogram overlays (righl plots) compare CFSE dilu tion in CD45RO+ (dark fi ll ) or CD45RO- (no fill) CD4+ or CD8+ 
T cells. C, The percentage of CD4+ T cells, CD8+ T cell s, or NK cells in the postvaccination, 7 d-restimulated PB MC popu lat ion that had not divided, or 
had divided one or more times. Data represent mean + SE for fo ur donors. D, Estimated proportions of the precursor popu lations of NK cell s and CD45RO+ 
or CD45RO - T cells th at did not divide, or that divided one or more times during the 7 d restimulation assay. Data represent means for fo ur donors . 
that to purified rNCP and we investigated the effect on the NK cell 
recall response of adding or neutralizing IL-12 and IL-1 8 in the 
presence or absence of rIL-2 (Fig. 7). Suboptimal concentrations 
of rhIL-12, IL-1 8, and IL-2 that do not, alone or in combination, 
induce NK cell acti vation were determined by titration ; for each 
cytokine a concentration of 0.0 I ng/ml was selected. 
FIGURE 7. IL-1 2 and IL-1 8 synergize with IL-2 
10 acti va te NK cell s after vaccination . Pre- and post-
vaccination PBMCs fro m five donors were res timu-
lated in vitro with inac ti vated whole rabies virus (071 
162) or with purified rNCP, in the presence or ab-
sence of recombinant human IL-2 or IL-12 plus IL-
lS, or in the presence or absence of neutrali zing Abs 
to IL-2 or IL-1 2 plus IL-18, for 24 h and analyzed by 
How cytometry for CD69 and IFN-I' expression. A, 
Representative fl ow cytometry plots showing IFN-I' 
production and CD69 expression in postvaccinati on 
NK cells cultured with or without rNCP in the 
presence or absence of rhIL-2, rhIL-1 2, and rhlL-
IS. S, Percentage of NK cells produci ng IFN-I'+ 
after restimulation with rNCP in the presence or 
absence of recombinant cytokines. Data represent 
mean ± SE of five subjects . The p values are 
derived fro m two-ta iled pa ired Student t test. C, Per-
centage of NK cells producing IFN-I'+ after restimu-
lalion with rabies virus 071162 in the presence or 
absence of neutralizing Abs to rL-2, IL-12 , and IL-
lS. Sand C, Dala represe nt mean ± SE. 
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NK cells among postvaccination PBMCs incubated with rNCP 
alone did not produce IFN-'Y or upregulate CD69 (I = 2.1, df = 4, 
P = 0.6), but when cultured with rNCP plus 0.0 I ng/ml rhIL-12 
rhIL-18, a~d rhIL-2 they responded strongly (t = 8.94, df = 4, p ~ 
0.0009) (FIg. 7A ,. 7B). No NK cell response was seen in prevacci-
natIOn PBM~s. wIth any of the combinations of stimuli tested (Fig. 
7B). Neutrahzmg Abs to IL-12 and IL-18 completely ablated the 
rabies virus 071162-induced NK cell IFN-'Y response in post-
v.accination PBMCs (t = 8.5, df ~ 4, p = 0.001) (Fig. 7C), in a very 
SImIlar manner to IL-2 neutralIzation. We conclude that signals 
from two accessory cell populations (myeloid cells and T cells) 
are required for the recall response of NK cells and that inacti-
vated virus but not rNCP (which presumably lacks the TLR-
activating ligands present in whole virus) is able to induce a recall 
response in NK cells. 
Pre vaccination NK cells respond to rabies virus 071162 when 
cultured with primed (postvaccination) T cells 
Recent reports suggest that exposure to haptenated proteins, MCMV, 
or cytokines can enhance the subsequent response of murine 
NK cells to reactivation by the same stimuli, raising the possibility 
that NK cells can acquire a "memory" phenotype (14-16). To 
determine whether the enhanced antiviral response of postvacci-
nation NK cells results from such an "adaptive" response to prior 
Ag exposure, we compared the 071162-induced IFN-'Y, CD69, and 
LAMP-l responses of pre- and postvaccination PBMCs with the 
responses of prevaccination, CD3 T cell-depleted PBMCs to 
which purified postvaccination T cells had been added; as a con-
trol , C03-depleted postvaccination PBMCs were mixed with 
purified prevaccination T cells (Fig. 8) . We observed that prevac-
ciration NK cells responded vigorously to inactivated rabies virus 
07/ 162 when cultured together with postvaccination T cells and 
the magnitude of the NK response was proportional to the number 
of T cells added to the culture. Conversely CD3-depleted post-
vaccination NK cells cultured with naive T cells were fully re-
sponsive to high-dose IL-12/18 but were unable to respond to 
rabies virus. These data suggest that there are no intrinsic differ-
ences between prevaccination and postvaccination NK cells and 
that postvaccination NK cells are simply responding to the high 
levels of cytokines emanating from rabies virus-specific CD4+ 
T cells and myeloid accessory cells. 
Discussion 
The purpose of vaccination is to expand and differentiate small 
populations of naive, Ag-specific T and B lymphocytes into larger 
populations of memory cell s with enhanced effector functi on, to 
accelerate the clearance of pathogenic microorganisms. Evaluation 
of vaccine-induced immune responses typically includes measure-
ment of Ab titers and some assay of cell-mediated immunity, such 
as lymphocyte proliferation, cytokine secretion, or cytotoxicity. Al-
though bulk assays (in which the responding cell type is not known) 
can now be supplemented by single-cell assays (such as flow cytom-
etry, which allows both the number and phenotype of responding 
cells to be assessed), these assays are typically designed-and their 
outputs interpreted-on the assumption that differences in cell-
mediated effector responses postvaccination, and especially after 
recall Ag stimul ation of cells in vitro, are due solely to the actions 
of Ag-specific effector cells. Two recent examples, from otherwise 
groundbreaking studi es, serve to illustrate the pervasiveness of these 
assumption . In a study using functional genomics, polychromatic 
Row cy tometry and systems bi ology to evaluate the global response 
to yellow feve r vaccination, onl y the effector functions of C04+ 
T cells were characteri zed at the single-cell level and I FN-'Y 
secreted by PBMC cultures was assumed to be derived from 
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FIGURE 8_ Prevaccinali on NK cell s respond to rabies virus 07/ 162 
when cultured with postvaccinat ion T ce lls. PBMCs, collec ted either be-
fore (white bars) or after (bl ack bars) vaccination, were cul tured withou t 
stimulus (OM) or with rh1L-1 2 and rhfL-18, or with 0711 62, fo r 24 h and 
stained for intracellular fFN--y (A); CD69 (8); and LAMP- I (C). Responses 
of whole PBMCs were compared with those of CD3-depleted pos tvacci-
nation PBMCs to which naive (prevaccinat ion) T ce lls had been added 
(di agonall y cross-hatched bars) and with those of CD3-depleted prevacci-
nation PBMCs to whi ch varying numbers of memory (postvaccination) 
T cells had been added (hori zontall y cross-hatched bars); po tvaccination 
T cells were added to prevaccination PB MCs at rati os of I T cel l per 
PBMC, or I T cell per 2, 5, or 10 PBMCs. 
Th I cells, despite evidence that NK cells-a well-documented 
source of IFN-'Y-were proliferating in the firs t 7 d after vacci-
nation (17). A similar analysis of yellow fever vaccine-induced 
responses examined correlates only of C08+ T cell and Ab re-
sponses (18). 
In thi s study, we compare, for the first time, pre- and po tvacci-
nation NK cell effector responses (IFN-'Y production and exocyto i 
of cytotoxic granules), demonstrate that these re pon e are aug-
mented in an Ag-specific manner by vaccination and demon trate 
that NK cells contribute signi fican tly to the po tvaccination re-
sponse, especially, but not exclusively, during the fir t hour and 
days after re-exposure to the vaccine Ag. Moreover, and again for 
the first time, we have elucidated the activation ignal required for 
thi s postvaccination NK cell "recall" re pon e. Our finding indi-
cate that IL-2-mediated NK activation hould be con Idered a an 
additional-and potenti ally very important-indi ator of va - ine 
efficacy. 
In many way, our finding are not urpri ing. It ha been kn \\ n 
for several year that K cell can repre ent a ignifi ant pr p rtl n 
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of IFN-'l cells in the initial stages of a classical recall response 
(19), that IL-2 can augment NK cell responses (20, 21), that the 
NK cell response to influenza virus depends on IL-2 and T cells 
(9), and that increased numbers of IFN--y-producing NK cells can 
be detected after influenza vaccination (10) . However, the logical 
conclusion of these observations-that Ag-specific IL-2 secretion 
from memory T cells may recruit NK cells as effectors of adaptive 
immunity and, thus, that NK cell responses can be potentiated by 
vaccination-has not previously been made explicit and has not 
been formally tested. Indeed, our collective fixation on NK cells 
as cells that can mediate effector function without prior sensitiza-
tion (22, 23) has blinded us to the notion that they may perform 
their effector functions even more effectively after sensitization. 
By detailed analysis of the response to rabies vaccination, we have 
shown that Ag-specific, CD45RO+ CD4+ T cells secrete IL-2 within 
6 h of re-exposure to Ag and that this IL-2-in combination with 
IL-12 and IL-18 induced by the interaction of whole virus with 
other accessory cells- activates NK cells to produce IFN--y and 
to degranulate, releasing perforin. A proposed schematic for the 
NK recall response is shown in Fig. 9. Importantly, these NK 
effector responses occur extremely rapidly, starting within 6 h 
(i .e., significantly earlier than the equivalent T cell responses), 
and are very robust, with 30-40% of all NK cells responding. 
Consequently, in the first 12-18 h after re-exposure to Ag, >70% 
of all IFN--y- producing cells are NK cells . Importantly, however, 
NK cells also show a marked and prolonged proliferative response 
to the vaccine Ag and they continue to contribute to the effector cell 
population for at least 7 dafter Ag re-exposure; indeed the second-
ary peak in the NK IFN--y response may well represent maturation 
and activation of cells that have divided during the first few days of 
the response. Lastly, the recall NK cell response is extremely 
durable; we have repeated this analysis >4 mo after the last vacci-
nation without any noticeable decline in the response (data not 
shown) . 
A 
CD4+ T CELL-DEPENDENT NK CELL EFFECTOR FUNCTIO 
The indirect route of NK cell acti vation ha largel been 
overl~oked until recentl y but it is now clear that inftanunarory 
cytokines (1L-12, 1L-1 8, and IFN-a ) and costimularory ignal 
from myeloid accessory cells are essen tial for optimal K cell 
responsiveness to a wide range of viral, bacterial, and protozoal 
infections (5). Our finding that intact rabies virus, but no t purified 
recombinant protein, was able to acti vate NK cell after accina-
tion in an 1L-12- and IL-18--dependent man ner, is con i tent with 
a requirement for myeloid accessory cell-derived as well a T cell-
derived signals for inducti on of recall NK respon e . either the 
rabies virus encoded ligands for pattern recognition receptor 
(PRRs) nor the PRRs themsel ves are known. Although TLR3 i 
upregulated in brains of rabies virus-infected mice (24, 25) and 
humans (26), TLR3 preferentially recognizes dsRNA rather than 
ssRNA and is thus not an obvious cand idate for recognition of 
rabies virus . Human TLR8/murine TLR7s are receptor for orne 
ssRNAs (27, 28) and may thus be more likely innate receptor for 
rabies virus . One practical implication of the need fo r myeloid 
acessory cell stimuli for induction of reca ll NK responses i that 
evaluation of vaccine-induced immune responses by restimul ation 
of PBMCs with purified protein Ags or syntheti c peptides may not 
reveal the full extent of the NK recall response that may occur 
after exposure to whole pathogens. It is likely that NK reca ll 
responses will be further enhanced, after vacc inati on, by the pre ence 
of specific Ab; Ag-Ab complexes binding to CD 16 are a powerful 
route for NK cell activation and in preliminary experiments we have 
observed that rabies virus restimul ation of postvaccination PBMC 
in the presence of autologous serum (i.e., contai ning anti-rabies Abs) 
leads to even more florid NK cell responses than the ones shown here. 
Our finding that, in the absence of T cell s, rIL-2 is suffi cient to 
restore NK recall responses indicates that LL-2 is the onl y T cell-
derived signal that is essential for the NK recall response. In sup-
port of thi s scenario, we have shown that although T cell s are 
required for optimal acti vation of NK cell s by malaria- in fec ted 
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RBCs, there is no requirement for NK cell-T cell contact and that 
the T cell-dependent signal can be delivered to the NK cells via 
a semipermeable membrane (29). Our data therefore reveal an 
important new role for vaccine-induced IL-2-secreting memory 
T cells and may, in part, explain the emerging consensus that 
polyfunctionaI T cells, which secrete IL-2 in addition to IFN-'Y or 
TNF-a, are associated with positive outcomes of viral infection 
(30-32) and with particularly effective vaccination regimes (33, 34). 
It was noticeable that whichever parameter we assayed (CD69 
upregulation, IFN-'Y production, degranulation), the NK cell response 
to rabies vaccination among the vaccinees was remarkably homo-
geneous. Overall, for different parts of the study, we assayed re-
sponses from 30 individuals and in every case there was a robust 
and persistent NK cell recall response. T~is is in marked contrast to 
our previous findings for NK cell responses to malaria-infected 
RBCs, Mycobacterium bovis bacillus CaImette-Guerin and bacte-
rial LPS where NK IFN-'Y responses are extremely heterogeneous, 
but similar (in homogeneity, if not magnitude) to responses we 
observed to high-dose rhIL-l2"1:L-18 (35). We have proposed that 
heterogeneity in NK cell IFN-'Y responses to pathogens reflects 
both differences in the strength of accessory stimuli and variable 
expression of polymorphic NK cell receptors (which fine-tune the 
degree of activation) (35). The results of this vaccination study sug-
gest that if the accessory cell stimulus is sufficiently strong (which 
may require synergism of signals from myeloid cells and T cells) 
then the effect of NK cell regulatory receptors may be overcome. If 
so, genetic diversity in NK cell regulatory receptors may not repre-
sent a major hurdle to effective vaccination. 
Although there are superficial similarities between the "recall" 
NK response that we have described and the "memory-like" 
NK cells recently described in mice (14-16), there are important 
differences between the cytokine-driven response described in this 
study and some of the mouse studies. In mice infected with murine 
CMY (MCMV), NK cells proliferate, persist at higher than normal 
frequencies for several months and show enhanced cytokine and 
degranulation responses on reactivation (16); however, NK cell 
activation in this model is driven by binding of the activating 
NK Ly49H receptor to the m157 viral protein expressed on 
MCMV-infected cells (36) and may thus occur independently of 
accessory cell stimuli. Indeed, expansion of the Ly49H+ NK ~ell 
subset in MCMV+ mice is reminiscent of the expanded populatton 
of NKG2C+ NK cells in individuals seropositive for human CMV 
(37). Similarly, the original description of murine memory-like 
NK cells, in a contact hypersensitivity model, specificall~ involved 
Ly49C+/Ly491+ cells, which might conceivably be actIvated by 
haptenated MHC class I molecules and, at least inasmuch as 
T cells were not required, would appear to be IL-2 indep.end~nt 
(15). Importantly, the "memory" component of the postvaccmatt~n 
NK response to rabies virus described in this study appears. to he 
entirely within the T cell population: NK cells from unv~ccmat.ed 
individuals were fully able to respond to the virus when ffilxed ~Ith 
autologous memory T cells. It is not known whether nonspeCIfic 
inflammatory stimuli can maintain human NK cells in a prolonged 
hyper-reactive state, as recently described for murine NK cells. ac-
tivated in vitro with a mixture of accessory cell-derived cytokines 
(14), but this might be interesting to explore in the context of 
vaccine adjuvants. . 
Our study raises interesting questions regarding .the fu~ctI~nal 
significance of enhanced NK cell responses after I.mmumz.atlOn. 
For infections where a protective role for NK cells IS estabhshed, 
evaluation of NK responses postvaccination is likely to be.a us~ful 
indicator of vaccine efficacy but for other infections the ImplIca-
tions are less clear and further studies are required. In t~e .case of 
rabies virus vaccination, it is widely accepted that neutrahzmg Abs 
2817 
are essential for protection (38) but experimental infections in mice 
suggest that cell-mediated immune responses (including signaling 
through the IFN-'YR) are required for efficient viral clearance (39) 
and that proinflammatory cytokines (IFN-'Y and IL-2) enhance vac-
cine immunogenicity, leading to significantly higher neutralizing 
Ab titers (40). The potential for NK cell IFN-'Y responses to con-
tribute to the efficacy of rabies vaccines thus deserves to be evalu-
ated. The role of the degranulation response is less obvious. In these 
particular experiments, using killed virus, it is unlikely that NK 
cells are degranulating in response to infected cells and degranula-
tion may simply be a marker of NK cell activation. 
In summary, we have demonstrated that NK cells are major 
contributors to the effector lymphocyte population during the recall 
response to rabies vaccination. This should lead us to reconsider the 
precise roles of Ag-specific memory T cells in vaccine-induced im-
munity. Assays of CD4+ T cell IL-2 production, NK cell IFN-'Y 
production and NK cytotoxicity need to be included in the arsenal 
of tools for evaluating correlates of vaccine-induced immunity. 
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